data_2agm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2agm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.467 ' H ' HG13 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 121.314 0.397 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 CA-C-O 120.778 0.099 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.409 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.448 ' CG ' HD12 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 136' ' ' ASP . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 134' ' ' THR . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.54 ' HA ' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.54 HD21 ' HA ' ' A' ' 137' ' ' LEU . 32.5 t30 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . 0.517 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.487 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.469 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.437 ' CG ' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.48 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 127' ' ' VAL . 0.2 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 69' ' ' ASN . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.404 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.457 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.484 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.517 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 N-CA-C 112.77 -0.132 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.492 ' H ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.413 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 140' ' ' ALA . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 138' ' ' SER . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.492 ' CG1' ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' ILE . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.609 ' CG ' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.415 ' C ' ' HE ' ' A' ' 62' ' ' ARG . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.415 ' HE ' ' C ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 106.735 -2.546 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.471 ' CG ' ' HG ' ' A' ' 85' ' ' SER . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.471 ' HG ' ' CG ' ' A' ' 83' ' ' ASP . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.491 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.483 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.459 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.21 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.497 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 CA-C-O 122.844 1.247 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB2' ' HD1' ' A' ' 133' ' ' HIS . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . 0.411 ' HD1' ' HB2' ' A' ' 77' ' ' ALA 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.457 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 85' ' ' SER . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 83' ' ' ASP . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 121' ' ' GLU . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.428 ' HG3' ' CG1' ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.428 ' CG1' ' HG3' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' H ' ' A' ' 12' ' ' THR . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.423 ' H ' ' H ' ' A' ' 11' ' ' ASP . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -87.47 95.65 10.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.11 172.46 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.51 14.99 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.506 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.467 ' H ' HG13 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.97 -28.08 61.93 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 49.4 51.68 15.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.309 1.444 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 50.21 30.7 4.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.913 2.485 . . . . 0.0 115.093 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.5 t -65.32 176.77 1.27 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 111.559 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.44 179.53 53.11 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.21 0.895 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.1 p -70.83 -178.93 2.03 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.998 1.719 . . . . 0.0 109.192 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 152' ' ' GLU . 10.0 t -143.84 48.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.558 -1.339 . . . . 0.0 109.193 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.21 34.48 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.685 -1.259 . . . . 0.0 108.534 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 150' ' ' THR . 47.9 mm-40 -87.94 151.54 22.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.671 1.988 . . . . 0.0 111.258 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 mp -144.51 70.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -125.7 54.58 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.204 1.002 . . . . 0.0 110.326 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -136.93 152.87 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.771 1.228 . . . . 0.0 108.255 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -117.15 92.37 3.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.352 1.461 . . . . 0.0 109.529 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 115.66 -57.61 0.48 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 124.451 1.024 . . . . 0.0 111.993 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -102.32 -167.92 1.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.667 1.187 . . . . 0.0 108.058 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 m -139.27 164.86 28.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.234 1.814 . . . . 0.0 107.441 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 150.81 158.17 8.16 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.823 0.68 . . . . 0.0 113.625 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 m -79.14 22.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.176 2.19 . . . . 0.0 112.19 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -147.0 107.48 4.08 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 120.233 -1.542 . . . . 0.0 109.691 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.49 137.27 58.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.13 166.21 32.55 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.915 1.721 . . . . 0.0 109.336 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -158.67 165.61 34.0 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.396 1.079 . . . . 0.0 108.587 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.1 mt -122.32 123.01 67.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -152.96 -81.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.04 143.69 49.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.17 -157.05 10.15 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 123.858 0.724 . . . . 0.0 112.964 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.454 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -24.32 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 64.12 56.69 1.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -147.55 176.27 10.19 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 126.616 1.966 . . . . 0.0 111.396 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.1 p -129.39 2.74 5.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.849 2.06 . . . . 0.0 110.041 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.49 -150.04 9.69 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 125.979 1.752 . . . . 0.0 112.377 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 p -114.86 -174.81 2.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.154 2.182 . . . . 0.0 110.632 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.5 p -132.26 167.75 19.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.794 1.638 . . . . 0.0 107.48 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.5 t -82.98 -178.61 7.18 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.973 0.909 . . . . 0.0 109.225 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -92.24 -157.0 0.49 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.682 2.393 . . . . 0.0 107.865 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.25 40.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.26 2.224 . . . . 0.0 111.078 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 25.83 72.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 129.548 3.139 . . . . 0.0 112.525 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.86 166.36 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.72 3.55 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.256 1.822 . . . . 0.0 115.161 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.1 30.22 67.87 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -67.37 171.73 5.66 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.323 1.449 . . . . 0.0 111.605 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 m -111.52 154.4 24.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.289 1.836 . . . . 0.0 107.357 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 158.87 -68.85 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 p -112.75 125.9 54.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 47.88 60.92 3.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.346 1.058 . . . . 0.0 109.513 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.97 55.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.01 -177.35 14.83 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 122.819 1.233 . . . . 0.0 113.452 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.76 172.13 18.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.686 1.994 . . . . 0.0 107.267 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.82 144.62 37.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.252 1.189 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.17 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -61.95 133.67 55.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -149.62 161.88 41.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.2 2.2 . . . . 0.0 107.803 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 -171.02 23.74 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.976 1.75 . . . . 0.0 113.294 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.409 ' H ' HD22 ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.448 ' CG ' HD12 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 136' ' ' ASP . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.46 ' H ' ' C ' ' A' ' 134' ' ' THR . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.54 ' HA ' HD21 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.54 HD21 ' HA ' ' A' ' 137' ' ' LEU . 32.5 t30 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.27 -29.42 58.09 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.38 53.21 12.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.842 1.257 . . . . 0.0 109.036 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.14 31.34 6.51 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.782 2.033 . . . . 0.0 114.161 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.2 t -77.38 151.03 35.04 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.87 -81.88 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -146.06 112.01 5.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.684 1.594 . . . . 0.0 106.886 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.24 5.53 0.74 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.725 0.81 . . . . 0.0 113.083 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 p -117.24 139.56 50.64 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.688 -1.258 . . . . 0.0 107.973 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -160.2 171.88 18.42 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.262 0.625 . . . . 0.0 111.178 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.81 83.76 5.3 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.99 148.99 33.37 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.4 153.37 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.051 -1.031 . . . . 0.0 109.136 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.1 tp -68.21 108.31 3.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -157.84 -96.57 0.12 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -132.34 -26.7 1.84 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 112.828 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.0 m -167.81 163.34 14.08 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.06 1.344 . . . . 0.0 111.622 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.62 -150.98 7.84 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.22 2.343 . . . . 0.0 107.413 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.8 m -75.6 -43.58 47.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.09 -1.241 . . . . 0.0 107.752 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -72.4 -68.18 0.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.837 -0.601 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.1 -166.27 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.717 1.607 . . . . 0.0 109.042 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.5 159.09 20.87 Favored Glycine 0 CA--C 1.535 1.321 1 C-N-CA 132.187 4.708 . . . . 0.0 105.394 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -174.42 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.659 1.729 . . . . 0.0 113.202 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.6 mp -125.22 59.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.031 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -175.892 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.602 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -76.79 170.06 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -63.01 -31.09 72.15 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.7 162.84 24.64 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.623 1.106 . . . . 0.0 111.328 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.517 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.517 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.13 -40.8 14.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.71 121.16 0.69 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.5 84.26 0.06 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.237 1.415 . . . . 0.0 112.428 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 26.4 p -64.76 176.68 1.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.827 1.651 . . . . 0.0 111.057 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.63 -176.19 28.82 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -135.14 164.5 27.52 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.613 1.165 . . . . 0.0 108.376 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.22 90.04 2.56 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.853 2.061 . . . . 0.0 108.638 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -160.36 157.3 27.65 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.846 1.658 . . . . 0.0 106.8 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.68 143.74 55.81 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.91 -2.75 24.23 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 156' ' ' LEU . 0.0 OUTLIER -155.24 153.38 30.56 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.625 0.77 . . . . 0.0 109.3 179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.39 26.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.51 2.324 . . . . 0.0 113.314 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.459 ' H ' ' C ' ' A' ' 154' ' ' GLU . 13.9 tp -54.35 151.44 7.51 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.63 1.972 . . . . 0.0 109.009 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -61.41 41.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 120.275 2.87 . . . . 0.0 120.275 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -150.05 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.778 2.289 . . . . 0.0 109.575 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.8 m -67.66 172.86 4.73 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.74 2.416 . . . . 0.0 113.021 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.77 -160.68 7.88 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.9 p -64.78 84.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.699 1.199 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -150.82 81.99 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.223 1.409 . . . . 0.0 110.11 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.51 145.33 47.58 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.07 80.22 0.82 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.248 1.404 . . . . 0.0 111.778 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.29 167.92 23.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.938 2.495 . . . . 0.0 107.433 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.3 tt -140.04 -179.24 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.586 1.085 . . . . 0.0 111.176 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.19 -169.85 2.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 108.323 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -100.15 -50.25 4.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.435 1.894 . . . . 0.0 109.541 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.58 150.85 20.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.487 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.444 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -41.42 38.03 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.64 107.54 0.07 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.468 1.907 . . . . 0.0 107.023 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.66 94.58 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.595 1.558 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.261 40.7 p 56.49 14.87 1.81 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.58 159.52 42.55 Favored Glycine 0 C--N 1.338 0.654 0 O-C-N 121.128 -0.982 . . . . 0.0 112.43 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.1 p -136.15 -178.47 5.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.671 1.189 . . . . 0.0 110.403 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 p -74.78 91.31 2.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.782 2.833 . . . . 0.0 109.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 p -115.61 166.2 12.18 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.315 1.446 . . . . 0.0 112.912 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -100.48 143.45 30.64 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.066 1.346 . . . . 0.0 109.168 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.14 73.25 10.1 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.253 8.3 pt-20 41.88 40.97 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.913 2.085 . . . . 0.0 114.091 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -72.98 146.6 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -87.79 99.92 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -179.36 -165.49 33.63 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.67 -88.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.1 m -145.56 179.61 7.3 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.133 1.373 . . . . 0.0 109.351 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.15 100.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 124.171 0.891 . . . . 0.0 112.748 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -66.09 119.69 11.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -156.06 -166.86 2.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.273 1.429 . . . . 0.0 108.336 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.05 158.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.16 0.584 . . . . 0.0 110.931 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 151.86 52.08 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.79 -179.77 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.758 1.623 . . . . 0.0 113.08 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.26 166.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.602 1.961 . . . . 0.0 108.55 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.245 0.82 0 C-N-CA 127.238 2.215 . . . . 0.0 105.302 179.371 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -89.46 121.6 31.85 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.812 1.245 . . . . 0.0 110.237 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.92 161.39 37.95 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.522 2.729 . . . . 0.0 107.014 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.94 -171.13 55.05 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.469 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.437 ' CG ' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.48 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -53.88 53.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.36 92.77 0.12 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.297 2.239 . . . . 0.0 105.18 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -166.69 80.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.576 1.55 . . . . 0.0 108.995 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 t -79.08 -3.35 44.9 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.422 -1.275 . . . . 0.0 114.001 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.58 -36.5 0.13 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 121.771 2.078 . . . . 0.0 116.434 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -67.94 96.45 0.6 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.094 1.447 . . . . 0.0 109.071 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.538 ' H ' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -66.7 155.29 38.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.819 -0.55 . . . . 0.0 109.653 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -116.47 4.22 13.29 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -165.68 -159.72 0.42 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.686 3.994 . . . . 0.0 105.899 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 56.59 28.7 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.445 2.298 . . . . 0.0 110.254 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.94 99.69 8.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.22 153.51 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.63 1.172 . . . . 0.0 110.231 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.33 87.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.434 1.494 . . . . 0.0 110.822 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.6 -31.38 1.38 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-O 119.217 -0.769 . . . . 0.0 113.091 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.98 172.27 13.75 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.966 0.883 . . . . 0.0 110.554 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.9 m -57.49 146.61 29.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.8 0.84 . . . . 0.0 110.099 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.56 155.32 23.25 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.503 -0.748 . . . . 0.0 112.228 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.538 HG22 ' H ' ' A' ' 150' ' ' THR . 4.4 p -78.77 172.74 13.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 117.731 0.765 . . . . 0.0 112.401 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 61.46 52.99 3.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.96 2.104 . . . . 0.0 110.605 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.47 100.62 13.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.08 -177.76 52.04 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.715 1.175 . . . . 0.0 112.757 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -128.0 171.11 12.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.083 1.753 . . . . 0.0 110.543 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.2 tt -142.66 -16.87 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.007 1.323 . . . . 0.0 111.516 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.245 0.85 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -153.17 163.07 40.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.513 1.157 . . . . 0.0 108.467 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 35.07 59.6 0.72 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.197 2.599 . . . . 0.0 113.598 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.73 171.16 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.454 HD21 ' HA ' ' A' ' 127' ' ' VAL . 0.2 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 69' ' ' ASN . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -54.53 22.32 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.2 114.15 0.31 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.993 2.917 . . . . 0.0 104.579 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.24 91.38 0.11 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.04 0.936 . . . . 0.0 110.336 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.7 p -129.21 -170.91 2.37 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.076 1.351 . . . . 0.0 110.489 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.8 53.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.7 t -149.41 178.63 8.62 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.878 -0.778 . . . . 0.0 110.014 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.2 p -66.76 167.27 11.59 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 112.132 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -163.99 152.29 13.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 127.252 2.221 . . . . 0.0 106.457 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.95 113.74 7.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.4 tp -134.95 10.97 3.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.354 1.462 . . . . 0.0 110.623 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.36 172.17 8.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.258 1.423 . . . . 0.0 110.495 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.44 141.7 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -57.57 130.51 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.577 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.0 -51.8 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -158.24 175.44 13.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.392 3.077 . . . . 0.0 105.146 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.2 t -148.01 140.03 24.08 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 120.758 1.617 . . . . 0.0 108.776 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -25.14 56.12 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.58 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -118.87 11.26 12.55 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.705 1.202 . . . . 0.0 112.403 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -154.7 96.26 1.86 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 119.11 0.868 . . . . 0.0 110.345 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.59 121.58 10.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.582 0.753 . . . . 0.0 111.178 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.21 -174.82 27.59 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.564 1.554 . . . . 0.0 111.876 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -157.33 160.47 38.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.886 1.675 . . . . 0.0 107.884 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.87 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.066 1.746 . . . . 0.0 108.535 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.99 2.516 . . . . 0.0 105.037 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -89.42 123.37 33.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.52 -16.91 27.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.43 -146.82 20.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.301 1.429 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.457 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.517 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.517 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.455 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.09 -51.29 13.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.59 118.47 0.36 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 130.576 3.55 . . . . 0.0 107.727 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 3.21 107.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 131.479 3.912 . . . . 0.0 115.637 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.1 t -121.83 -156.53 0.69 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.721 2.008 . . . . 0.0 108.887 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.16 78.88 0.06 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.616 1.103 . . . . 0.0 110.707 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 m -132.84 114.77 14.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.176 0.99 . . . . 0.0 108.966 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.5 p -66.61 23.04 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.219 3.408 . . . . 0.0 114.833 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.1 m 67.48 -19.07 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.151 2.181 . . . . 0.0 115.074 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -122.99 179.56 4.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.92 -11.8 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.101 1.76 . . . . 0.0 111.08 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.32 154.21 19.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.416 1.487 . . . . 0.0 107.045 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 p -95.74 5.44 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 124.719 2.199 . . . . 0.0 114.203 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.1 tt -81.37 84.6 6.61 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 129.004 2.922 . . . . 0.0 105.775 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -152.85 119.19 0.94 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.95 148.64 50.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.415 1.886 . . . . 0.0 107.743 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t 45.02 45.96 9.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.209 2.204 . . . . 0.0 112.63 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.51 -168.46 14.95 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.98 1.276 . . . . 0.0 110.092 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 -78.36 0.14 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.04 142.79 52.68 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.75 156.72 39.16 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.48 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.03 -172.19 14.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 123.955 0.788 . . . . 0.0 111.686 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.87 172.48 17.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.566 1.147 . . . . 0.0 109.064 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.0 tt -147.84 -174.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.944 1.298 . . . . 0.0 109.393 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 C--O 1.248 1.013 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -152.25 152.69 32.5 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.143 0.971 . . . . 0.0 108.446 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.48 173.33 10.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.23 163.0 28.74 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 121.76 -0.588 . . . . 0.0 112.77 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.413 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.492 ' H ' ' CG1' ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.413 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.449 ' C ' ' H ' ' A' ' 140' ' ' ALA . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 138' ' ' SER . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.492 ' CG1' ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.56 -28.74 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.39 63.26 1.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.283 1.833 . . . . 0.0 108.838 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -53.34 124.23 14.11 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.418 1.487 . . . . 0.0 109.079 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.1 p -84.67 -166.11 1.37 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.11 1.764 . . . . 0.0 109.43 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.05 -105.4 3.02 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 103.648 -3.781 . . . . 0.0 103.648 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.5 p -142.13 94.44 2.66 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -147.01 46.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.593 0.757 . . . . 0.0 109.714 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.9 t -111.72 135.72 51.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.507 -0.746 . . . . 0.0 109.879 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.3 161.77 21.34 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.034 1.334 . . . . 0.0 108.194 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 tp -153.82 -0.14 0.22 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.062 0.945 . . . . 0.0 112.313 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -126.85 -178.74 4.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.914 2.086 . . . . 0.0 108.972 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.85 26.06 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 123.492 1.615 . . . . 0.0 111.633 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.7 164.29 10.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.815 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.46 -31.18 14.02 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.513 -0.742 . . . . 0.0 112.172 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.8 153.91 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 128.021 2.529 . . . . 0.0 110.236 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -133.91 100.01 4.62 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.919 0.887 . . . . 0.0 109.258 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.67 -21.35 69.22 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.943 1.259 . . . . 0.0 115.433 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 p -80.7 174.76 11.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.44 2.12 . . . . 0.0 110.705 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.28 168.73 13.62 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.35 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 37.99 57.58 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.475 2.71 . . . . 0.0 116.864 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.89 -25.94 30.65 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.06 4.97 5.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.424 2.29 . . . . 0.0 112.786 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.58 179.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.142 0.977 . . . . 0.0 108.594 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.246 0.896 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.647 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -138.19 46.13 2.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.009 1.724 . . . . 0.0 107.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.04 9.84 13.61 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.35 1.46 . . . . 0.0 111.476 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.19 169.85 36.85 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.377 1.465 . . . . 0.0 110.051 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 33' ' ' ILE . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' H ' ' CG ' ' A' ' 32' ' ' ASP . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -51.16 9.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.61 116.46 0.06 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.47 1.508 . . . . 0.0 108.754 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.9 179.85 0.82 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 125.467 1.507 . . . . 0.0 107.437 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.273 5.8 t 53.46 7.65 0.1 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.412 2.285 . . . . 0.0 115.603 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.02 -176.18 30.56 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 119.924 -1.735 . . . . 0.0 113.63 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.0 t -114.45 162.65 16.4 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.382 1.473 . . . . 0.0 109.678 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -125.69 50.96 1.78 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.492 1.517 . . . . 0.0 109.62 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.99 172.19 18.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 150.81 17.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.668 1.187 . . . . 0.0 108.084 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.1 -72.43 0.2 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.712 0.805 . . . . 0.0 111.747 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.81 53.83 1.98 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 127.187 2.195 . . . . 0.0 110.453 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.09 168.3 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.52 106.67 3.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.17 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.41 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.4 t0 15.72 72.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.019 2.928 . . . . 0.0 113.637 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.2 m -133.28 -175.4 3.79 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.613 1.565 . . . . 0.0 108.888 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -166.39 -173.16 34.51 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -113.12 -19.03 12.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.0 110.216 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -78.2 122.71 26.02 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -88.12 -173.45 4.24 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.331 1.052 . . . . 0.0 109.512 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.48 135.51 3.12 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.052 1.311 . . . . 0.0 112.994 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.68 14.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.442 1.897 . . . . 0.0 107.767 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 49.0 mt -142.64 126.59 15.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.247 0.928 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.164 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 CA-C-O 118.844 -0.975 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -114.03 143.49 44.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.813 1.245 . . . . 0.0 110.787 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.4 52.38 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.494 1.918 . . . . 0.0 105.855 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.37 170.43 42.96 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 121.721 -0.612 . . . . 0.0 112.351 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.609 ' CG ' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' C ' ' HE ' ' A' ' 62' ' ' ARG . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.415 ' HE ' ' C ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.412 ' CB ' ' HA ' ' A' ' 145' ' ' ALA . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.42 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -48.38 71.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 85' ' ' SER . . . -170.01 115.79 0.53 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.011 2.924 . . . . 0.0 105.02 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.07 95.82 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.548 1.139 . . . . 0.0 111.444 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -155.92 -172.53 4.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.685 1.594 . . . . 0.0 109.073 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.21 68.38 0.3 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.0 p -124.11 137.88 54.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 p -134.09 -177.58 4.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 110.382 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 t -144.22 -161.53 1.3 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.229 3.012 . . . . 0.0 103.435 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 8.83 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 131.379 3.872 . . . . 0.0 113.677 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 31.19 6.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.294 1.838 . . . . 0.0 111.201 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -73.42 152.2 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.06 149.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . 0.349 1.5 pp 50.89 -0.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 130.68 3.592 . . . . 0.0 118.503 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.34 90.75 0.37 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.28 129.89 43.48 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m 57.27 34.59 24.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.092 0.957 . . . . 0.0 110.054 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -40.07 -46.75 3.31 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.621 2.057 . . . . 0.0 115.506 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -65.72 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.03 122.88 16.52 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 119.766 -1.834 . . . . 0.0 111.564 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.96 170.4 4.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.44 139.54 3.68 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.9 -178.32 4.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.147 0.979 . . . . 0.0 110.422 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.8 pt -109.1 -145.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.066 1.746 . . . . 0.0 108.518 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.246 0.884 0 C-N-CA 128.671 2.788 . . . . 0.0 105.976 179.145 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.8 65.85 0.8 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -28.72 68.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.299 1.039 . . . . 0.0 113.635 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.03 45.66 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 128.931 3.157 . . . . 0.0 106.735 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' CG ' ' HG ' ' A' ' 85' ' ' SER . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.471 ' HG ' ' CG ' ' A' ' 83' ' ' ASP . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.491 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.447 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -107.87 -43.05 4.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.39 103.54 0.35 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.812 2.045 . . . . 0.0 107.039 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -159.19 -162.49 1.07 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.749 1.159 . . . . 0.0 112.031 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 t -134.71 161.92 33.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 128.129 2.572 . . . . 0.0 106.138 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 97.95 1.69 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p -143.23 85.44 1.86 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.445 1.098 . . . . 0.0 108.103 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -12.22 60.02 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.558 2.343 . . . . 0.0 115.805 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER 106.21 18.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.518 3.927 . . . . 0.0 109.61 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -25.27 132.61 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.837 3.655 . . . . 0.0 113.314 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.4 8.48 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 44.26 43.09 5.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.057 1.743 . . . . 0.0 113.513 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.67 168.62 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.163 2.185 . . . . 0.0 111.695 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.91 47.4 1.74 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.226 1.41 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -171.9 155.49 23.92 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 120.753 -1.217 . . . . 0.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.74 141.22 58.85 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -172.87 -176.58 1.46 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.08 2.552 . . . . 0.0 107.707 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.97 160.81 28.44 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.308 1.432 . . . . 0.0 110.757 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.5 m -78.66 -15.93 57.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.371 1.068 . . . . 0.0 112.915 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -133.85 -65.02 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 121.043 1.747 . . . . 0.0 114.105 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.83 110.4 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.968 1.707 . . . . 0.0 110.024 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.36 99.39 1.17 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.03 27.42 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.571 1.148 . . . . 0.0 108.823 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.1 mm 109.0 151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 1 C-N-CA 132.93 4.492 . . . . 0.0 105.82 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.254 1.294 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 179.313 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -65.47 172.38 3.33 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 122.664 1.221 . . . . 0.0 111.816 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.2 173.0 10.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.275 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.63 159.17 40.09 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.483 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.459 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -47.82 7.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.3 116.25 0.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.921 2.488 . . . . 0.0 108.593 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -159.34 172.59 17.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.266 2.226 . . . . 0.0 108.993 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.4 p -145.28 1.49 0.95 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.839 1.255 . . . . 0.0 111.821 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 164.13 10.93 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.2 m -69.23 143.77 53.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.9 p -60.3 139.95 57.34 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.341 1.057 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 t -69.0 165.41 20.21 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.764 0.792 . . . . 0.0 109.824 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.38 164.63 5.4 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 128.373 2.669 . . . . 0.0 115.364 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.96 -0.43 16.74 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.122 2.169 . . . . 0.0 112.59 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.52 82.94 2.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.49 151.61 16.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.39 1.476 . . . . 0.0 107.384 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.55 79.0 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.864 1.266 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.56 159.27 13.82 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.856 1.253 . . . . 0.0 114.617 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.23 -7.8 49.27 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.972 2.509 . . . . 0.0 114.239 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.9 t -62.5 155.57 25.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.628 0.728 . . . . 0.0 111.266 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -142.32 28.63 2.2 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.482 1.992 . . . . 0.0 110.155 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.2 m 68.35 1.06 2.75 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.527 1.531 . . . . 0.0 112.24 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.62 -66.06 0.91 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.604 1.562 . . . . 0.0 108.025 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.59 172.6 14.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.829 2.852 . . . . 0.0 107.328 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.15 157.84 11.59 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -171.05 173.46 5.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.859 1.664 . . . . 0.0 109.326 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.22 146.3 18.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.326 1.05 . . . . 0.0 108.71 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.245 0.855 0 C-N-CA 125.098 1.359 . . . . 0.0 111.142 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 CA-C-O 119.505 -0.609 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -37.07 134.75 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.12 2.568 . . . . 0.0 113.293 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.12 160.26 28.19 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.89 2.076 . . . . 0.0 107.992 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 142.58 16.19 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.512 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -54.56 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.09 113.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.81 97.04 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 110.473 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 t -178.15 -173.21 0.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.641 2.776 . . . . 0.0 107.289 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.1 100.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -159.22 122.89 3.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -139.82 168.39 19.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.237 1.415 . . . . 0.0 108.562 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -166.77 136.95 3.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -134.83 168.51 18.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.426 1.89 . . . . 0.0 106.763 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.77 3.35 11.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 51.1 36.66 16.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.593 1.557 . . . . 0.0 111.633 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.11 152.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.62 92.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.824 1.249 . . . . 0.0 109.954 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.91 176.49 14.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.267 0.937 . . . . 0.0 111.192 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -82.16 84.17 7.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.12 147.36 31.47 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.72 -129.42 7.67 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.139 -3.584 . . . . 0.0 104.139 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.8 p -71.91 -17.51 62.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.226 1.513 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -108.56 152.21 25.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.623 2.369 . . . . 0.0 105.494 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -123.75 163.69 20.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.591 1.156 . . . . 0.0 109.953 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 162.14 179.07 36.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.69 -82.75 0.11 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.115 1.366 . . . . 0.0 107.98 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.281 2.0 mp 66.14 87.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 127.146 2.178 . . . . 0.0 109.061 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.244 0.789 0 C-N-CA 128.721 2.808 . . . . 0.0 105.622 179.309 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.639 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 p -92.0 165.48 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.709 0.803 . . . . 0.0 111.347 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -125.21 17.35 8.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 110.423 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.82 169.63 34.86 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 128.745 3.069 . . . . 0.0 107.445 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.497 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.83 -54.42 7.32 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 179.83 87.82 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.708 2.003 . . . . 0.0 108.859 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.58 168.45 24.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.247 2.619 . . . . 0.0 108.744 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 t -92.68 -47.65 6.98 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -104.33 166.05 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.13 -149.54 0.41 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.133 0.968 . . . . 0.0 112.454 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -87.57 -177.66 5.93 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.833 3.653 . . . . 0.0 108.776 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 90.5 1.15 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.03 123.58 22.41 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.2 -2.41 46.31 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 171.88 12.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.28 1.032 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 p -146.74 15.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 125.06 2.362 . . . . 0.0 112.948 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.1 tp -97.73 80.71 2.82 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.801 -2.454 . . . . 0.0 108.935 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 166.58 42.5 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.63 144.12 54.6 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 110.05 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.59 -167.37 2.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.477 1.035 . . . . 0.0 111.601 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -168.04 65.89 0.19 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.4 p 60.28 -19.52 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.398 3.479 . . . . 0.0 115.401 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.71 169.05 8.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.265 1.826 . . . . 0.0 112.897 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.54 167.23 10.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.19 -169.79 31.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.36 37.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.985 0.914 . . . . 0.0 109.481 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.17 -8.13 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.748 0.819 . . . . 0.0 110.118 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.076 2.15 . . . . 0.0 105.958 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -125.49 -72.66 0.65 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.287 1.044 . . . . 0.0 109.905 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.75 157.35 30.47 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 118.396 0.543 . . . . 0.0 111.056 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.99 -175.36 0.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.041 1.782 . . . . 0.0 114.623 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.411 ' HB2' ' HD1' ' A' ' 133' ' ' HIS . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . 0.411 ' HD1' ' HB2' ' A' ' 77' ' ' ALA 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -53.36 -31.98 47.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 60.27 75.07 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.682 2.393 . . . . 0.0 109.772 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.54 108.82 0.25 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 t -148.26 131.32 16.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.05 -105.26 0.82 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.475 1.512 . . . . 0.0 109.901 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.4 m -147.92 171.77 15.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.489 2.316 . . . . 0.0 107.017 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 t -61.56 157.37 17.47 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.195 -0.941 . . . . 0.0 108.49 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.9 t -151.39 103.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.641 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -61.26 119.2 7.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.47 76.49 10.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -58.61 129.96 44.56 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 p -141.48 173.74 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.422 1.089 . . . . 0.0 110.791 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.81 140.26 42.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.68 -88.77 1.59 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.75 161.56 26.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.704 1.601 . . . . 0.0 109.526 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.9 t 125.73 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.316 4.646 . . . . 0.0 110.195 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 170.96 -96.12 0.11 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.808 2.146 . . . . 0.0 108.067 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -138.6 4.4 2.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.247 1.024 . . . . 0.0 112.769 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -133.76 62.06 1.66 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.586 1.154 . . . . 0.0 110.396 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -42.29 112.95 0.39 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.763 1.625 . . . . 0.0 113.064 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 145.81 -148.03 19.47 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.98 174.63 5.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.115 0.966 . . . . 0.0 110.432 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.79 132.22 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.07 0 C-N-CA 124.599 1.16 . . . . 0.0 109.398 -179.51 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -137.01 96.13 3.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -144.73 117.65 8.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.45 -177.03 22.48 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.457 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.457 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.463 ' C ' ' H ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 58' ' ' GLU . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 85' ' ' SER . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 83' ' ' ASP . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -48.57 8.87 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.35 114.83 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.865 2.066 . . . . 0.0 106.066 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.35 111.58 1.01 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.1 p -146.14 174.27 11.46 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.816 1.247 . . . . 0.0 109.703 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.06 6.48 30.76 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.144 0.878 . . . . 0.0 111.941 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.9 m -71.91 167.96 18.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.27 1.428 . . . . 0.0 110.998 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -71.7 151.31 43.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.833 2.053 . . . . 0.0 109.05 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.82 163.79 13.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.222 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 154' ' ' GLU . 68.6 mm-40 -122.7 -171.1 2.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.431 1.492 . . . . 0.0 111.538 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.1 tp 65.35 -10.63 0.19 Allowed 'General case' 0 C--N 1.343 0.308 1 C-N-CA 131.943 4.097 . . . . 0.0 110.932 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 152' ' ' GLU . 1.6 tp10 -85.03 81.4 8.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.21 23.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.344 1.458 . . . . 0.0 112.165 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.31 63.46 1.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 126.493 1.917 . . . . 0.0 109.717 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.32 -179.26 39.89 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.21 169.1 8.68 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.948 2.099 . . . . 0.0 108.87 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.3 p 41.56 40.18 1.3 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.405 1.882 . . . . 0.0 113.84 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.29 -166.87 35.45 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.7 p -67.96 -20.72 65.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.354 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.83 99.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.963 2.105 . . . . 0.0 110.604 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.59 119.96 3.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.635 1.574 . . . . 0.0 106.818 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.53 -94.05 0.49 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -161.47 161.07 29.97 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.266 1.827 . . . . 0.0 106.587 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.291 16.1 pt 51.4 13.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 127.31 2.244 . . . . 0.0 116.925 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.379 14.5 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 114.371 -2.728 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.7 m -157.85 163.72 37.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.172 1.789 . . . . 0.0 107.597 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -123.58 -16.81 6.64 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 111.101 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.86 168.56 24.22 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 121' ' ' GLU . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 119' ' ' ASP . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.427 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.3 -28.08 68.42 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 52.49 77.4 0.16 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.104 2.162 . . . . 0.0 111.195 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -48.32 114.58 0.98 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.583 1.553 . . . . 0.0 108.606 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 t -127.6 -14.33 5.22 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.119 0.968 . . . . 0.0 112.726 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.81 -174.65 46.78 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.73 81.72 1.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.32 127.54 14.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.116 1.366 . . . . 0.0 109.199 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -136.46 72.66 1.43 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -78.96 160.06 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.409 0.684 . . . . 0.0 109.805 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.19 19.9 3.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.062 0.545 . . . . 0.0 112.329 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.52 47.4 21.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.464 1.106 . . . . 0.0 111.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.6 t -74.97 145.21 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.38 92.78 4.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.04 59.15 0.03 OUTLIER Glycine 0 C--O 1.226 -0.371 0 CA-C-O 118.418 -1.212 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.6 t0 35.78 53.93 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.864 2.466 . . . . 0.0 112.336 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.4 t -160.52 -179.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.778 1.631 . . . . 0.0 107.706 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.34 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 125.54 1.543 . . . . 0.0 109.58 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 p -75.77 -0.81 22.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.563 1.945 . . . . 0.0 114.479 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -144.84 153.11 41.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.72 1.145 . . . . 0.0 108.179 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -131.74 160.56 35.17 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.345 1.058 . . . . 0.0 109.673 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.52 -63.52 1.92 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 51.02 18.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.306 1.842 . . . . 0.0 115.453 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.27 149.73 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.626 1.17 . . . . 0.0 109.314 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 179.193 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 68.9 6.93 5.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.349 1.459 . . . . 0.0 111.193 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.43 -18.83 58.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.37 1.868 . . . . 0.0 109.475 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.17 37.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.073 2.273 . . . . 0.0 110.461 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.428 ' HG3' ' CG1' ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.428 ' CG1' ' HG3' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.08 65.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 55.6 65.52 1.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.735 2.014 . . . . 0.0 112.301 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 52.45 37.67 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.626 1.97 . . . . 0.0 116.172 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.0 t -155.8 -173.95 4.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.798 1.639 . . . . 0.0 107.341 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.8 71.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 119.536 1.062 . . . . 0.0 113.139 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 156.71 48.26 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.287 71.1 p 39.79 33.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.302 3.041 . . . . 0.0 113.039 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -69.35 2.25 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.539 2.736 . . . . 0.0 113.941 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -53.06 109.13 0.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.959 1.704 . . . . 0.0 109.396 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.43 -9.88 4.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.53 64.66 0.99 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.165 2.986 . . . . 0.0 116.51 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.0 t -109.16 16.42 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.76 1.743 . . . . 0.0 114.803 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.5 mt -99.99 169.47 9.17 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.926 1.29 . . . . 0.0 110.469 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.13 60.7 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.52 114.85 7.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.689 1.995 . . . . 0.0 108.081 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -160.51 -171.38 3.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.437 1.495 . . . . 0.0 110.537 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.37 166.45 10.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.555 1.55 . . . . 0.0 111.074 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 p -94.12 149.72 20.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.722 1.209 . . . . 0.0 109.196 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 45.17 32.7 0.98 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.936 2.094 . . . . 0.0 113.141 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.81 33.45 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.49 0.662 . . . . 0.0 110.602 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.26 -173.74 37.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -149.51 170.71 17.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.678 1.991 . . . . 0.0 107.097 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 tp -151.82 171.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.087 1.355 . . . . 0.0 107.616 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.247 0.924 0 C-N-CA 128.259 2.624 . . . . 0.0 104.549 179.223 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -145.74 132.39 19.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.92 65.63 9.3 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 148.17 21.32 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' H ' ' H ' ' A' ' 12' ' ' THR . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.423 ' H ' ' H ' ' A' ' 11' ' ' ASP . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.515 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.528 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.528 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -26.58 64.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.17 79.22 0.23 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.551 2.341 . . . . 0.0 107.989 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.34 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.976 1.71 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -124.75 -35.58 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.987 1.715 . . . . 0.0 108.485 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.36 129.73 1.97 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.67 . . . . 0.0 112.32 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -175.44 175.95 2.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.009 2.524 . . . . 0.0 106.23 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.4 p -73.79 174.24 8.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.253 0.933 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.3 m -65.16 158.05 27.05 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 109.106 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.88 159.66 27.82 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.6 tt -88.17 64.83 7.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.87 -172.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.878 1.271 . . . . 0.0 109.203 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.09 164.08 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.804 1.287 . . . . 0.0 111.82 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -77.36 98.27 5.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.4 -179.09 19.76 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -82.34 51.99 1.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.198 0.999 . . . . 0.0 109.07 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 m -165.78 157.7 14.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.044 2.137 . . . . 0.0 108.759 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.49 12.11 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.111 0.862 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -123.91 13.65 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.899 1.28 . . . . 0.0 111.216 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -137.09 168.49 19.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.343 2.257 . . . . 0.0 107.682 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.4 174.12 14.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.904 1.282 . . . . 0.0 108.173 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.26 176.35 44.58 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.48 171.64 19.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.098 1.759 . . . . 0.0 107.763 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.93 -177.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.486 1.914 . . . . 0.0 106.657 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.246 0.875 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.18 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HB ' ' A' ' 51' ' ' THR . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.434 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' H ' HG12 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 121.314 0.397 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 27' ' ' GLY . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 87' ' ' LEU . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CE2' ' HD2' ' A' ' 123' ' ' ARG . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 55' ' ' SER . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.499 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.44 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 61' ' ' TYR . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 CA-C-O 120.778 0.099 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CG ' HD11 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.582 HD11 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 68' ' ' PHE . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 33' ' ' ILE . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 129' ' ' LEU . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' A' ' 75' ' ' PHE . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.6 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.6 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HA ' HG23 ' A' ' 33' ' ' ILE . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' HA2' ' A' ' 27' ' ' GLY . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' SER . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 15' ' ' GLN . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' SER . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.5 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 129' ' ' LEU . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 142' ' ' VAL . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.436 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 75' ' ' PHE . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 82' ' ' ILE . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.479 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.426 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' HD13 ' A' ' 87' ' ' LEU . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 133' ' ' HIS . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 55' ' ' SER . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.456 HD23 ' HA2' ' A' ' 88' ' ' GLY . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 123' ' ' ARG . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.589 HG22 ' HG3' ' A' ' 123' ' ' ARG . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 69' ' ' ASN . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.533 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 115' ' ' SER . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 100' ' ' LEU . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' HG22 ' A' ' 63' ' ' THR . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 16' ' ' LEU . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.558 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' A' ' 9' ' ' GLY . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.555 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.741 ' HA ' HD13 ' A' ' 87' ' ' LEU 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 69' ' ' ASN . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 67' ' ' VAL . 36.6 t-20 -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD13 ' HA ' ' A' ' 55' ' ' SER . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.561 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 N-CA-C 112.77 -0.132 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 33' ' ' ILE . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' HD13 ' A' ' 87' ' ' LEU . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 133' ' ' HIS . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' H ' HG12 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 55' ' ' SER . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' LEU . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.401 HD22 ' HB ' ' A' ' 111' ' ' THR . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.453 ' CG ' HG23 ' A' ' 33' ' ' ILE . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 16' ' ' LEU . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.453 HG23 ' CG ' ' A' ' 15' ' ' GLN . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 81' ' ' ARG . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 25' ' ' LEU . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.653 ' HG3' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HA ' HD21 ' A' ' 87' ' ' LEU . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HA ' ' HG3' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 102' ' ' LEU . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HB2' ' HE ' ' A' ' 124' ' ' ARG . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 120' ' ' ALA . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 106.735 -2.546 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 34' ' ' LEU . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 16' ' ' LEU . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.573 ' OG ' HD22 ' A' ' 87' ' ' LEU . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.573 HD22 ' OG ' ' A' ' 60' ' ' SER . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 101' ' ' LEU . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 100' ' ' LEU . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 7' ' ' LEU . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 51' ' ' THR . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.598 ' HB ' HG22 ' A' ' 33' ' ' ILE . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 99' ' ' THR . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.409 ' H ' ' H ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 96' ' ' TYR . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 92' ' ' LEU . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.566 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.516 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 124' ' ' ARG . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.21 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.54 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' SER . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 72' ' ' ILE . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 87' ' ' LEU . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 62' ' ' ARG . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 43' ' ' LEU . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 54' ' ' PHE . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' H ' HD13 ' A' ' 101' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 134' ' ' THR . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 33' ' ' ILE . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.461 HG23 ' HG3' ' A' ' 123' ' ' ARG . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 129' ' ' LEU . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.461 ' HG3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 72' ' ' ILE . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 CA-C-O 122.844 1.247 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' SER . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.601 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.557 HD11 HG13 ' A' ' 72' ' ' ILE . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 33' ' ' ILE . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 43' ' ' LEU . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.65 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.539 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 25' ' ' LEU . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 58' ' ' GLU . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 87' ' ' LEU . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.624 ' HA ' ' HB1' ' A' ' 86' ' ' ALA . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 67' ' ' VAL . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 62' ' ' ARG . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 129' ' ' LEU . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 84' ' ' LEU . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 56' ' ' ALA . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 55' ' ' SER . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 94' ' ' ASP . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 72' ' ' ILE . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 12' ' ' THR . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 11' ' ' ASP . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' A' ' 51' ' ' THR . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.509 ' HB ' HG22 ' A' ' 33' ' ' ILE . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 69' ' ' ASN . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.523 ' H ' HG12 ' A' ' 67' ' ' VAL . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 87' ' ' LEU . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' CD1' HD22 ' A' ' 84' ' ' LEU . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 124' ' ' ARG . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 120' ' ' ALA . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 71' ' ' LEU . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 111' ' ' THR . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 138' ' ' SER . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 82' ' ' ILE . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' HG3' HD11 ' A' ' 33' ' ' ILE . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 82' ' ' ILE . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 67' ' ' VAL . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 62' ' ' ARG . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 129' ' ' LEU . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.62 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 82' ' ' ILE . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -87.47 95.65 10.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.11 172.46 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.51 14.99 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HB ' ' A' ' 51' ' ' THR . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.434 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' H ' HG12 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.97 -28.08 61.93 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 49.4 51.68 15.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.309 1.444 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 50.21 30.7 4.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.913 2.485 . . . . 0.0 115.093 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.5 t -65.32 176.77 1.27 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 111.559 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.44 179.53 53.11 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.21 0.895 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.1 p -70.83 -178.93 2.03 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.998 1.719 . . . . 0.0 109.192 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -143.84 48.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.558 -1.339 . . . . 0.0 109.193 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.21 34.48 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.685 -1.259 . . . . 0.0 108.534 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -87.94 151.54 22.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.671 1.988 . . . . 0.0 111.258 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 mp -144.51 70.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -125.7 54.58 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.204 1.002 . . . . 0.0 110.326 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -136.93 152.87 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.771 1.228 . . . . 0.0 108.255 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -117.15 92.37 3.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.352 1.461 . . . . 0.0 109.529 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 115.66 -57.61 0.48 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 124.451 1.024 . . . . 0.0 111.993 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -102.32 -167.92 1.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.667 1.187 . . . . 0.0 108.058 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 m -139.27 164.86 28.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.234 1.814 . . . . 0.0 107.441 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 150.81 158.17 8.16 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.823 0.68 . . . . 0.0 113.625 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 m -79.14 22.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.176 2.19 . . . . 0.0 112.19 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -147.0 107.48 4.08 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 120.233 -1.542 . . . . 0.0 109.691 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.49 137.27 58.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.13 166.21 32.55 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.915 1.721 . . . . 0.0 109.336 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -158.67 165.61 34.0 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.396 1.079 . . . . 0.0 108.587 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.1 mt -122.32 123.01 67.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -152.96 -81.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.04 143.69 49.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.17 -157.05 10.15 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 123.858 0.724 . . . . 0.0 112.964 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 27' ' ' GLY . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 87' ' ' LEU . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CE2' ' HD2' ' A' ' 123' ' ' ARG . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 55' ' ' SER . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.499 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.44 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 61' ' ' TYR . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 145' ' ' ALA . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -24.32 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.486 ' H ' HG12 ' A' ' 143' ' ' VAL . . . 64.12 56.69 1.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -147.55 176.27 10.19 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 126.616 1.966 . . . . 0.0 111.396 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.1 p -129.39 2.74 5.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.849 2.06 . . . . 0.0 110.041 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.49 -150.04 9.69 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 125.979 1.752 . . . . 0.0 112.377 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 p -114.86 -174.81 2.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.154 2.182 . . . . 0.0 110.632 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.5 p -132.26 167.75 19.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.794 1.638 . . . . 0.0 107.48 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.413 HG21 ' CD ' ' A' ' 154' ' ' GLU . 13.5 t -82.98 -178.61 7.18 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.973 0.909 . . . . 0.0 109.225 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -92.24 -157.0 0.49 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.682 2.393 . . . . 0.0 107.865 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.25 40.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.26 2.224 . . . . 0.0 111.078 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' CD ' HG21 ' A' ' 151' ' ' THR . 5.8 mm-40 25.83 72.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 129.548 3.139 . . . . 0.0 112.525 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.86 166.36 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.72 3.55 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.256 1.822 . . . . 0.0 115.161 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.1 30.22 67.87 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -67.37 171.73 5.66 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.323 1.449 . . . . 0.0 111.605 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 m -111.52 154.4 24.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.289 1.836 . . . . 0.0 107.357 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 158.87 -68.85 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 p -112.75 125.9 54.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 47.88 60.92 3.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.346 1.058 . . . . 0.0 109.513 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.97 55.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.01 -177.35 14.83 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 122.819 1.233 . . . . 0.0 113.452 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.76 172.13 18.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.686 1.994 . . . . 0.0 107.267 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.82 144.62 37.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.252 1.189 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.17 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -61.95 133.67 55.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -149.62 161.88 41.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.2 2.2 . . . . 0.0 107.803 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 -171.02 23.74 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.976 1.75 . . . . 0.0 113.294 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CG ' HD11 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.582 HD11 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.27 -29.42 58.09 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.38 53.21 12.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.842 1.257 . . . . 0.0 109.036 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.14 31.34 6.51 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.782 2.033 . . . . 0.0 114.161 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.2 t -77.38 151.03 35.04 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.87 -81.88 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -146.06 112.01 5.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.684 1.594 . . . . 0.0 106.886 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.24 5.53 0.74 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.725 0.81 . . . . 0.0 113.083 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 p -117.24 139.56 50.64 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.688 -1.258 . . . . 0.0 107.973 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -160.2 171.88 18.42 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.262 0.625 . . . . 0.0 111.178 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -91.81 83.76 5.3 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.99 148.99 33.37 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.4 153.37 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.051 -1.031 . . . . 0.0 109.136 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.1 tp -68.21 108.31 3.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -157.84 -96.57 0.12 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -132.34 -26.7 1.84 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 112.828 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.0 m -167.81 163.34 14.08 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.06 1.344 . . . . 0.0 111.622 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.62 -150.98 7.84 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.22 2.343 . . . . 0.0 107.413 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.8 m -75.6 -43.58 47.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.09 -1.241 . . . . 0.0 107.752 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -72.4 -68.18 0.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.837 -0.601 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.1 -166.27 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.717 1.607 . . . . 0.0 109.042 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.5 159.09 20.87 Favored Glycine 0 CA--C 1.535 1.321 1 C-N-CA 132.187 4.708 . . . . 0.0 105.394 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -174.42 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.659 1.729 . . . . 0.0 113.202 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.6 mp -125.22 59.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.031 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -175.892 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.602 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -76.79 170.06 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -63.01 -31.09 72.15 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.7 162.84 24.64 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.623 1.106 . . . . 0.0 111.328 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 68' ' ' PHE . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 33' ' ' ILE . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 129' ' ' LEU . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' A' ' 75' ' ' PHE . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.6 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.6 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.13 -40.8 14.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.71 121.16 0.69 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.5 84.26 0.06 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.237 1.415 . . . . 0.0 112.428 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 26.4 p -64.76 176.68 1.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.827 1.651 . . . . 0.0 111.057 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.63 -176.19 28.82 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -135.14 164.5 27.52 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.613 1.165 . . . . 0.0 108.376 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.22 90.04 2.56 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.853 2.061 . . . . 0.0 108.638 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -160.36 157.3 27.65 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.846 1.658 . . . . 0.0 106.8 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.68 143.74 55.81 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.91 -2.75 24.23 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.24 153.38 30.56 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.625 0.77 . . . . 0.0 109.3 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.39 26.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.51 2.324 . . . . 0.0 113.314 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.35 151.44 7.51 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.63 1.972 . . . . 0.0 109.009 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -61.41 41.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 120.275 2.87 . . . . 0.0 120.275 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -150.05 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.778 2.289 . . . . 0.0 109.575 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.8 m -67.66 172.86 4.73 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.74 2.416 . . . . 0.0 113.021 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.77 -160.68 7.88 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.9 p -64.78 84.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.699 1.199 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -150.82 81.99 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.223 1.409 . . . . 0.0 110.11 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.51 145.33 47.58 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.07 80.22 0.82 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.248 1.404 . . . . 0.0 111.778 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.29 167.92 23.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.938 2.495 . . . . 0.0 107.433 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.3 tt -140.04 -179.24 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.586 1.085 . . . . 0.0 111.176 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.19 -169.85 2.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 108.323 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -100.15 -50.25 4.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.435 1.894 . . . . 0.0 109.541 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.58 150.85 20.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HA ' HG23 ' A' ' 33' ' ' ILE . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' HA2' ' A' ' 27' ' ' GLY . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' SER . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 15' ' ' GLN . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' SER . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.5 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 129' ' ' LEU . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 142' ' ' VAL . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.436 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 75' ' ' PHE . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 82' ' ' ILE . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -41.42 38.03 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.64 107.54 0.07 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.468 1.907 . . . . 0.0 107.023 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.66 94.58 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.595 1.558 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.261 40.7 p 56.49 14.87 1.81 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.58 159.52 42.55 Favored Glycine 0 C--N 1.338 0.654 0 O-C-N 121.128 -0.982 . . . . 0.0 112.43 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.1 p -136.15 -178.47 5.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.671 1.189 . . . . 0.0 110.403 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 p -74.78 91.31 2.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.782 2.833 . . . . 0.0 109.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 p -115.61 166.2 12.18 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.315 1.446 . . . . 0.0 112.912 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -100.48 143.45 30.64 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.066 1.346 . . . . 0.0 109.168 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.14 73.25 10.1 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.253 8.3 pt-20 41.88 40.97 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.913 2.085 . . . . 0.0 114.091 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -72.98 146.6 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -87.79 99.92 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -179.36 -165.49 33.63 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.67 -88.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.1 m -145.56 179.61 7.3 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.133 1.373 . . . . 0.0 109.351 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.15 100.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 124.171 0.891 . . . . 0.0 112.748 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -66.09 119.69 11.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -156.06 -166.86 2.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.273 1.429 . . . . 0.0 108.336 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.05 158.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.16 0.584 . . . . 0.0 110.931 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 151.86 52.08 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.79 -179.77 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.758 1.623 . . . . 0.0 113.08 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.26 166.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.602 1.961 . . . . 0.0 108.55 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.245 0.82 0 C-N-CA 127.238 2.215 . . . . 0.0 105.302 179.371 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -89.46 121.6 31.85 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.812 1.245 . . . . 0.0 110.237 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.92 161.39 37.95 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.522 2.729 . . . . 0.0 107.014 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.94 -171.13 55.05 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.479 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.426 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' HD13 ' A' ' 87' ' ' LEU . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 133' ' ' HIS . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 55' ' ' SER . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.456 HD23 ' HA2' ' A' ' 88' ' ' GLY . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 123' ' ' ARG . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -53.88 53.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.36 92.77 0.12 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.297 2.239 . . . . 0.0 105.18 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -166.69 80.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.576 1.55 . . . . 0.0 108.995 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 t -79.08 -3.35 44.9 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.422 -1.275 . . . . 0.0 114.001 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.58 -36.5 0.13 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 121.771 2.078 . . . . 0.0 116.434 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -67.94 96.45 0.6 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.094 1.447 . . . . 0.0 109.071 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -66.7 155.29 38.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.819 -0.55 . . . . 0.0 109.653 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -116.47 4.22 13.29 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -165.68 -159.72 0.42 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.686 3.994 . . . . 0.0 105.899 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 56.59 28.7 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.445 2.298 . . . . 0.0 110.254 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.94 99.69 8.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.22 153.51 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.63 1.172 . . . . 0.0 110.231 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.33 87.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.434 1.494 . . . . 0.0 110.822 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.6 -31.38 1.38 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-O 119.217 -0.769 . . . . 0.0 113.091 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.98 172.27 13.75 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.966 0.883 . . . . 0.0 110.554 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.9 m -57.49 146.61 29.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.8 0.84 . . . . 0.0 110.099 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.56 155.32 23.25 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.503 -0.748 . . . . 0.0 112.228 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 150' ' ' THR . 4.4 p -78.77 172.74 13.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 117.731 0.765 . . . . 0.0 112.401 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 61.46 52.99 3.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.96 2.104 . . . . 0.0 110.605 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.47 100.62 13.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.08 -177.76 52.04 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.715 1.175 . . . . 0.0 112.757 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -128.0 171.11 12.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.083 1.753 . . . . 0.0 110.543 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.2 tt -142.66 -16.87 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.007 1.323 . . . . 0.0 111.516 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.245 0.85 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -153.17 163.07 40.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.513 1.157 . . . . 0.0 108.467 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 35.07 59.6 0.72 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.197 2.599 . . . . 0.0 113.598 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.73 171.16 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.589 HG22 ' HG3' ' A' ' 123' ' ' ARG . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 69' ' ' ASN . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.533 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 115' ' ' SER . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 100' ' ' LEU . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' HG22 ' A' ' 63' ' ' THR . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -54.53 22.32 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.2 114.15 0.31 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.993 2.917 . . . . 0.0 104.579 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.24 91.38 0.11 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.04 0.936 . . . . 0.0 110.336 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.7 p -129.21 -170.91 2.37 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.076 1.351 . . . . 0.0 110.489 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.8 53.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.7 t -149.41 178.63 8.62 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.878 -0.778 . . . . 0.0 110.014 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.2 p -66.76 167.27 11.59 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 112.132 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -163.99 152.29 13.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 127.252 2.221 . . . . 0.0 106.457 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.95 113.74 7.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.4 tp -134.95 10.97 3.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.354 1.462 . . . . 0.0 110.623 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.36 172.17 8.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.258 1.423 . . . . 0.0 110.495 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.44 141.7 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -57.57 130.51 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.577 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.0 -51.8 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -158.24 175.44 13.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.392 3.077 . . . . 0.0 105.146 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.2 t -148.01 140.03 24.08 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 120.758 1.617 . . . . 0.0 108.776 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -25.14 56.12 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.58 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -118.87 11.26 12.55 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.705 1.202 . . . . 0.0 112.403 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -154.7 96.26 1.86 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 119.11 0.868 . . . . 0.0 110.345 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.59 121.58 10.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.582 0.753 . . . . 0.0 111.178 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.21 -174.82 27.59 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.564 1.554 . . . . 0.0 111.876 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -157.33 160.47 38.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.886 1.675 . . . . 0.0 107.884 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.87 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.066 1.746 . . . . 0.0 108.535 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.99 2.516 . . . . 0.0 105.037 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -89.42 123.37 33.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.52 -16.91 27.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.43 -146.82 20.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.301 1.429 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 16' ' ' LEU . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.558 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' A' ' 9' ' ' GLY . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.555 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.741 ' HA ' HD13 ' A' ' 87' ' ' LEU 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 69' ' ' ASN . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 67' ' ' VAL . 36.6 t-20 -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD13 ' HA ' ' A' ' 55' ' ' SER . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.561 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.09 -51.29 13.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.59 118.47 0.36 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 130.576 3.55 . . . . 0.0 107.727 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 3.21 107.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 131.479 3.912 . . . . 0.0 115.637 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.1 t -121.83 -156.53 0.69 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.721 2.008 . . . . 0.0 108.887 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.16 78.88 0.06 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.616 1.103 . . . . 0.0 110.707 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 m -132.84 114.77 14.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.176 0.99 . . . . 0.0 108.966 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.5 p -66.61 23.04 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.219 3.408 . . . . 0.0 114.833 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.1 m 67.48 -19.07 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.151 2.181 . . . . 0.0 115.074 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -122.99 179.56 4.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.92 -11.8 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.101 1.76 . . . . 0.0 111.08 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.32 154.21 19.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.416 1.487 . . . . 0.0 107.045 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 p -95.74 5.44 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 124.719 2.199 . . . . 0.0 114.203 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.1 tt -81.37 84.6 6.61 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 129.004 2.922 . . . . 0.0 105.775 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -152.85 119.19 0.94 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.95 148.64 50.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.415 1.886 . . . . 0.0 107.743 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t 45.02 45.96 9.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.209 2.204 . . . . 0.0 112.63 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.51 -168.46 14.95 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.98 1.276 . . . . 0.0 110.092 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 -78.36 0.14 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.04 142.79 52.68 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.75 156.72 39.16 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.48 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.03 -172.19 14.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 123.955 0.788 . . . . 0.0 111.686 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.87 172.48 17.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.566 1.147 . . . . 0.0 109.064 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.0 tt -147.84 -174.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.944 1.298 . . . . 0.0 109.393 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 C--O 1.248 1.013 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -152.25 152.69 32.5 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.143 0.971 . . . . 0.0 108.446 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.48 173.33 10.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.23 163.0 28.74 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 121.76 -0.588 . . . . 0.0 112.77 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 33' ' ' ILE . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' HD13 ' A' ' 87' ' ' LEU . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 133' ' ' HIS . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' H ' HG12 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 55' ' ' SER . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' LEU . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.401 HD22 ' HB ' ' A' ' 111' ' ' THR . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.56 -28.74 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.39 63.26 1.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.283 1.833 . . . . 0.0 108.838 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -53.34 124.23 14.11 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.418 1.487 . . . . 0.0 109.079 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.1 p -84.67 -166.11 1.37 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.11 1.764 . . . . 0.0 109.43 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.05 -105.4 3.02 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 103.648 -3.781 . . . . 0.0 103.648 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.5 p -142.13 94.44 2.66 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -147.01 46.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.593 0.757 . . . . 0.0 109.714 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.9 t -111.72 135.72 51.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.507 -0.746 . . . . 0.0 109.879 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.3 161.77 21.34 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.034 1.334 . . . . 0.0 108.194 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 tp -153.82 -0.14 0.22 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.062 0.945 . . . . 0.0 112.313 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -126.85 -178.74 4.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.914 2.086 . . . . 0.0 108.972 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.85 26.06 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 123.492 1.615 . . . . 0.0 111.633 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.7 164.29 10.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.815 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.46 -31.18 14.02 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.513 -0.742 . . . . 0.0 112.172 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.8 153.91 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 128.021 2.529 . . . . 0.0 110.236 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -133.91 100.01 4.62 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.919 0.887 . . . . 0.0 109.258 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.67 -21.35 69.22 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.943 1.259 . . . . 0.0 115.433 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 p -80.7 174.76 11.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.44 2.12 . . . . 0.0 110.705 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.28 168.73 13.62 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.35 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 37.99 57.58 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.475 2.71 . . . . 0.0 116.864 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.89 -25.94 30.65 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.06 4.97 5.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.424 2.29 . . . . 0.0 112.786 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.58 179.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.142 0.977 . . . . 0.0 108.594 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.246 0.896 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.647 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -138.19 46.13 2.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.009 1.724 . . . . 0.0 107.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.04 9.84 13.61 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.35 1.46 . . . . 0.0 111.476 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.19 169.85 36.85 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.377 1.465 . . . . 0.0 110.051 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.453 ' CG ' HG23 ' A' ' 33' ' ' ILE . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 16' ' ' LEU . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.453 HG23 ' CG ' ' A' ' 15' ' ' GLN . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 81' ' ' ARG . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -51.16 9.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.61 116.46 0.06 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.47 1.508 . . . . 0.0 108.754 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.9 179.85 0.82 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 125.467 1.507 . . . . 0.0 107.437 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.273 5.8 t 53.46 7.65 0.1 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.412 2.285 . . . . 0.0 115.603 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.02 -176.18 30.56 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 119.924 -1.735 . . . . 0.0 113.63 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.0 t -114.45 162.65 16.4 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.382 1.473 . . . . 0.0 109.678 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -125.69 50.96 1.78 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.492 1.517 . . . . 0.0 109.62 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.99 172.19 18.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 150.81 17.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.668 1.187 . . . . 0.0 108.084 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.1 -72.43 0.2 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.712 0.805 . . . . 0.0 111.747 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.81 53.83 1.98 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 127.187 2.195 . . . . 0.0 110.453 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.09 168.3 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.52 106.67 3.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.17 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.41 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.4 t0 15.72 72.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.019 2.928 . . . . 0.0 113.637 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.2 m -133.28 -175.4 3.79 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.613 1.565 . . . . 0.0 108.888 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -166.39 -173.16 34.51 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -113.12 -19.03 12.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.0 110.216 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -78.2 122.71 26.02 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -88.12 -173.45 4.24 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.331 1.052 . . . . 0.0 109.512 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.48 135.51 3.12 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.052 1.311 . . . . 0.0 112.994 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.68 14.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.442 1.897 . . . . 0.0 107.767 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 49.0 mt -142.64 126.59 15.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.247 0.928 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.164 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 CA-C-O 118.844 -0.975 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -114.03 143.49 44.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.813 1.245 . . . . 0.0 110.787 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.4 52.38 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.494 1.918 . . . . 0.0 105.855 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.37 170.43 42.96 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 121.721 -0.612 . . . . 0.0 112.351 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 25' ' ' LEU . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.653 ' HG3' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HA ' HD21 ' A' ' 87' ' ' LEU . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HA ' ' HG3' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 145' ' ' ALA . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 102' ' ' LEU . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HB2' ' HE ' ' A' ' 124' ' ' ARG . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 120' ' ' ALA . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -48.38 71.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 85' ' ' SER . . . -170.01 115.79 0.53 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.011 2.924 . . . . 0.0 105.02 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.07 95.82 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.548 1.139 . . . . 0.0 111.444 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -155.92 -172.53 4.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.685 1.594 . . . . 0.0 109.073 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.21 68.38 0.3 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.0 p -124.11 137.88 54.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 p -134.09 -177.58 4.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 110.382 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 t -144.22 -161.53 1.3 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.229 3.012 . . . . 0.0 103.435 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 8.83 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 131.379 3.872 . . . . 0.0 113.677 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 31.19 6.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.294 1.838 . . . . 0.0 111.201 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -73.42 152.2 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.06 149.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . 0.349 1.5 pp 50.89 -0.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 130.68 3.592 . . . . 0.0 118.503 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.34 90.75 0.37 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.28 129.89 43.48 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m 57.27 34.59 24.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.092 0.957 . . . . 0.0 110.054 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -40.07 -46.75 3.31 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.621 2.057 . . . . 0.0 115.506 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -65.72 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.03 122.88 16.52 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 119.766 -1.834 . . . . 0.0 111.564 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.96 170.4 4.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.44 139.54 3.68 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.9 -178.32 4.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.147 0.979 . . . . 0.0 110.422 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.8 pt -109.1 -145.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.066 1.746 . . . . 0.0 108.518 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.246 0.884 0 C-N-CA 128.671 2.788 . . . . 0.0 105.976 179.145 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.8 65.85 0.8 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -28.72 68.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.299 1.039 . . . . 0.0 113.635 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.03 45.66 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 128.931 3.157 . . . . 0.0 106.735 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 34' ' ' LEU . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 16' ' ' LEU . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.573 ' OG ' HD22 ' A' ' 87' ' ' LEU . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.573 HD22 ' OG ' ' A' ' 60' ' ' SER . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 101' ' ' LEU . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 100' ' ' LEU . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -107.87 -43.05 4.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.39 103.54 0.35 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.812 2.045 . . . . 0.0 107.039 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB3' HG11 ' A' ' 143' ' ' VAL . . . -159.19 -162.49 1.07 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.749 1.159 . . . . 0.0 112.031 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 t -134.71 161.92 33.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 128.129 2.572 . . . . 0.0 106.138 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 97.95 1.69 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p -143.23 85.44 1.86 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.445 1.098 . . . . 0.0 108.103 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -12.22 60.02 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.558 2.343 . . . . 0.0 115.805 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER 106.21 18.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.518 3.927 . . . . 0.0 109.61 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -25.27 132.61 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.837 3.655 . . . . 0.0 113.314 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.4 8.48 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 44.26 43.09 5.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.057 1.743 . . . . 0.0 113.513 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.67 168.62 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.163 2.185 . . . . 0.0 111.695 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.91 47.4 1.74 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.226 1.41 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -171.9 155.49 23.92 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 120.753 -1.217 . . . . 0.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.74 141.22 58.85 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -172.87 -176.58 1.46 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.08 2.552 . . . . 0.0 107.707 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.97 160.81 28.44 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.308 1.432 . . . . 0.0 110.757 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.5 m -78.66 -15.93 57.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.371 1.068 . . . . 0.0 112.915 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -133.85 -65.02 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 121.043 1.747 . . . . 0.0 114.105 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.83 110.4 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.968 1.707 . . . . 0.0 110.024 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.36 99.39 1.17 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.03 27.42 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.571 1.148 . . . . 0.0 108.823 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.1 mm 109.0 151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 1 C-N-CA 132.93 4.492 . . . . 0.0 105.82 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.254 1.294 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 179.313 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -65.47 172.38 3.33 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 122.664 1.221 . . . . 0.0 111.816 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.2 173.0 10.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.275 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.63 159.17 40.09 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 7' ' ' LEU . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 51' ' ' THR . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.598 ' HB ' HG22 ' A' ' 33' ' ' ILE . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 99' ' ' THR . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.409 ' H ' ' H ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 96' ' ' TYR . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 92' ' ' LEU . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.566 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.516 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 124' ' ' ARG . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -47.82 7.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.3 116.25 0.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.921 2.488 . . . . 0.0 108.593 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -159.34 172.59 17.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.266 2.226 . . . . 0.0 108.993 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.4 p -145.28 1.49 0.95 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.839 1.255 . . . . 0.0 111.821 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 164.13 10.93 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.2 m -69.23 143.77 53.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.9 p -60.3 139.95 57.34 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.341 1.057 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 t -69.0 165.41 20.21 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.764 0.792 . . . . 0.0 109.824 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.38 164.63 5.4 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 128.373 2.669 . . . . 0.0 115.364 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.96 -0.43 16.74 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.122 2.169 . . . . 0.0 112.59 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.52 82.94 2.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.49 151.61 16.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.39 1.476 . . . . 0.0 107.384 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.55 79.0 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.864 1.266 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.56 159.27 13.82 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.856 1.253 . . . . 0.0 114.617 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.23 -7.8 49.27 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.972 2.509 . . . . 0.0 114.239 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.9 t -62.5 155.57 25.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.628 0.728 . . . . 0.0 111.266 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -142.32 28.63 2.2 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.482 1.992 . . . . 0.0 110.155 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.2 m 68.35 1.06 2.75 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.527 1.531 . . . . 0.0 112.24 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.62 -66.06 0.91 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.604 1.562 . . . . 0.0 108.025 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.59 172.6 14.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.829 2.852 . . . . 0.0 107.328 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.15 157.84 11.59 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -171.05 173.46 5.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.859 1.664 . . . . 0.0 109.326 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.22 146.3 18.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.326 1.05 . . . . 0.0 108.71 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.245 0.855 0 C-N-CA 125.098 1.359 . . . . 0.0 111.142 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 CA-C-O 119.505 -0.609 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -37.07 134.75 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.12 2.568 . . . . 0.0 113.293 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.12 160.26 28.19 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.89 2.076 . . . . 0.0 107.992 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 142.58 16.19 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.54 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' SER . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 72' ' ' ILE . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 87' ' ' LEU . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 62' ' ' ARG . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 43' ' ' LEU . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 54' ' ' PHE . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' H ' HD13 ' A' ' 101' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 134' ' ' THR . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -54.56 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.09 113.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.81 97.04 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 110.473 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 t -178.15 -173.21 0.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.641 2.776 . . . . 0.0 107.289 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.1 100.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -159.22 122.89 3.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -139.82 168.39 19.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.237 1.415 . . . . 0.0 108.562 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -166.77 136.95 3.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -134.83 168.51 18.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.426 1.89 . . . . 0.0 106.763 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.77 3.35 11.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 51.1 36.66 16.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.593 1.557 . . . . 0.0 111.633 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.11 152.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.62 92.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.824 1.249 . . . . 0.0 109.954 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.91 176.49 14.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.267 0.937 . . . . 0.0 111.192 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -82.16 84.17 7.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.12 147.36 31.47 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.72 -129.42 7.67 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.139 -3.584 . . . . 0.0 104.139 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.8 p -71.91 -17.51 62.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.226 1.513 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -108.56 152.21 25.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.623 2.369 . . . . 0.0 105.494 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -123.75 163.69 20.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.591 1.156 . . . . 0.0 109.953 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 162.14 179.07 36.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.69 -82.75 0.11 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.115 1.366 . . . . 0.0 107.98 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.281 2.0 mp 66.14 87.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 127.146 2.178 . . . . 0.0 109.061 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.244 0.789 0 C-N-CA 128.721 2.808 . . . . 0.0 105.622 179.309 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.639 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 p -92.0 165.48 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.709 0.803 . . . . 0.0 111.347 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -125.21 17.35 8.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 110.423 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.82 169.63 34.86 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 128.745 3.069 . . . . 0.0 107.445 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 33' ' ' ILE . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.461 HG23 ' HG3' ' A' ' 123' ' ' ARG . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 129' ' ' LEU . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.461 ' HG3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 72' ' ' ILE . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.83 -54.42 7.32 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 179.83 87.82 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.708 2.003 . . . . 0.0 108.859 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.58 168.45 24.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.247 2.619 . . . . 0.0 108.744 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 t -92.68 -47.65 6.98 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -104.33 166.05 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.13 -149.54 0.41 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.133 0.968 . . . . 0.0 112.454 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -87.57 -177.66 5.93 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.833 3.653 . . . . 0.0 108.776 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 90.5 1.15 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.03 123.58 22.41 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.2 -2.41 46.31 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 171.88 12.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.28 1.032 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 p -146.74 15.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 125.06 2.362 . . . . 0.0 112.948 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.1 tp -97.73 80.71 2.82 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.801 -2.454 . . . . 0.0 108.935 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 166.58 42.5 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.63 144.12 54.6 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 110.05 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.59 -167.37 2.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.477 1.035 . . . . 0.0 111.601 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -168.04 65.89 0.19 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.4 p 60.28 -19.52 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.398 3.479 . . . . 0.0 115.401 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.71 169.05 8.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.265 1.826 . . . . 0.0 112.897 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.54 167.23 10.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.19 -169.79 31.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.36 37.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.985 0.914 . . . . 0.0 109.481 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.17 -8.13 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.748 0.819 . . . . 0.0 110.118 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.076 2.15 . . . . 0.0 105.958 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -125.49 -72.66 0.65 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.287 1.044 . . . . 0.0 109.905 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.75 157.35 30.47 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 118.396 0.543 . . . . 0.0 111.056 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.99 -175.36 0.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.041 1.782 . . . . 0.0 114.623 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' SER . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.601 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.557 HD11 HG13 ' A' ' 72' ' ' ILE . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 33' ' ' ILE . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 43' ' ' LEU . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.65 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 145' ' ' ALA . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -53.36 -31.98 47.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 60.27 75.07 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.682 2.393 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.54 108.82 0.25 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 t -148.26 131.32 16.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.05 -105.26 0.82 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.475 1.512 . . . . 0.0 109.901 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.4 m -147.92 171.77 15.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.489 2.316 . . . . 0.0 107.017 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 t -61.56 157.37 17.47 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.195 -0.941 . . . . 0.0 108.49 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.9 t -151.39 103.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.641 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -61.26 119.2 7.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.47 76.49 10.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -58.61 129.96 44.56 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 p -141.48 173.74 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.422 1.089 . . . . 0.0 110.791 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.81 140.26 42.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.68 -88.77 1.59 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.75 161.56 26.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.704 1.601 . . . . 0.0 109.526 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.9 t 125.73 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.316 4.646 . . . . 0.0 110.195 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 170.96 -96.12 0.11 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.808 2.146 . . . . 0.0 108.067 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -138.6 4.4 2.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.247 1.024 . . . . 0.0 112.769 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -133.76 62.06 1.66 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.586 1.154 . . . . 0.0 110.396 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -42.29 112.95 0.39 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.763 1.625 . . . . 0.0 113.064 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 145.81 -148.03 19.47 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.98 174.63 5.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.115 0.966 . . . . 0.0 110.432 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.79 132.22 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.07 0 C-N-CA 124.599 1.16 . . . . 0.0 109.398 -179.51 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -137.01 96.13 3.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -144.73 117.65 8.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.45 -177.03 22.48 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.539 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 25' ' ' LEU . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 58' ' ' GLU . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 87' ' ' LEU . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.624 ' HA ' ' HB1' ' A' ' 86' ' ' ALA . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 67' ' ' VAL . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 62' ' ' ARG . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 129' ' ' LEU . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 84' ' ' LEU . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 56' ' ' ALA . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 55' ' ' SER . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 94' ' ' ASP . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 72' ' ' ILE . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -48.57 8.87 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.35 114.83 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.865 2.066 . . . . 0.0 106.066 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.35 111.58 1.01 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.1 p -146.14 174.27 11.46 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.816 1.247 . . . . 0.0 109.703 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.06 6.48 30.76 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.144 0.878 . . . . 0.0 111.941 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.9 m -71.91 167.96 18.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.27 1.428 . . . . 0.0 110.998 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -71.7 151.31 43.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.833 2.053 . . . . 0.0 109.05 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.82 163.79 13.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.222 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' GLU . 68.6 mm-40 -122.7 -171.1 2.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.431 1.492 . . . . 0.0 111.538 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.1 tp 65.35 -10.63 0.19 Allowed 'General case' 0 C--N 1.343 0.308 1 C-N-CA 131.943 4.097 . . . . 0.0 110.932 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' GLU . 1.6 tp10 -85.03 81.4 8.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.21 23.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.344 1.458 . . . . 0.0 112.165 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.31 63.46 1.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 126.493 1.917 . . . . 0.0 109.717 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.32 -179.26 39.89 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.21 169.1 8.68 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.948 2.099 . . . . 0.0 108.87 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.3 p 41.56 40.18 1.3 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.405 1.882 . . . . 0.0 113.84 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.29 -166.87 35.45 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.7 p -67.96 -20.72 65.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.354 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.83 99.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.963 2.105 . . . . 0.0 110.604 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.59 119.96 3.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.635 1.574 . . . . 0.0 106.818 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.53 -94.05 0.49 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -161.47 161.07 29.97 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.266 1.827 . . . . 0.0 106.587 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.291 16.1 pt 51.4 13.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 127.31 2.244 . . . . 0.0 116.925 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.379 14.5 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 114.371 -2.728 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.7 m -157.85 163.72 37.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.172 1.789 . . . . 0.0 107.597 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -123.58 -16.81 6.64 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 111.101 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.86 168.56 24.22 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 12' ' ' THR . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 11' ' ' ASP . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' A' ' 51' ' ' THR . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.509 ' HB ' HG22 ' A' ' 33' ' ' ILE . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 69' ' ' ASN . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.523 ' H ' HG12 ' A' ' 67' ' ' VAL . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 87' ' ' LEU . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' CD1' HD22 ' A' ' 84' ' ' LEU . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 124' ' ' ARG . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 120' ' ' ALA . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 71' ' ' LEU . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 111' ' ' THR . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 138' ' ' SER . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.3 -28.08 68.42 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 52.49 77.4 0.16 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.104 2.162 . . . . 0.0 111.195 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -48.32 114.58 0.98 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.583 1.553 . . . . 0.0 108.606 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 t -127.6 -14.33 5.22 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.119 0.968 . . . . 0.0 112.726 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.81 -174.65 46.78 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.73 81.72 1.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.32 127.54 14.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.116 1.366 . . . . 0.0 109.199 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -136.46 72.66 1.43 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 152' ' ' GLU . 1.1 pm0 -78.96 160.06 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.409 0.684 . . . . 0.0 109.805 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.19 19.9 3.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.062 0.545 . . . . 0.0 112.329 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.52 47.4 21.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.464 1.106 . . . . 0.0 111.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.6 t -74.97 145.21 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.38 92.78 4.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.04 59.15 0.03 OUTLIER Glycine 0 C--O 1.226 -0.371 0 CA-C-O 118.418 -1.212 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.6 t0 35.78 53.93 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.864 2.466 . . . . 0.0 112.336 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.4 t -160.52 -179.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.778 1.631 . . . . 0.0 107.706 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.34 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 125.54 1.543 . . . . 0.0 109.58 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 p -75.77 -0.81 22.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.563 1.945 . . . . 0.0 114.479 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -144.84 153.11 41.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.72 1.145 . . . . 0.0 108.179 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -131.74 160.56 35.17 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.345 1.058 . . . . 0.0 109.673 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.52 -63.52 1.92 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 51.02 18.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.306 1.842 . . . . 0.0 115.453 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.27 149.73 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.626 1.17 . . . . 0.0 109.314 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 179.193 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 68.9 6.93 5.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.349 1.459 . . . . 0.0 111.193 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.43 -18.83 58.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.37 1.868 . . . . 0.0 109.475 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.17 37.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.073 2.273 . . . . 0.0 110.461 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 82' ' ' ILE . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.08 65.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 55.6 65.52 1.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.735 2.014 . . . . 0.0 112.301 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 52.45 37.67 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.626 1.97 . . . . 0.0 116.172 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.0 t -155.8 -173.95 4.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.798 1.639 . . . . 0.0 107.341 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.8 71.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 119.536 1.062 . . . . 0.0 113.139 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 156.71 48.26 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.287 71.1 p 39.79 33.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.302 3.041 . . . . 0.0 113.039 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -69.35 2.25 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.539 2.736 . . . . 0.0 113.941 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -53.06 109.13 0.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.959 1.704 . . . . 0.0 109.396 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.43 -9.88 4.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.53 64.66 0.99 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.165 2.986 . . . . 0.0 116.51 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.0 t -109.16 16.42 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.76 1.743 . . . . 0.0 114.803 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.5 mt -99.99 169.47 9.17 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.926 1.29 . . . . 0.0 110.469 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.13 60.7 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.52 114.85 7.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.689 1.995 . . . . 0.0 108.081 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -160.51 -171.38 3.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.437 1.495 . . . . 0.0 110.537 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.37 166.45 10.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.555 1.55 . . . . 0.0 111.074 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 p -94.12 149.72 20.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.722 1.209 . . . . 0.0 109.196 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 45.17 32.7 0.98 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.936 2.094 . . . . 0.0 113.141 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.81 33.45 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.49 0.662 . . . . 0.0 110.602 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.26 -173.74 37.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -149.51 170.71 17.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.678 1.991 . . . . 0.0 107.097 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 tp -151.82 171.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.087 1.355 . . . . 0.0 107.616 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.247 0.924 0 C-N-CA 128.259 2.624 . . . . 0.0 104.549 179.223 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -145.74 132.39 19.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.92 65.63 9.3 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 148.17 21.32 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' HG3' HD11 ' A' ' 33' ' ' ILE . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 82' ' ' ILE . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 67' ' ' VAL . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 62' ' ' ARG . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 129' ' ' LEU . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.62 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 82' ' ' ILE . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -26.58 64.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.17 79.22 0.23 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.551 2.341 . . . . 0.0 107.989 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.34 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.976 1.71 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -124.75 -35.58 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.987 1.715 . . . . 0.0 108.485 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.36 129.73 1.97 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.67 . . . . 0.0 112.32 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -175.44 175.95 2.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.009 2.524 . . . . 0.0 106.23 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.4 p -73.79 174.24 8.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.253 0.933 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.3 m -65.16 158.05 27.05 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 109.106 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.88 159.66 27.82 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.6 tt -88.17 64.83 7.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.87 -172.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.878 1.271 . . . . 0.0 109.203 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.09 164.08 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.804 1.287 . . . . 0.0 111.82 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -77.36 98.27 5.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.4 -179.09 19.76 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -82.34 51.99 1.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.198 0.999 . . . . 0.0 109.07 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 m -165.78 157.7 14.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.044 2.137 . . . . 0.0 108.759 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.49 12.11 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.111 0.862 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -123.91 13.65 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.899 1.28 . . . . 0.0 111.216 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -137.09 168.49 19.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.343 2.257 . . . . 0.0 107.682 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.4 174.12 14.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.904 1.282 . . . . 0.0 108.173 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.26 176.35 44.58 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.48 171.64 19.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.098 1.759 . . . . 0.0 107.763 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.93 -177.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.486 1.914 . . . . 0.0 106.657 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.246 0.875 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.18 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HB ' ' A' ' 51' ' ' THR . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.434 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' H ' HG12 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.688 0 CA-C-O 121.314 0.397 . . . . 0.0 112.964 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.572 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 27' ' ' GLY . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 87' ' ' LEU . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CE2' ' HD2' ' A' ' 123' ' ' ARG . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 55' ' ' SER . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.499 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.44 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 61' ' ' TYR . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.572 0 CA-C-O 120.778 0.099 . . . . 0.0 113.294 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CG ' HD11 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.582 HD11 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HA ' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.636 HD22 ' HA ' ' A' ' 137' ' ' LEU . 32.5 t30 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 68' ' ' PHE . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 33' ' ' ILE . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 129' ' ' LEU . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' A' ' 75' ' ' PHE . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.6 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.6 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HA ' HG23 ' A' ' 33' ' ' ILE . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' HA2' ' A' ' 27' ' ' GLY . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' SER . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 15' ' ' GLN . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' SER . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.5 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 129' ' ' LEU . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 142' ' ' VAL . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.436 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 75' ' ' PHE . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 82' ' ' ILE . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.479 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.426 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' HD13 ' A' ' 87' ' ' LEU . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.479 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 133' ' ' HIS . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 55' ' ' SER . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.456 HD23 ' HA2' ' A' ' 88' ' ' GLY . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 123' ' ' ARG . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.483 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.589 HG22 ' HG3' ' A' ' 123' ' ' ARG . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 69' ' ' ASN . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.533 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 115' ' ' SER . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 100' ' ' LEU . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' HG22 ' A' ' 63' ' ' THR . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 69' ' ' ASN . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.181 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 16' ' ' LEU . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.558 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' A' ' 9' ' ' GLY . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.555 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.741 ' HA ' HD13 ' A' ' 87' ' ' LEU 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 69' ' ' ASN . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.741 HD13 ' HA ' ' A' ' 55' ' ' SER . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.561 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.532 0 N-CA-C 112.77 -0.132 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 33' ' ' ILE . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' HD13 ' A' ' 87' ' ' LEU . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 133' ' ' HIS . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' H ' HG12 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 55' ' ' SER . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' LEU . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.401 HD22 ' HB ' ' A' ' 111' ' ' THR . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.827 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.453 ' CG ' HG23 ' A' ' 33' ' ' ILE . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 16' ' ' LEU . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.453 HG23 ' CG ' ' A' ' 15' ' ' GLN . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 81' ' ' ARG . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 112.351 -0.3 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 25' ' ' LEU . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.653 ' HG3' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HA ' HD21 ' A' ' 87' ' ' LEU . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HA ' ' HG3' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 102' ' ' LEU . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HB2' ' HE ' ' A' ' 124' ' ' ARG . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 120' ' ' ALA . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 106.735 -2.546 . . . . 0.0 106.735 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 34' ' ' LEU . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 16' ' ' LEU . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.573 ' OG ' HD22 ' A' ' 87' ' ' LEU . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.573 HD22 ' OG ' ' A' ' 60' ' ' SER . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 101' ' ' LEU . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 100' ' ' LEU . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 7' ' ' LEU . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 51' ' ' THR . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.598 ' HB ' HG22 ' A' ' 33' ' ' ILE . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 99' ' ' THR . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.409 ' H ' ' H ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 96' ' ' TYR . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 92' ' ' LEU . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.566 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.516 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 124' ' ' ARG . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.459 0.21 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.54 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' SER . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 72' ' ' ILE . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 87' ' ' LEU . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 62' ' ' ARG . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 43' ' ' LEU . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 54' ' ' PHE . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.514 ' H ' HD13 ' A' ' 101' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 134' ' ' THR . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 33' ' ' ILE . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.461 HG23 ' HG3' ' A' ' 123' ' ' ARG . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.524 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 129' ' ' LEU . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.461 ' HG3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 72' ' ' ILE . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.917 0 CA-C-O 122.844 1.247 . . . . 0.0 114.623 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' SER . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.601 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.557 HD11 HG13 ' A' ' 72' ' ' ILE . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 33' ' ' ILE . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 43' ' ' LEU . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.65 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.539 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 25' ' ' LEU . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 58' ' ' GLU . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 87' ' ' LEU . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.624 ' HA ' ' HB1' ' A' ' 86' ' ' ALA . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.402 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 67' ' ' VAL . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 62' ' ' ARG . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 129' ' ' LEU . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 84' ' ' LEU . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 56' ' ' ALA . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 55' ' ' SER . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 94' ' ' ASP . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 72' ' ' ILE . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 12' ' ' THR . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 11' ' ' ASP . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' A' ' 51' ' ' THR . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.509 ' HB ' HG22 ' A' ' 33' ' ' ILE . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 69' ' ' ASN . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.523 ' H ' HG12 ' A' ' 67' ' ' VAL . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 87' ' ' LEU . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' CD1' HD22 ' A' ' 84' ' ' LEU . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 124' ' ' ARG . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 120' ' ' ALA . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 71' ' ' LEU . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 111' ' ' THR . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 138' ' ' SER . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 82' ' ' ILE . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.434 ' HG3' HD11 ' A' ' 33' ' ' ILE . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 82' ' ' ILE . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 67' ' ' VAL . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 62' ' ' ARG . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 129' ' ' LEU . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.62 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 82' ' ' ILE . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.818 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 p -87.47 95.65 10.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 103.032 -2.951 . . . . 0.0 103.032 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -143.11 172.46 12.69 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 110.21 -157.51 14.99 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-O 119.506 -0.608 . . . . 0.0 112.402 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -114.45 84.43 9.7 Favored Pre-proline 0 CA--C 1.539 0.541 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.46 129.98 13.4 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.545 2.163 . . . . 0.0 107.062 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.8 tp -109.15 101.5 10.53 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.956 1.302 . . . . 0.0 108.409 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.8 t -105.26 101.39 12.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 104.648 -2.353 . . . . 0.0 104.648 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 162.1 114.81 0.33 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.812 -0.994 . . . . 0.0 112.024 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -177.72 82.19 0.07 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 128.619 3.009 . . . . 0.0 106.037 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -109.12 -7.47 15.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.43 1.892 . . . . 0.0 113.956 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 127.34 25.95 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 128.06 2.544 . . . . 0.0 105.472 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -45.55 135.77 6.22 Favored 'General case' 0 CA--C 1.513 -0.476 0 C-N-CA 125.931 1.692 . . . . 0.0 115.149 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -175.72 -163.08 0.11 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -120.98 129.67 53.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.589 1.956 . . . . 0.0 105.78 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -125.36 132.3 52.83 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 124.536 1.134 . . . . 0.0 108.828 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.39 145.72 49.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 121.094 -1.004 . . . . 0.0 113.353 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.68 -41.99 10.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.8 -82.93 1.47 Allowed Glycine 0 C--N 1.336 0.559 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.4 t -168.46 161.79 11.93 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.222 1.009 . . . . 0.0 109.446 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.11 -128.31 9.51 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.254 2.359 . . . . 0.0 110.964 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.82 93.35 3.94 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.525 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 0.5 OUTLIER -134.34 105.84 6.8 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.89 2.076 . . . . 0.0 108.212 -177.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.2 101.22 13.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.09 138.31 34.8 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -147.31 112.43 5.49 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 126.302 1.841 . . . . 0.0 108.096 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.79 -66.3 2.38 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 108.633 -1.787 . . . . 0.0 108.633 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -62.45 0.64 Allowed Glycine 0 C--N 1.331 0.286 0 CA-C-O 118.756 -1.025 . . . . 0.0 113.695 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.03 118.92 4.99 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 118.051 0.926 . . . . 0.0 109.585 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.21 -162.88 34.28 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-O 122.751 1.195 . . . . 0.0 114.907 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -135.19 42.34 2.75 Favored 'General case' 0 C--N 1.324 -0.543 1 C-N-CA 131.878 4.071 . . . . 0.0 104.389 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.21 166.67 14.77 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 130.03 3.332 . . . . 0.0 110.417 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HG22 ' HB ' ' A' ' 51' ' ' THR . 19.3 pt -120.3 123.92 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.79 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.3 151.95 43.65 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.325 0.65 . . . . 0.0 111.37 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -141.67 119.96 12.25 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.35 1.86 . . . . 0.0 110.268 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -66.03 -19.78 68.22 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.037 1.303 . . . . 0.0 115.994 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.43 -172.14 35.54 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.692 1.746 . . . . 0.0 114.785 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB2' ' HG3' ' A' ' 58' ' ' GLU . . . -74.41 171.25 14.07 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 127.877 2.471 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.2 -152.8 23.02 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -117.28 98.16 6.29 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' CG ' ' H ' ' A' ' 23' ' ' ASP 0.261 4.0 m-20 -132.12 163.25 28.9 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 120.878 1.672 . . . . 0.0 115.457 -176.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -120.93 146.47 46.61 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.356 1.462 . . . . 0.0 109.625 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pp -143.36 150.41 39.09 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 125.939 1.696 . . . . 0.0 110.196 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.41 120.49 7.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 101.745 -3.428 . . . . 0.0 101.745 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.73 -49.32 50.3 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 121.545 1.975 . . . . 0.0 109.369 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 135.23 -164.95 24.8 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.38 103.72 12.97 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.52 -169.89 42.99 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.41 68.77 0.73 Allowed 'General case' 0 C--O 1.238 0.463 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -76.15 165.41 24.95 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 122.229 1.014 . . . . 0.0 111.94 -176.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.434 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -121.75 103.89 9.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -178.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -81.76 95.78 7.37 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.9 t -80.82 133.94 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -143.98 133.93 24.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 104.44 -2.429 . . . . 0.0 104.44 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.0 m -137.79 6.15 2.67 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . 0.253 . . 39.29 42.63 0.82 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 126.85 2.06 . . . . 0.0 115.861 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -89.3 -34.99 16.37 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 102.804 -3.035 . . . . 0.0 102.804 175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' HG3' ' HB2' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -105.76 -38.58 6.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 128.545 2.738 . . . . 0.0 110.97 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -82.33 149.2 27.88 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.34 -74.11 0.22 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.948 1.299 . . . . 0.0 109.11 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.423 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 0.4 OUTLIER -166.53 177.97 6.35 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 120.991 -1.068 . . . . 0.0 110.077 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.14 152.12 34.3 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 p -133.38 172.88 12.1 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -63.42 -34.88 78.7 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.9 p -103.37 -2.69 26.61 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.62 99.31 2.3 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 119.383 0.992 . . . . 0.0 111.315 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.5 t -94.32 123.23 46.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -123.6 35.79 4.77 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.99 136.44 37.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 O-C-N 121.215 -0.928 . . . . 0.0 111.836 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.72 147.25 41.57 Favored 'General case' 0 C--O 1.246 0.888 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.51 105.16 7.66 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.953 0.501 . . . . 0.0 110.049 178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.22 131.52 33.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.9 tp -108.9 158.63 17.5 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.751 1.62 . . . . 0.0 111.842 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.0 t0 31.94 46.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 131.578 3.951 . . . . 0.0 116.07 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -63.41 125.83 25.46 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -113.83 96.31 5.78 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.88 1.672 . . . . 0.0 107.13 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.82 -16.21 16.07 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -74.14 -22.37 59.47 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 120.586 -1.321 . . . . 0.0 111.24 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -127.61 -50.37 1.38 Allowed 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.028 1.285 . . . . 0.0 113.837 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -57.28 142.59 42.69 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.029 1.731 . . . . 0.0 112.943 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 12.7 mtt85 -131.71 166.09 22.28 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.957 0.903 . . . . 0.0 109.434 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 mt -139.65 131.22 33.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 O-C-N 121.37 -0.831 . . . . 0.0 112.919 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -83.93 95.63 8.57 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' H ' HG12 ' A' ' 143' ' ' VAL . 1.0 OUTLIER -130.59 54.24 1.9 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.537 1.935 . . . . 0.0 108.276 -178.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.1 p -87.71 -44.41 11.19 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 121.045 -1.035 . . . . 0.0 109.222 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.59 -2.96 43.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.707 1.203 . . . . 0.0 112.036 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 11.5 mt -120.05 121.33 38.64 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.94 103.52 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.106 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -68.25 178.77 1.79 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.871 1.268 . . . . 0.0 109.852 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.5 m -107.91 1.28 22.55 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.407 1.483 . . . . 0.0 112.825 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -115.51 105.48 1.44 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.8 mt -69.63 172.49 7.34 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.88 0.848 . . . . 0.0 110.163 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.39 -101.67 0.18 Allowed Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -140.13 10.53 2.36 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.45 14.04 82.91 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-N 120.025 1.284 . . . . 0.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -92.05 -129.65 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.806 1.243 . . . . 0.0 109.929 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.32 65.67 0.02 OUTLIER Glycine 0 C--N 1.333 0.362 1 C-N-CA 131.478 4.37 . . . . 0.0 114.596 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.1 33.86 22.44 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.932 1.253 . . . . 0.0 113.409 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 48.2 p -122.26 172.83 8.01 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.396 1.098 . . . . 0.0 109.699 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.88 147.12 52.46 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.417 1.487 . . . . 0.0 108.907 -179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 tt -141.45 129.45 21.97 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.953 0.501 . . . . 0.0 109.896 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.04 153.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 126.736 2.014 . . . . 0.0 108.961 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -155.37 160.19 40.5 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.445 -1.707 . . . . 0.0 108.655 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 24.7 p -124.82 151.11 45.63 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.723 0.773 . . . . 0.0 110.167 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -71.54 178.07 3.7 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -46.19 -53.37 10.66 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.445 1.098 . . . . 0.0 113.584 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.7 mt-10 -84.69 -10.82 56.92 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.45 -2.26 85.65 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 120.65 -1.281 . . . . 0.0 111.367 -177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.6 m -63.82 -31.75 73.04 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.179 1.791 . . . . 0.0 109.888 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -115.73 121.56 42.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.762 0.825 . . . . 0.0 111.55 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.3 m -103.03 119.01 38.08 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 106.652 -1.611 . . . . 0.0 106.652 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -118.2 118.78 32.77 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.23 163.82 26.92 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.846 1.259 . . . . 0.0 109.504 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.44 121.8 22.76 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.865 1.266 . . . . 0.0 111.652 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -99.9 106.95 18.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 87.9 t80 52.0 94.9 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.726 1.61 . . . . 0.0 112.976 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -113.02 179.15 4.04 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.594 1.558 . . . . 0.0 110.558 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -134.78 -147.47 0.28 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.99 1.316 . . . . 0.0 108.543 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -79.96 152.16 29.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.093 2.557 . . . . 0.0 110.034 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.27 -10.8 5.07 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.362 1.865 . . . . 0.0 114.55 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -114.65 -21.52 10.19 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.563 1.545 . . . . 0.0 110.23 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.01 -72.3 1.13 Allowed Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 178.11 138.44 0.08 Allowed 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 125.501 1.521 . . . . 0.0 108.882 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 mtp-105 -132.72 117.95 18.47 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -81.4 121.26 26.01 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -148.58 137.15 21.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.07 162.69 13.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 126.336 1.854 . . . . 0.0 108.079 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.98 121.54 28.21 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.02 0.928 . . . . 0.0 109.262 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.1 tt -113.01 127.16 56.16 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.0 106.96 17.45 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 177.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -87.2 170.47 41.16 Favored Glycine 0 CA--C 1.52 0.374 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -142.46 -52.79 0.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.202 1.401 . . . . 0.0 107.337 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -92.27 -112.04 0.1 Allowed 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.75 122.48 30.7 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 124.172 0.989 . . . . 0.0 109.116 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.39 26.25 10.83 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.247 -0.752 . . . . 0.0 111.724 179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -120.01 144.42 47.53 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.57 1.185 . . . . 0.0 111.721 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.9 mp -113.62 157.52 22.01 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 126.322 1.849 . . . . 0.0 107.737 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.9 t -151.79 -177.14 5.95 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.885 1.674 . . . . 0.0 106.716 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -55.11 -22.49 16.82 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 127.314 2.246 . . . . 0.0 113.822 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -92.51 -38.68 11.8 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.478 1.111 . . . . 0.0 110.14 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.6 -10.48 56.25 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.55 1.94 . . . . 0.0 112.939 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.7 t -129.04 154.42 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.2 p -56.43 149.15 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.97 -28.08 61.93 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 49.4 51.68 15.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.309 1.444 . . . . 0.0 110.33 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 50.21 30.7 4.52 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.913 2.485 . . . . 0.0 115.093 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.5 t -65.32 176.77 1.27 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.508 1.123 . . . . 0.0 111.559 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.44 179.53 53.11 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 122.21 0.895 . . . . 0.0 112.923 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.1 p -70.83 -178.93 2.03 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.998 1.719 . . . . 0.0 109.192 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -143.84 48.77 1.4 Allowed 'General case' 0 CA--C 1.531 0.221 0 O-C-N 120.558 -1.339 . . . . 0.0 109.193 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -81.21 34.48 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 O-C-N 120.685 -1.259 . . . . 0.0 108.534 179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -87.94 151.54 22.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.671 1.988 . . . . 0.0 111.258 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 mp -144.51 70.02 1.28 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 105.875 -1.898 . . . . 0.0 105.875 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -125.7 54.58 1.49 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.204 1.002 . . . . 0.0 110.326 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -136.93 152.87 28.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.771 1.228 . . . . 0.0 108.255 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 tt -117.15 92.37 3.83 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.352 1.461 . . . . 0.0 109.529 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 115.66 -57.61 0.48 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 124.451 1.024 . . . . 0.0 111.993 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -102.32 -167.92 1.46 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.667 1.187 . . . . 0.0 108.058 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.1 m -139.27 164.86 28.72 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 126.234 1.814 . . . . 0.0 107.441 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 150.81 158.17 8.16 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-O 121.823 0.68 . . . . 0.0 113.625 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.8 m -79.14 22.43 0.41 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.176 2.19 . . . . 0.0 112.19 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -147.0 107.48 4.08 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 120.233 -1.542 . . . . 0.0 109.691 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -62.49 137.27 58.23 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.13 166.21 32.55 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 125.915 1.721 . . . . 0.0 109.336 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -158.67 165.61 34.0 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.396 1.079 . . . . 0.0 108.587 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 33.1 mt -122.32 123.01 67.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.256 1.404 0 N-CA-C 105.327 -2.101 . . . . 0.0 105.327 -179.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.648 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -152.96 -81.31 0.09 Allowed 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.04 143.69 49.03 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 56.17 -157.05 10.15 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 123.858 0.724 . . . . 0.0 112.964 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -149.49 134.95 9.75 Favored Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.71 153.66 48.73 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.943 2.428 . . . . 0.0 114.402 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 139.63 52.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.32 3.048 . . . . 0.0 104.922 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.27 125.06 47.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 125.261 1.424 . . . . 0.0 107.357 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.39 -175.95 46.17 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.678 1.132 . . . . 0.0 111.919 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.93 -99.1 2.39 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 125.133 1.349 . . . . 0.0 110.932 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.64 -16.04 0.37 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.462 1.505 . . . . 0.0 114.417 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 p -90.62 123.29 34.13 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.422 1.889 . . . . 0.0 108.135 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -52.91 145.76 12.08 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 126.183 1.793 . . . . 0.0 113.387 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -169.87 -173.45 1.59 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.806 0.843 . . . . 0.0 108.829 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -121.18 120.9 36.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mp -121.45 132.51 54.77 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 125.601 1.56 . . . . 0.0 107.199 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -131.79 150.21 52.22 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -96.77 -41.71 3.52 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.74 174.1 49.91 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.057 1.313 . . . . 0.0 110.55 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.9 p -58.81 125.35 23.16 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.753 -0.851 . . . . 0.0 110.788 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.38 -158.97 27.09 Favored Glycine 0 N--CA 1.438 -1.167 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.34 94.8 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -106.61 160.77 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 126.579 1.952 . . . . 0.0 109.953 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.8 98.22 3.35 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -105.37 158.57 16.55 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -139.84 122.25 16.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.754 1.222 . . . . 0.0 108.454 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.572 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -54.18 -52.87 40.96 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 126.261 1.886 . . . . 0.0 114.191 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.44 -90.43 0.62 Allowed Glycine 0 C--O 1.237 0.337 0 N-CA-C 108.141 -1.984 . . . . 0.0 108.141 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -170.85 84.63 0.09 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.79 1.636 . . . . 0.0 110.192 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.27 -162.46 16.47 Favored Glycine 0 CA--C 1.527 0.842 0 O-C-N 121.853 -0.529 . . . . 0.0 112.427 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -110.04 47.15 0.97 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.002 3.321 . . . . 0.0 107.059 178.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.49 164.53 17.78 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.877 -1.51 . . . . 0.0 111.255 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -123.11 105.26 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.89 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 27' ' ' GLY . 10.9 mp -102.92 117.03 33.7 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -120.42 101.39 7.75 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.89 -69.47 1.25 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 124.408 1.004 . . . . 0.0 111.138 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.81 -175.77 16.82 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 118.798 1.299 . . . . 0.0 114.587 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.6 107.72 2.2 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 122.191 -0.594 . . . . 0.0 111.846 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.14 167.6 11.16 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 126.567 2.032 . . . . 0.0 110.639 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.83 98.43 5.58 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -93.9 162.24 13.98 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 130.401 3.48 . . . . 0.0 110.1 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.44 100.34 4.63 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.65 156.66 18.38 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.773 0.829 . . . . 0.0 110.265 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 m -150.2 129.99 13.28 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.081 1.352 . . . . 0.0 107.576 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -82.69 -55.61 2.96 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 107.175 -2.37 . . . . 0.0 107.175 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.79 -164.79 17.47 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 105.053 -3.219 . . . . 0.0 105.053 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.62 102.33 8.84 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.17 -161.57 14.41 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 127.666 2.555 . . . . 0.0 107.634 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.57 67.14 1.54 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 103.602 -2.74 . . . . 0.0 103.602 178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.29 166.84 22.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 123.46 1.6 . . . . 0.0 113.524 -176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 m -133.53 93.74 3.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.197 -1.82 . . . . 0.0 109.913 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -81.87 110.83 17.52 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.652 -1.28 . . . . 0.0 107.89 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -104.91 101.59 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 126.13 1.772 . . . . 0.0 110.417 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -92.1 122.86 34.99 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.444 ' HA ' HD13 ' A' ' 87' ' ' LEU . 1.3 m -150.42 -2.14 0.38 Allowed 'General case' 0 C--O 1.24 0.596 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.67 154.19 42.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -59.92 -32.61 70.94 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 113.505 -1.68 . . . . 0.0 110.947 178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.08 -20.47 13.83 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 117.45 -1.262 . . . . 0.0 111.516 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -84.85 54.49 3.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 121.107 1.776 . . . . 0.0 108.991 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.5 t -127.38 -17.35 4.7 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 120.075 -1.64 . . . . 0.0 111.796 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CE2' ' HD2' ' A' ' 123' ' ' ARG . 1.4 p90 -166.63 176.5 7.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 122.638 1.209 . . . . 0.0 109.183 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.18 154.3 29.24 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 34.6 p -139.5 157.38 45.93 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -68.31 -11.88 60.18 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.3 p -90.11 -26.41 20.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.537 1.935 . . . . 0.0 109.498 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -167.67 112.89 0.7 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.699 1.2 . . . . 0.0 113.197 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.85 137.05 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 23.3 m-85 -138.51 32.06 2.3 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.539 1.136 . . . . 0.0 111.17 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -62.57 123.39 18.22 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.66 153.91 40.98 Favored 'General case' 0 C--O 1.245 0.843 0 C-N-CA 125.12 1.368 . . . . 0.0 109.605 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.7 tt -143.67 104.62 4.22 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.1 mt -97.02 125.81 49.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.5 147.27 31.95 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.646 1.578 . . . . 0.0 108.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.35 60.73 3.63 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.814 1.646 . . . . 0.0 114.139 177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.5 108.05 20.56 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.013 1.725 . . . . 0.0 109.018 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -100.92 94.47 6.04 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 120.463 1.483 . . . . 0.0 109.74 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 134' ' ' THR . . . -52.6 -19.52 2.38 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.6 m -63.76 -23.31 67.31 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.514 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -134.54 -52.61 0.82 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.39 2.276 . . . . 0.0 112.711 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.56 149.87 37.76 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 125.797 1.639 . . . . 0.0 112.449 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 21.0 mtt180 -137.55 164.14 29.47 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.2 tt -124.97 118.11 52.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 C-N-CA 124.221 1.009 . . . . 0.0 109.647 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.04 116.21 24.11 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.44 71.08 1.4 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 127.497 2.319 . . . . 0.0 105.354 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.9 p -120.02 -22.87 6.53 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.74 -49.14 3.74 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.723 1.609 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 55' ' ' SER . 5.7 mp -87.85 52.71 2.55 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 123.263 1.506 . . . . 0.0 109.14 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.04 123.92 1.67 Allowed Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 108.231 -1.948 . . . . 0.0 108.231 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -62.96 158.43 19.31 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -68.59 -12.71 61.68 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.488 -1.382 . . . . 0.0 110.291 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.1 121.74 7.77 Favored Glycine 0 C--N 1.336 0.558 0 O-C-N 121.136 -0.977 . . . . 0.0 111.25 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.71 168.89 10.71 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 178.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.45 -91.46 0.1 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-O 117.896 -1.502 . . . . 0.0 112.287 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -143.23 4.69 1.43 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 118.726 1.263 . . . . 0.0 113.1 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.93 11.7 83.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -89.75 -155.72 0.38 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -43.34 55.46 0.0 OUTLIER Glycine 0 CA--C 1.524 0.629 1 C-N-CA 133.314 5.245 . . . . 0.0 118.479 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.27 30.93 4.24 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 126.184 1.85 . . . . 0.0 111.626 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.5 p -131.11 -179.87 5.59 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 118.963 1.382 . . . . 0.0 112.374 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.8 tt -155.44 134.99 12.54 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.928 1.691 . . . . 0.0 109.147 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.499 ' N ' HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -145.86 155.18 42.72 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.517 1.127 . . . . 0.0 108.757 177.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.6 pt? -127.11 148.2 50.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 126.431 1.892 . . . . 0.0 110.782 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -142.43 164.96 28.72 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 126.439 1.896 . . . . 0.0 108.171 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.44 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 37.4 p -106.78 164.49 12.06 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 121.853 0.835 . . . . 0.0 109.948 179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -66.71 -179.72 0.92 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.294 1.438 . . . . 0.0 108.249 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.09 -54.77 26.33 Favored 'General case' 0 CA--C 1.528 0.134 0 O-C-N 121.197 -0.939 . . . . 0.0 112.374 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -71.39 -22.51 61.86 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 91.34 -0.21 74.52 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 126.291 1.901 . . . . 0.0 113.757 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 p -78.42 -17.55 56.22 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 128.318 2.647 . . . . 0.0 115.085 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -125.3 152.72 44.3 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 109.075 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 92.3 m -119.47 135.19 54.87 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 -178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -121.84 117.92 27.71 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.766 2.426 . . . . 0.0 108.511 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.6 pp -118.59 159.03 24.3 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.0 OUTLIER -142.37 123.0 14.17 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 123.924 0.89 . . . . 0.0 109.739 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.5 t -110.7 123.71 50.55 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.5 t80 25.16 85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.056 2.542 . . . . 0.0 113.324 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -104.48 166.65 10.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.797 0.839 . . . . 0.0 110.716 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -122.83 -142.36 0.32 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.535 1.134 . . . . 0.0 110.749 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.7 p30 -94.63 155.63 16.79 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 128.409 2.684 . . . . 0.0 109.609 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.93 -18.58 60.8 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -89.52 -17.73 28.04 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.31 1.044 . . . . 0.0 111.949 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -115.34 -36.6 1.18 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-O 116.696 -2.169 . . . . 0.0 115.788 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.404 ' HD2' ' CE2' ' A' ' 61' ' ' TYR . 7.8 ptt-85 160.15 135.5 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 120.263 2.031 . . . . 0.0 113.565 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.2 139.28 39.22 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 121.212 -0.93 . . . . 0.0 109.987 177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 4.7 t80 -82.63 118.71 23.52 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -143.04 112.79 6.96 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 35.0 t -139.13 163.85 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.634 1.974 . . . . 0.0 109.244 -178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.51 125.42 24.19 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.812 1.245 . . . . 0.0 111.489 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.6 tt -114.33 131.74 56.43 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.08 1.352 . . . . 0.0 108.419 178.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -66.65 117.95 9.53 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.558 1.543 . . . . 0.0 106.961 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -91.24 104.17 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-O 121.948 0.749 . . . . 0.0 112.567 -178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -146.26 97.44 2.94 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 127.757 2.423 . . . . 0.0 105.456 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 16.5 m170 64.3 -9.89 0.16 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 127.296 2.238 . . . . 0.0 113.636 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.549 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -64.39 -4.85 4.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.367 2.267 . . . . 0.0 114.805 179.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.87 -21.99 46.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 118.447 -1.196 . . . . 0.0 113.5 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -99.54 112.34 24.56 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.184 1.492 . . . . 0.0 111.68 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.94 129.64 45.71 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.913 0.885 . . . . 0.0 111.887 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -157.24 -70.83 0.1 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.49 -33.26 0.51 Allowed 'General case' 0 N--CA 1.462 0.166 0 C-N-CA 123.335 0.654 . . . . 0.0 111.904 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.03 -9.6 58.8 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.148 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -125.38 -6.74 7.02 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.772 1.229 . . . . 0.0 113.086 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.6 t -145.4 140.4 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 O-C-N 119.354 -2.091 . . . . 0.0 108.448 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 145' ' ' ALA . 81.5 t -72.7 146.84 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.97 -24.32 67.68 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.632 -1.293 . . . . 0.0 114.25 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.486 ' H ' HG12 ' A' ' 143' ' ' VAL . . . 64.12 56.69 1.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -147.55 176.27 10.19 Favored 'General case' 0 N--CA 1.425 -1.716 0 C-N-CA 126.616 1.966 . . . . 0.0 111.396 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.1 p -129.39 2.74 5.1 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.849 2.06 . . . . 0.0 110.041 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.49 -150.04 9.69 Favored Glycine 0 C--N 1.339 0.718 0 C-N-CA 125.979 1.752 . . . . 0.0 112.377 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 19.1 p -114.86 -174.81 2.56 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.154 2.182 . . . . 0.0 110.632 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 34.5 p -132.26 167.75 19.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.794 1.638 . . . . 0.0 107.48 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.413 HG21 ' CD ' ' A' ' 154' ' ' GLU . 13.5 t -82.98 -178.61 7.18 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.973 0.909 . . . . 0.0 109.225 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -92.24 -157.0 0.49 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.682 2.393 . . . . 0.0 107.865 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 tt -73.25 40.73 0.1 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.26 2.224 . . . . 0.0 111.078 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.413 ' CD ' HG21 ' A' ' 151' ' ' THR . 5.8 mm-40 25.83 72.71 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 129.548 3.139 . . . . 0.0 112.525 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.86 166.36 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.72 3.55 0.64 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.256 1.822 . . . . 0.0 115.161 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 71.1 30.22 67.87 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -67.37 171.73 5.66 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 125.323 1.449 . . . . 0.0 111.605 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.7 m -111.52 154.4 24.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 126.289 1.836 . . . . 0.0 107.357 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 158.87 -68.85 0.26 Allowed Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 73.1 p -112.75 125.9 54.83 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 47.88 60.92 3.24 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.346 1.058 . . . . 0.0 109.513 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.57 134.97 55.47 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -69.01 -177.35 14.83 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-O 122.819 1.233 . . . . 0.0 113.452 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.76 172.13 18.45 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.686 1.994 . . . . 0.0 107.267 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 4.1 mp -128.82 144.62 37.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 104.992 -2.225 . . . . 0.0 104.992 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.252 1.189 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.17 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.864 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 m -61.95 133.67 55.69 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -149.62 161.88 41.3 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.2 2.2 . . . . 0.0 107.803 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.54 -171.02 23.74 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 125.976 1.75 . . . . 0.0 113.294 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -141.04 131.36 13.24 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 125.16 1.384 . . . . 0.0 108.635 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -62.21 114.56 2.38 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.931 2.421 . . . . 0.0 112.847 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.81 101.37 12.95 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 102.976 -2.972 . . . . 0.0 102.976 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.1 t -95.86 117.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -67.61 -171.63 5.66 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 126.259 1.885 . . . . 0.0 113.33 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.5 -168.59 42.48 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 123.366 1.537 . . . . 0.0 114.06 -179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -107.55 -3.75 19.06 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.295 2.238 . . . . 0.0 111.92 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.4 p -133.6 147.34 51.5 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 131.32 3.848 . . . . 0.0 105.462 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -31.32 123.08 0.24 Allowed 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 128.496 2.718 . . . . 0.0 114.298 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -139.98 168.51 19.66 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 124.223 1.009 . . . . 0.0 109.306 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.62 96.57 4.43 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.45 124.43 32.03 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 126.617 1.967 . . . . 0.0 108.137 -178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -137.37 159.9 40.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.835 0.35 . . . . 0.0 111.148 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -119.87 -96.53 1.62 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 147.62 -56.39 0.5 Allowed Glycine 0 CA--C 1.521 0.429 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -166.49 172.7 10.57 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.781 0.791 . . . . 0.0 112.366 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.09 -143.95 17.73 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 125.726 1.631 . . . . 0.0 111.157 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.66 94.98 4.53 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.66 166.14 11.27 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.11 1.764 . . . . 0.0 109.276 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.53 103.51 3.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.07 148.2 33.16 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -137.74 117.22 12.88 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -38.49 -50.94 2.39 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 128.133 2.778 . . . . 0.0 114.182 -177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.05 -95.76 0.82 Allowed Glycine 0 C--O 1.239 0.426 0 N-CA-C 105.26 -3.136 . . . . 0.0 105.26 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.58 109.63 2.61 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.257 1.528 . . . . 0.0 111.979 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 132.89 -166.57 23.58 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-O 123.223 1.457 . . . . 0.0 112.029 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 2.6 p-10 -79.8 48.57 0.96 Allowed 'General case' 0 N--CA 1.413 -2.303 1 C-N-CA 133.208 4.603 . . . . 0.0 113.745 179.756 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -77.9 164.6 25.0 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.849 1.66 . . . . 0.0 111.219 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 tt -120.82 137.03 55.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.693 1.197 . . . . 0.0 108.4 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.36 137.51 45.91 Favored 'General case' 0 CA--C 1.554 1.125 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -177.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -147.12 103.75 3.62 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 127.826 2.45 . . . . 0.0 111.421 178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.33 -67.49 2.09 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.452 1.501 . . . . 0.0 112.629 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.38 -177.19 16.52 Favored Glycine 0 CA--C 1.531 1.039 0 CA-C-N 119.07 1.435 . . . . 0.0 113.886 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.15 107.86 0.6 Allowed 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.213 1.005 . . . . 0.0 111.289 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.11 -158.27 27.63 Favored Glycine 0 N--CA 1.427 -1.95 0 N-CA-C 106.852 -2.499 . . . . 0.0 106.852 -178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.38 97.63 6.14 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 126.018 1.727 . . . . 0.0 107.969 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.54 158.72 16.17 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 123.931 0.892 . . . . 0.0 109.994 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -118.78 100.32 7.33 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -91.63 148.48 22.24 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.363 -178.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.68 114.94 5.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 104.905 -2.257 . . . . 0.0 104.905 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -64.82 -56.07 18.71 Favored Glycine 0 CA--C 1.522 0.477 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.72 -165.28 20.02 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -68.64 104.61 2.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.63 -149.84 8.41 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 118.987 0.812 . . . . 0.0 112.229 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.25 73.09 1.13 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 102.008 -3.33 . . . . 0.0 102.008 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -74.59 168.23 20.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.001 2.12 . . . . 0.0 116.468 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.4 m -140.88 106.77 5.15 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.5 m-30 -88.31 141.97 28.12 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 t -136.7 99.68 1.97 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 119.067 0.849 . . . . 0.0 110.966 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -91.98 136.39 33.2 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 4.92 0.07 Allowed 'General case' 0 C--O 1.245 0.854 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.42 153.93 41.91 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 120.11 1.323 . . . . 0.0 113.15 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.36 -20.26 64.22 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.885 -0.51 . . . . 0.0 111.58 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.48 -35.78 7.77 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.302 1.041 . . . . 0.0 112.319 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -69.77 90.95 0.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.191 1.796 . . . . 0.0 110.644 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -171.22 -34.82 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.541 0.736 . . . . 0.0 111.923 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -163.99 -178.71 5.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 120.5 -1.375 . . . . 0.0 109.141 -177.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.49 162.0 17.27 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.7 p -133.84 163.78 28.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.344 1.458 . . . . 0.0 107.419 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -28.88 -68.09 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 129.748 3.219 . . . . 0.0 112.997 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.5 p -101.19 -2.31 31.63 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.293 1.837 . . . . 0.0 114.427 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.99 104.77 5.13 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 120.837 1.653 . . . . 0.0 111.579 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -94.28 128.59 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 C-N-CA 127.723 2.409 . . . . 0.0 108.798 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -134.24 53.02 2.02 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.452 1.501 . . . . 0.0 108.306 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.37 139.53 41.01 Favored 'General case' 0 N--CA 1.441 -0.877 0 O-C-N 121.553 -0.717 . . . . 0.0 111.122 179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -90.35 154.56 19.6 Favored 'General case' 0 C--O 1.246 0.92 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 47.3 tp -144.59 117.29 8.68 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 118.615 -0.707 . . . . 0.0 110.67 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.66 127.26 59.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.3 tp -107.83 150.82 26.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.199 1.399 . . . . 0.0 108.934 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t70 39.16 63.85 0.89 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.146 2.179 . . . . 0.0 114.074 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CG ' HD11 ' A' ' 129' ' ' LEU . 54.8 t80 -88.54 134.81 33.76 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -124.84 92.5 3.66 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 127.634 2.373 . . . . 0.0 107.576 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . -61.56 -11.95 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.111 -0.993 . . . . 0.0 111.073 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 t -60.49 -33.1 72.12 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.014 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.41 -36.79 1.44 Allowed 'General case' 0 C--O 1.235 0.33 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -60.75 153.63 23.76 Favored 'General case' 0 C--O 1.243 0.755 0 C-N-CA 127.579 2.352 . . . . 0.0 111.366 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -145.43 156.45 43.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.646 1.178 . . . . 0.0 110.605 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.3 mp -140.53 148.23 22.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 120.27 -1.519 . . . . 0.0 110.809 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -108.29 109.77 21.19 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 14.66 8.31 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.762 1.225 . . . . 0.0 112.202 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.6 m -91.87 -18.22 24.1 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 118.745 0.702 . . . . 0.0 110.508 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.26 -47.73 72.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.987 1.315 . . . . 0.0 114.008 -179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.1 mp -121.38 70.05 0.92 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.688 1.595 . . . . 0.0 110.502 -178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 174.82 -93.52 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 O-C-N 120.455 -1.403 . . . . 0.0 110.515 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -165.76 177.31 7.32 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.726 1.61 . . . . 0.0 108.011 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.0 m -113.74 5.31 16.35 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.835 1.254 . . . . 0.0 112.964 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -131.83 178.37 17.96 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 126.235 1.874 . . . . 0.0 110.483 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.8 pp -113.02 173.48 6.37 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 125.016 1.326 . . . . 0.0 111.531 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 171.42 -98.43 0.13 Allowed Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.344 -1.253 . . . . 0.0 112.262 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -138.99 -2.71 1.66 Allowed 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.19 18.11 59.75 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -131.87 162.22 31.13 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.113 2.165 . . . . 0.0 108.238 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 48.2 26.0 4.46 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.186 0.898 . . . . 0.0 114.569 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.3 63.85 1.69 Allowed Glycine 0 C--O 1.223 -0.566 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.9 p -141.8 -178.4 5.65 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.068 0.947 . . . . 0.0 109.383 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -133.95 137.15 44.66 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 127.263 2.225 . . . . 0.0 108.626 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 tt -144.75 140.08 28.29 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 126.276 1.83 . . . . 0.0 107.671 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.0 pt? -135.49 148.24 49.14 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.415 1.486 . . . . 0.0 110.323 178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt -153.86 172.45 17.35 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.006 2.122 . . . . 0.0 108.188 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.2 p -113.79 166.79 11.21 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.636 -0.665 . . . . 0.0 109.238 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -69.44 -175.65 0.85 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.141 1.377 . . . . 0.0 111.613 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.53 -26.3 42.34 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.026 1.731 . . . . 0.0 114.182 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -95.04 -56.41 2.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 129.73 -8.92 6.12 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 126.429 1.966 . . . . 0.0 112.963 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.1 p -70.22 -42.95 71.63 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.791 1.636 . . . . 0.0 112.421 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -88.05 130.77 34.89 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.25 127.76 49.07 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 125.97 1.708 . . . . 0.0 107.929 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -128.37 122.31 31.16 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.769 2.028 . . . . 0.0 110.732 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.6 pp -118.41 165.27 14.09 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.413 1.485 . . . . 0.0 111.002 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -134.65 122.36 22.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.861 1.664 . . . . 0.0 106.714 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -114.36 107.94 16.24 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.447 -2.797 . . . . 0.0 103.447 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 18.6 t80 36.95 67.57 0.33 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.543 1.937 . . . . 0.0 112.261 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -74.97 152.6 38.76 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 121.568 -0.707 . . . . 0.0 110.955 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -126.51 -145.57 0.32 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.916 0.887 . . . . 0.0 111.325 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -84.11 154.72 23.0 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.623 1.169 . . . . 0.0 113.184 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.77 -6.38 20.85 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.898 1.279 . . . . 0.0 112.319 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -113.31 -22.3 10.5 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 127.343 2.257 . . . . 0.0 109.926 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -92.15 -69.24 1.15 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -170.07 128.65 0.9 Allowed 'General case' 0 CA--C 1.512 -0.505 0 C-N-CA 124.189 0.996 . . . . 0.0 108.367 -178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttp85 -137.27 128.33 27.65 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 118.844 0.747 . . . . 0.0 111.231 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -80.79 129.23 34.42 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.671 1.988 . . . . 0.0 111.424 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -158.86 114.68 2.61 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.031 -2.581 . . . . 0.0 104.031 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 40.8 t -130.95 165.19 32.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.24 129.17 31.15 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.42 -0.8 . . . . 0.0 110.583 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.582 HD11 ' CG ' ' A' ' 75' ' ' PHE . 49.5 tp -121.09 112.59 18.88 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -108.4 107.01 17.39 Favored 'General case' 0 C--O 1.233 0.201 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -132.27 162.54 23.99 Favored Glycine 0 C--O 1.239 0.431 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.51 13.52 2.35 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 125.398 1.479 . . . . 0.0 110.285 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -130.14 76.51 1.73 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.974 2.11 . . . . 0.0 110.232 -178.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 2.4 t 43.48 74.08 0.13 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.634 1.973 . . . . 0.0 111.468 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.21 10.6 1.73 Allowed Glycine 0 CA--C 1.537 1.458 0 O-C-N 120.826 -1.171 . . . . 0.0 113.282 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.1 136.45 53.75 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.2 1.4 . . . . 0.0 111.3 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HA ' HD22 ' A' ' 141' ' ' ASN . 0.0 OUTLIER -81.7 152.06 27.24 Favored 'General case' 0 N--CA 1.455 -0.182 0 O-C-N 120.898 -1.127 . . . . 0.0 111.724 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.1 p -145.26 -171.6 3.69 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 127.482 2.313 . . . . 0.0 107.175 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -77.59 -15.56 59.15 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.646 -1.616 . . . . 0.0 108.797 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.79 -53.45 4.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.371 1.868 . . . . 0.0 109.527 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.636 HD22 ' HA ' ' A' ' 137' ' ' LEU . 32.5 t30 -52.96 -42.05 65.13 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.024 1.392 . . . . 0.0 111.568 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.69 146.19 6.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.0 p -61.46 162.85 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.27 -29.42 58.09 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.3 -0.875 . . . . 0.0 111.436 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.38 53.21 12.07 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.842 1.257 . . . . 0.0 109.036 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.14 31.34 6.51 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 126.782 2.033 . . . . 0.0 114.161 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.2 t -77.38 151.03 35.04 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.87 -81.88 0.83 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 107.819 -2.113 . . . . 0.0 107.819 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 p -146.06 112.01 5.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 125.684 1.594 . . . . 0.0 106.886 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -148.24 5.53 0.74 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.725 0.81 . . . . 0.0 113.083 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 p -117.24 139.56 50.64 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.688 -1.258 . . . . 0.0 107.973 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -160.2 171.88 18.42 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.262 0.625 . . . . 0.0 111.178 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 153' ' ' LEU . 1.0 OUTLIER -91.81 83.76 5.3 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 177.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -59.99 148.99 33.37 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.4 153.37 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.051 -1.031 . . . . 0.0 109.136 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 15.1 tp -68.21 108.31 3.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -157.84 -96.57 0.12 Allowed Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -132.34 -26.7 1.84 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.61 1.164 . . . . 0.0 112.828 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 5.0 m -167.81 163.34 14.08 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.06 1.344 . . . . 0.0 111.622 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.62 -150.98 7.84 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.22 2.343 . . . . 0.0 107.413 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 86.8 m -75.6 -43.58 47.39 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.09 -1.241 . . . . 0.0 107.752 178.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -72.4 -68.18 0.49 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.837 -0.601 . . . . 0.0 110.51 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.1 -166.27 0.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.717 1.607 . . . . 0.0 109.042 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 175.5 159.09 20.87 Favored Glycine 0 CA--C 1.535 1.321 1 C-N-CA 132.187 4.708 . . . . 0.0 105.394 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -174.42 -38.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.659 1.729 . . . . 0.0 113.202 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 1.6 mp -125.22 59.62 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 102.305 -3.22 . . . . 0.0 102.305 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.031 0 N-CA-C 103.668 -2.715 . . . . 0.0 103.668 -175.892 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.602 0 N-CA-C 110.169 -1.173 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 m -76.79 170.06 17.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -63.01 -31.09 72.15 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.7 162.84 24.64 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 124.623 1.106 . . . . 0.0 111.328 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -137.3 148.45 62.16 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 128.999 2.92 . . . . 0.0 107.03 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -76.03 146.38 29.03 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 N-CA-C 106.928 -1.989 . . . . 0.0 106.928 177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.65 134.74 51.76 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 t -136.71 99.54 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 126.165 1.786 . . . . 0.0 107.394 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.69 144.9 33.46 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.77 54.29 0.95 Allowed Glycine 0 CA--C 1.519 0.293 0 N-CA-C 119.282 2.473 . . . . 0.0 119.282 -176.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.1 t0 57.18 30.35 18.2 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 120.092 1.946 . . . . 0.0 112.078 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.0 p -146.77 139.56 25.18 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.56 1.544 . . . . 0.0 110.772 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -60.85 128.08 34.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.48 1.512 . . . . 0.0 112.585 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.49 174.99 13.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 127.419 2.287 . . . . 0.0 108.386 177.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -118.27 95.97 5.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.39 102.19 8.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.435 1.094 . . . . 0.0 109.79 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -97.06 152.42 18.77 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.26 1.391 . . . . 0.0 112.984 179.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -79.05 -31.57 42.6 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.301 0.953 . . . . 0.0 111.498 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 11.43 63.97 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 117.475 -1.736 . . . . 0.0 116.519 178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t 87.14 -12.31 0.53 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.78 2.432 . . . . 0.0 112.642 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -77.38 -169.52 32.47 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 107.401 -2.28 . . . . 0.0 107.401 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 93.44 4.49 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 102.455 -3.165 . . . . 0.0 102.455 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -102.89 165.38 11.07 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.261 1.424 . . . . 0.0 109.312 -178.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -142.06 98.46 3.33 Favored 'General case' 0 CA--C 1.51 -0.57 1 N-CA-C 99.315 -4.328 . . . . 0.0 99.315 177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.92 143.16 43.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.65 -1.159 . . . . 0.0 111.656 -177.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.16 131.29 30.17 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.123 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.23 -55.39 28.04 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 124.998 1.285 . . . . 0.0 110.739 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.09 -101.29 1.24 Allowed Glycine 0 CA--C 1.521 0.42 0 CA-C-O 118.897 -0.946 . . . . 0.0 112.318 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.44 94.37 2.5 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.34 -169.83 42.91 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.98 82.57 1.61 Allowed 'General case' 0 N--CA 1.429 -1.503 1 N-CA-C 98.874 -4.491 . . . . 0.0 98.874 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -126.56 165.06 19.86 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 127.421 2.288 . . . . 0.0 108.013 -176.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.506 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -132.31 155.01 41.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 119.762 1.165 . . . . 0.0 110.467 -178.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.79 164.93 27.11 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.838 0.855 . . . . 0.0 111.645 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.63 129.86 23.66 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.437 2.295 . . . . 0.0 109.747 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -74.81 -24.02 73.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 119.095 -0.836 . . . . 0.0 114.084 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.82 169.77 2.96 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.695 1.247 . . . . 0.0 111.747 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -72.57 105.41 4.2 Favored 'General case' 0 C--O 1.237 0.441 0 O-C-N 120.851 -1.382 . . . . 0.0 108.211 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.19 -169.61 35.4 Favored Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 126.456 1.979 . . . . 0.0 109.772 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HB3' ' HA ' ' A' ' 68' ' ' PHE . 5.7 ptt-85 -116.25 98.82 6.81 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 128.031 2.532 . . . . 0.0 106.361 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -111.81 163.03 14.62 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 125.15 1.38 . . . . 0.0 111.354 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.9 ttt180 -119.47 102.96 9.03 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.0 1.32 . . . . 0.0 109.696 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 pp -105.18 148.81 26.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -149.65 101.15 3.05 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.322 2.249 . . . . 0.0 105.123 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -63.88 -47.43 86.06 Favored Glycine 0 C--N 1.331 0.292 0 N-CA-C 115.787 1.075 . . . . 0.0 115.787 -177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.03 -174.82 34.55 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 -177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -60.65 122.24 14.23 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.948 0.874 . . . . 0.0 109.802 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.96 -178.21 31.78 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.57 76.58 0.98 Allowed 'General case' 0 C--O 1.237 0.433 1 N-CA-C 99.805 -4.146 . . . . 0.0 99.805 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.71 155.78 26.59 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 125.856 1.662 . . . . 0.0 111.836 -175.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.506 ' HB ' HG22 ' A' ' 33' ' ' ILE . 14.9 m -126.72 125.56 42.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.691 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -94.63 123.49 38.11 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.5 t -112.36 101.23 12.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -118.15 114.23 22.74 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 p -158.99 39.28 0.22 Allowed 'General case' 0 C--O 1.239 0.526 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.11 174.9 5.65 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 119.48 1.036 . . . . 0.0 111.064 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -62.71 -46.63 87.22 Favored 'General case' 0 N--CA 1.467 0.391 0 O-C-N 120.907 -1.121 . . . . 0.0 111.319 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 6.0 mt-10 -82.55 -37.39 25.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -77.75 65.33 3.2 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.957 1.303 . . . . 0.0 107.494 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.8 t -158.09 -36.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.295 1.038 . . . . 0.0 112.092 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -164.55 179.44 6.67 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.848 0.832 . . . . 0.0 110.597 -177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -114.16 155.02 26.82 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 177.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 p -135.08 161.27 35.79 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -58.31 -24.33 59.29 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.429 -0.32 . . . . 0.0 111.771 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 7.6 t -92.99 -20.22 20.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.844 0.858 . . . . 0.0 112.74 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HB1' ' CZ ' ' A' ' 68' ' ' PHE . . . -161.51 121.04 2.52 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 120.041 1.292 . . . . 0.0 113.338 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.0 t -89.74 134.62 28.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 125.073 1.349 . . . . 0.0 108.018 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.4 ' CZ ' ' HB1' ' A' ' 66' ' ' ALA . 36.0 m-85 -128.51 24.85 5.79 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.649 0.78 . . . . 0.0 110.616 178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.19 104.74 0.18 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 126.297 1.839 . . . . 0.0 111.92 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.49 155.08 40.47 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.133 1.373 . . . . 0.0 107.775 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.99 110.98 12.53 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.568 1.547 . . . . 0.0 108.344 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -99.64 134.76 37.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.82 162.71 13.93 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 31.12 60.25 0.25 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 128.436 2.695 . . . . 0.0 116.058 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HD11 ' A' ' 129' ' ' LEU . 39.9 t80 -62.72 146.15 53.04 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -136.86 73.54 1.45 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 119.889 1.222 . . . . 0.0 107.817 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.05 -17.06 0.1 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.411 1.884 . . . . 0.0 115.03 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -76.45 -28.06 56.41 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 118.391 -0.814 . . . . 0.0 111.366 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -131.01 -34.63 1.45 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.194 1.398 . . . . 0.0 113.851 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.4 161.01 14.96 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 123.666 1.698 . . . . 0.0 112.194 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 164.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 113.225 -1.807 . . . . 0.0 112.615 178.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.4 mt -135.78 146.71 29.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -113.36 116.15 29.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.67 13.3 2.31 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.146 0.978 . . . . 0.0 112.897 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.0 t -48.11 -34.99 10.62 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.018 0.927 . . . . 0.0 112.321 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -75.37 -33.75 61.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 93.04 2.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.509 1.049 . . . . 0.0 111.595 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.54 108.33 0.7 Allowed Glycine 0 C--N 1.333 0.381 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -66.31 170.84 5.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.38 -11.7 13.1 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.987 0.915 . . . . 0.0 112.549 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -93.92 104.52 3.17 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 106.714 -2.554 . . . . 0.0 106.714 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.72 151.88 45.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.4 -85.29 0.05 OUTLIER Glycine 0 C--N 1.331 0.272 0 N-CA-C 107.474 -2.251 . . . . 0.0 107.474 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -145.51 1.53 0.93 Allowed 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 25.31 64.34 Favored Glycine 0 N--CA 1.468 0.786 0 O-C-N 120.822 -1.174 . . . . 0.0 111.053 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -84.95 -72.54 0.47 Allowed 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.2 -104.78 2.33 Favored Glycine 0 C--N 1.308 -1.015 0 C-N-CA 126.859 2.171 . . . . 0.0 110.707 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.83 23.79 1.65 Allowed Glycine 0 CA--C 1.527 0.799 0 CA-C-O 118.653 -1.082 . . . . 0.0 110.985 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -131.44 162.89 29.16 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 119.129 1.465 . . . . 0.0 110.13 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.32 165.56 16.77 Favored 'General case' 0 N--CA 1.423 -1.816 0 C-N-CA 128.38 2.672 . . . . 0.0 107.346 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.8 tt -140.15 142.95 35.93 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 126.467 1.907 . . . . 0.0 107.129 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD12 ' C ' ' A' ' 102' ' ' LEU . 0.6 OUTLIER -129.36 143.3 50.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -148.69 170.4 18.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 123.622 0.769 . . . . 0.0 109.646 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 p -130.1 151.84 50.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.752 1.221 . . . . 0.0 109.511 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -70.03 178.24 2.82 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.35 0.66 . . . . 0.0 109.747 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.84 -49.83 67.54 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.374 0.67 . . . . 0.0 111.703 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -71.3 -34.24 70.44 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.148 0.579 . . . . 0.0 111.323 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.86 -9.57 63.94 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 128.307 2.86 . . . . 0.0 113.217 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.23 -9.72 58.83 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 125.209 1.404 . . . . 0.0 111.549 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -121.67 125.9 47.73 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 120.937 -1.102 . . . . 0.0 109.319 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.6 m -100.49 129.0 46.39 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.53 115.82 19.42 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 pp -124.25 164.43 19.58 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.616 1.167 . . . . 0.0 108.597 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 121.98 14.52 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.15 1.78 . . . . 0.0 109.204 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.5 107.47 18.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 46.75 76.28 0.11 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 126.74 2.016 . . . . 0.0 112.26 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.07 156.76 22.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -129.0 -113.09 0.26 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -109.5 155.3 21.51 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.004 0.922 . . . . 0.0 109.095 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.38 -13.07 11.23 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.628 1.571 . . . . 0.0 113.385 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -108.29 -38.86 5.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.838 0.855 . . . . 0.0 110.831 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -70.37 -68.57 1.6 Allowed Glycine 0 C--N 1.338 0.685 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.68 131.19 0.54 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.921 1.288 . . . . 0.0 110.148 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -136.76 127.38 27.03 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -80.95 121.79 26.46 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.546 0.738 . . . . 0.0 110.21 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -146.83 117.56 7.59 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.44 166.07 25.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 124.744 1.218 . . . . 0.0 107.956 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.82 123.58 26.37 Favored 'General case' 0 CA--C 1.522 -0.133 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' A' ' 75' ' ' PHE . 9.8 tt -123.38 123.87 41.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -107.15 107.09 17.9 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.443 1.097 . . . . 0.0 112.983 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.91 167.17 40.16 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 119.348 0.977 . . . . 0.0 113.769 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -105.69 -35.39 7.41 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 113.411 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -83.71 -1.2 53.6 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.629 1.172 . . . . 0.0 114.145 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.7 t -65.16 175.54 1.59 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.218 3.407 . . . . 0.0 111.137 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 97.05 -36.46 3.89 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -85.43 132.1 34.28 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.906 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -129.38 150.89 50.54 Favored 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 127.567 2.347 . . . . 0.0 105.413 178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.6 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 46.4 p -148.76 179.14 8.06 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 123.508 1.623 . . . . 0.0 106.996 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.47 -19.55 65.82 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 112.476 -2.147 . . . . 0.0 109.85 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.71 -14.7 26.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.322 1.449 . . . . 0.0 110.237 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.6 ' HB3' ' H ' ' A' ' 138' ' ' SER . 18.4 t-20 -91.33 -11.51 37.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.205 1.402 . . . . 0.0 111.564 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.7 t -134.85 141.21 43.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.755 1.222 . . . . 0.0 112.092 -178.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 77.1 t -84.81 131.17 34.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -87.13 -40.8 14.3 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.71 1.204 . . . . 0.0 109.137 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.71 121.16 0.69 Allowed 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 102.573 -3.121 . . . . 0.0 102.573 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.5 84.26 0.06 Allowed 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 125.237 1.415 . . . . 0.0 112.428 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 26.4 p -64.76 176.68 1.1 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.827 1.651 . . . . 0.0 111.057 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.63 -176.19 28.82 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.817 -0.513 . . . . 0.0 111.817 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.5 m -135.14 164.5 27.52 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.613 1.165 . . . . 0.0 108.376 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.22 90.04 2.56 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.853 2.061 . . . . 0.0 108.638 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -160.36 157.3 27.65 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.846 1.658 . . . . 0.0 106.8 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.68 143.74 55.81 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.91 -2.75 24.23 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.24 153.38 30.56 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.625 0.77 . . . . 0.0 109.3 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.39 26.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.51 2.324 . . . . 0.0 113.314 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.9 tp -54.35 151.44 7.51 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 126.63 1.972 . . . . 0.0 109.009 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -61.41 41.98 0.05 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 120.275 2.87 . . . . 0.0 120.275 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -150.05 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 120.778 2.289 . . . . 0.0 109.575 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.8 m -67.66 172.86 4.73 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.74 2.416 . . . . 0.0 113.021 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -74.77 -160.68 7.88 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.9 p -64.78 84.61 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.699 1.199 . . . . 0.0 109.579 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -150.82 81.99 1.34 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.223 1.409 . . . . 0.0 110.11 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.51 145.33 47.58 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.07 80.22 0.82 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 125.248 1.404 . . . . 0.0 111.778 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.29 167.92 23.91 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.938 2.495 . . . . 0.0 107.433 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.3 tt -140.04 -179.24 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 119.586 1.085 . . . . 0.0 111.176 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.252 1.228 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.605 0 N-CA-C 112.013 -0.435 . . . . 0.0 112.013 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.19 -169.85 2.59 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.362 1.465 . . . . 0.0 108.323 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -100.15 -50.25 4.03 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 126.435 1.894 . . . . 0.0 109.541 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.58 150.85 20.39 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 106.453 -2.659 . . . . 0.0 106.453 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -121.59 84.84 43.03 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.513 1.525 . . . . 0.0 110.581 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.34 136.45 40.13 Favored 'Trans proline' 0 C--N 1.354 0.837 1 C-N-CA 125.558 4.172 . . . . 0.0 112.437 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.93 114.08 21.52 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.028 1.331 . . . . 0.0 108.946 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.2 t -97.69 102.34 13.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.16 173.97 7.82 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 125.165 1.364 . . . . 0.0 111.491 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.65 -108.27 2.13 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 114.859 0.704 . . . . 0.0 114.859 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -148.55 17.32 1.03 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.786 2.035 . . . . 0.0 110.219 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 p -133.89 135.93 43.98 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.828 1.651 . . . . 0.0 109.359 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -63.86 151.11 43.32 Favored 'General case' 0 N--CA 1.452 -0.363 0 O-C-N 124.363 1.039 . . . . 0.0 112.893 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -179.36 176.29 0.85 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.251 2.22 . . . . 0.0 107.492 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' HA ' HG23 ' A' ' 33' ' ' ILE . 23.3 mt-30 -96.1 136.81 36.05 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.516 1.126 . . . . 0.0 110.143 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD11 ' HA2' ' A' ' 27' ' ' GLY . 57.3 mt -120.9 132.65 55.09 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.41 2.284 . . . . 0.0 109.018 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.11 110.74 8.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.97 -91.02 0.18 Allowed Glycine 0 C--O 1.238 0.373 0 N-CA-C 104.527 -3.429 . . . . 0.0 104.527 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.91 97.79 1.68 Allowed Glycine 0 N--CA 1.448 -0.534 0 O-C-N 122.023 -0.692 . . . . 0.0 113.212 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 38' ' ' ALA . 1.4 m 63.43 171.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.342 1.857 . . . . 0.0 113.81 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.0 -161.26 41.12 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.63 94.33 4.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.932 -2.247 . . . . 0.0 104.932 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -97.51 163.48 12.84 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -138.59 97.97 3.47 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 100.948 -3.723 . . . . 0.0 100.948 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.59 156.07 17.86 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 44' ' ' SER . 12.1 t70 -145.98 137.21 24.71 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 124.868 1.267 . . . . 0.0 108.702 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 16' ' ' LEU . . . -82.37 -51.22 4.46 Favored Glycine 0 N--CA 1.466 0.643 0 C-N-CA 124.742 1.163 . . . . 0.0 112.327 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.69 -89.7 0.47 Allowed Glycine 0 CA--C 1.522 0.505 0 CA-C-O 118.366 -1.241 . . . . 0.0 111.534 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.38 95.53 1.35 Allowed 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.835 1.317 . . . . 0.0 109.938 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 175.48 -169.03 41.73 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-O 123.11 1.395 . . . . 0.0 111.707 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.22 53.2 1.5 Allowed 'General case' 0 N--CA 1.406 -2.674 0 C-N-CA 130.512 3.525 . . . . 0.0 106.314 178.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.6 165.42 24.8 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 127.774 2.43 . . . . 0.0 112.816 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.499 HG23 ' HA ' ' A' ' 15' ' ' GLN . 16.9 tt -138.08 132.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pp -140.16 141.43 36.03 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 121.627 -0.67 . . . . 0.0 112.333 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -126.09 107.49 10.45 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 126.883 2.073 . . . . 0.0 106.723 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -54.68 -68.29 1.75 Allowed Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.981 1.753 . . . . 0.0 112.74 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 110.73 177.61 20.63 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.068 1.318 . . . . 0.0 113.909 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 20' ' ' SER . . . -65.14 107.24 1.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.517 1.127 . . . . 0.0 112.74 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.05 163.84 9.76 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 125.968 1.746 . . . . 0.0 110.046 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -70.56 97.37 1.31 Allowed 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.19 161.14 13.86 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 126.573 1.949 . . . . 0.0 110.855 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -127.7 100.06 5.81 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 pp -96.01 143.91 26.76 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 3.6 t -149.42 101.71 3.13 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 101.951 -3.352 . . . . 0.0 101.951 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -65.28 -59.64 7.64 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 136.79 -169.35 23.9 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 103.978 -3.649 . . . . 0.0 103.978 -178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.89 102.52 11.72 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 102.688 -3.079 . . . . 0.0 102.688 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.72 -170.71 37.47 Favored Glycine 0 CA--C 1.52 0.364 0 O-C-N 121.317 -0.864 . . . . 0.0 112.216 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.88 66.32 0.72 Allowed 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.71 164.03 19.88 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 123.469 0.707 . . . . 0.0 110.911 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.417 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 38.0 m -127.04 105.15 8.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -83.61 144.44 29.45 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.5 t -127.57 123.36 61.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 O-C-N 121.301 -0.874 . . . . 0.0 110.035 -178.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -107.72 107.12 17.76 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.0 p -130.24 -6.55 4.31 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.16 133.72 33.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 121.263 1.847 . . . . 0.0 114.881 -177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -62.89 -27.67 69.52 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.68 -29.19 51.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 116.543 -1.694 . . . . 0.0 111.234 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -81.56 -0.68 43.23 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 125.74 2.686 . . . . 0.0 113.437 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.5 m -69.46 -39.71 77.58 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 -177.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -154.52 -179.62 8.14 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 120.604 1.547 . . . . 0.0 108.671 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.32 157.59 21.63 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -125.06 176.25 6.81 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 124.434 1.083 . . . . 0.0 110.056 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -56.77 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.405 0 C-N-CA 128.893 2.877 . . . . 0.0 110.727 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 20.6 p 76.65 13.5 2.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 129.909 3.284 . . . . 0.0 113.805 179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.91 83.16 2.02 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' CG2' ' H ' ' A' ' 69' ' ' ASN . 0.2 OUTLIER -88.12 142.83 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -120.13 20.07 12.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.957 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.5 ' H ' ' CG2' ' A' ' 67' ' ' VAL . 0.5 OUTLIER -49.76 128.18 17.56 Favored 'General case' 0 C--N 1.343 0.311 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -178.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.66 156.0 29.23 Favored 'General case' 0 C--O 1.247 0.949 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.48 105.53 5.44 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.881 1.672 . . . . 0.0 107.385 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.2 mt -85.69 134.99 25.91 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 124.838 1.255 . . . . 0.0 108.511 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.0 mp -107.96 157.43 18.22 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 125.836 1.655 . . . . 0.0 108.407 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 29.8 55.62 0.15 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.85 2.86 . . . . 0.0 112.668 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD2' HD21 ' A' ' 129' ' ' LEU . 89.2 t80 -67.85 119.28 12.28 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.591 1.156 . . . . 0.0 110.962 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -134.09 82.87 2.0 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.65 1.58 . . . . 0.0 111.604 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.13 -10.62 0.88 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.375 1.47 . . . . 0.0 112.958 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 45.6 t -54.73 -40.27 69.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 120.148 1.34 . . . . 0.0 109.047 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -130.81 -21.36 2.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 117.897 -1.049 . . . . 0.0 112.516 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.95 163.73 21.48 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 119.126 0.876 . . . . 0.0 112.044 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HG2' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -149.41 154.76 39.38 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 125.254 1.422 . . . . 0.0 111.277 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.407 HG23 HG13 ' A' ' 142' ' ' VAL . 13.2 tt -132.09 124.94 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 O-C-N 121.64 -0.662 . . . . 0.0 111.299 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -87.63 95.61 10.12 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tp -116.95 -10.69 10.91 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.225 1.01 . . . . 0.0 113.296 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.7 p -66.18 -21.14 66.31 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.289 -0.882 . . . . 0.0 112.413 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.12 -47.69 78.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.193 1.397 . . . . 0.0 110.822 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.6 mp -126.89 87.66 2.69 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.595 1.558 . . . . 0.0 107.816 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.19 -97.45 0.13 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 107.921 -2.071 . . . . 0.0 107.921 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -166.32 173.53 9.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.071 0.948 . . . . 0.0 109.083 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 m -98.62 5.97 47.39 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.208 1.403 . . . . 0.0 112.773 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -166.45 -168.6 28.89 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 127.933 2.683 . . . . 0.0 109.573 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.06 179.97 3.85 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.782 1.233 . . . . 0.0 112.772 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.99 -108.74 0.24 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -133.4 10.71 4.1 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.782 0.791 . . . . 0.0 112.579 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.9 13.38 63.92 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 121.465 -0.772 . . . . 0.0 111.562 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -86.45 -138.92 0.09 Allowed 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 128.601 2.76 . . . . 0.0 106.814 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.8 63.06 0.0 OUTLIER Glycine 0 C--N 1.338 0.685 1 C-N-CA 131.769 4.509 . . . . 0.0 115.38 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 78.3 54.65 4.29 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 125.946 1.736 . . . . 0.0 110.717 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.3 p -134.61 -174.24 3.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.321 1.048 . . . . 0.0 108.349 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.49 137.83 32.38 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 119.94 1.246 . . . . 0.0 110.733 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.402 HD23 ' H ' ' A' ' 102' ' ' LEU . 1.0 OUTLIER -145.53 141.97 28.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.868 1.267 . . . . 0.0 111.569 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 1.1 pt? -134.92 148.88 50.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 128.185 2.594 . . . . 0.0 108.903 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 166.14 33.34 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.128 0.971 . . . . 0.0 108.493 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.434 ' HB ' ' HA2' ' A' ' 108' ' ' GLY . 2.6 p -92.79 152.04 19.68 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.661 0.743 . . . . 0.0 110.094 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.4 OUTLIER -70.28 172.74 7.7 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.1 -35.08 59.22 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.01 -22.15 36.67 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.434 ' HA2' ' HB ' ' A' ' 104' ' ' THR . . . 82.36 -13.04 42.31 Favored Glycine 0 CA--C 1.533 1.219 0 C-N-CA 126.37 1.938 . . . . 0.0 112.86 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 27.8 m -73.55 -17.47 61.19 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 111.462 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.436 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 78.4 mtm-85 -126.2 156.05 40.82 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 126.142 1.777 . . . . 0.0 109.898 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 m -126.55 150.4 48.84 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.683 1.593 . . . . 0.0 108.867 179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -132.05 118.88 20.25 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.613 2.365 . . . . 0.0 106.265 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 1.7 pt? -123.59 156.32 35.98 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.962 1.305 . . . . 0.0 109.133 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -148.73 128.82 13.6 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.298 0.639 . . . . 0.0 110.806 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.9 m -106.63 107.35 18.32 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.444 -1.688 . . . . 0.0 106.444 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.6 t80 44.72 88.32 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.42 2.288 . . . . 0.0 113.54 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.28 173.14 7.54 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.174 -0.954 . . . . 0.0 112.778 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -136.83 -146.44 0.23 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 109.311 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -106.03 157.78 17.28 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.31 2.244 . . . . 0.0 109.827 -178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.79 -26.5 2.42 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 116.162 1.912 . . . . 0.0 116.162 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -99.09 0.35 43.43 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 121.039 1.745 . . . . 0.0 110.672 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.54 -52.41 0.92 Allowed Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 126.701 2.096 . . . . 0.0 109.4 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 141.12 142.18 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 131.049 3.74 . . . . 0.0 107.008 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -130.0 144.0 51.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 120.514 -1.366 . . . . 0.0 108.892 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -81.21 126.27 31.3 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -142.97 120.03 11.39 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.206 1.002 . . . . 0.0 108.83 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.53 165.1 10.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 C-N-CA 127.668 2.387 . . . . 0.0 107.851 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.73 136.98 39.44 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.452 HD21 ' CD2' ' A' ' 75' ' ' PHE . 5.3 tt -127.29 121.18 30.41 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.5 107.1 17.8 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.692 0.62 . . . . 0.0 109.674 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 160.1 150.17 5.78 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 125.212 1.387 . . . . 0.0 110.061 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -147.59 27.43 1.0 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.649 1.98 . . . . 0.0 109.953 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -61.18 -58.93 6.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.119 1.368 . . . . 0.0 112.023 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.251 1.9 p -135.38 149.78 49.76 Favored 'General case' 0 N--CA 1.424 -1.755 0 C-N-CA 128.567 2.747 . . . . 0.0 106.719 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -125.47 22.87 6.13 Favored Glycine 0 N--CA 1.465 0.576 0 O-C-N 120.956 -1.09 . . . . 0.0 112.257 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -86.69 120.79 28.37 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.4 mp -119.64 116.06 25.23 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.2 m -151.35 171.92 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.046 4.138 . . . . 0.0 103.293 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.52 -14.53 5.23 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 125.238 1.415 . . . . 0.0 113.966 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.55 -34.18 60.7 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.807 0.843 . . . . 0.0 110.715 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -86.06 -94.21 0.08 Allowed 'General case' 0 C--N 1.343 0.32 0 C-N-CA 127.611 2.365 . . . . 0.0 108.956 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.407 HG13 HG23 ' A' ' 82' ' ' ILE . 49.0 t -72.51 131.79 34.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.73 127.95 23.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -77.7 -41.42 38.03 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 122.883 0.473 . . . . 0.0 111.503 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.64 107.54 0.07 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.468 1.907 . . . . 0.0 107.023 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.66 94.58 0.2 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 125.595 1.558 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.261 40.7 p 56.49 14.87 1.81 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 115.081 1.511 . . . . 0.0 115.081 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.58 159.52 42.55 Favored Glycine 0 C--N 1.338 0.654 0 O-C-N 121.128 -0.982 . . . . 0.0 112.43 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.1 p -136.15 -178.47 5.17 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.671 1.189 . . . . 0.0 110.403 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 p -74.78 91.31 2.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 128.782 2.833 . . . . 0.0 109.146 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 18.4 p -115.61 166.2 12.18 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.315 1.446 . . . . 0.0 112.912 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -100.48 143.45 30.64 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.066 1.346 . . . . 0.0 109.168 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.14 73.25 10.1 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.253 8.3 pt-20 41.88 40.97 1.71 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.913 2.085 . . . . 0.0 114.091 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 15.8 t -72.98 146.6 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -87.79 99.92 12.46 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -179.36 -165.49 33.63 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -80.67 -88.84 0.07 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.1 m -145.56 179.61 7.3 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 125.133 1.373 . . . . 0.0 109.351 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.15 100.0 1.49 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 124.171 0.891 . . . . 0.0 112.748 178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.2 t -66.09 119.69 11.85 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -156.06 -166.86 2.29 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.273 1.429 . . . . 0.0 108.336 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.05 158.59 19.18 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.16 0.584 . . . . 0.0 110.931 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -66.21 151.86 52.08 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -72.79 -179.77 3.28 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.758 1.623 . . . . 0.0 113.08 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.26 166.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.602 1.961 . . . . 0.0 108.55 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 C--O 1.245 0.82 0 C-N-CA 127.238 2.215 . . . . 0.0 105.302 179.371 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 107.753 -2.139 . . . . 0.0 107.753 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -89.46 121.6 31.85 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 124.812 1.245 . . . . 0.0 110.237 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.92 161.39 37.95 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 128.522 2.729 . . . . 0.0 107.014 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.94 -171.13 55.05 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 73.16 131.66 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.983 2.913 . . . . 0.0 115.033 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -59.16 113.1 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 124.504 3.469 . . . . 0.0 112.858 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.55 101.66 12.95 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.3 t -84.61 111.07 19.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 103.303 -2.851 . . . . 0.0 103.303 178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.6 -175.93 1.41 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 125.78 1.657 . . . . 0.0 113.674 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.3 -138.54 5.07 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 124.999 1.285 . . . . 0.0 113.289 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -140.7 13.89 2.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.652 3.581 . . . . 0.0 109.568 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.5 p -146.39 167.24 24.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.102 2.561 . . . . 0.0 111.34 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -52.32 128.06 24.12 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.839 2.856 . . . . 0.0 115.875 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -169.04 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 125.576 1.55 . . . . 0.0 109.143 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -128.16 115.69 18.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.736 2.014 . . . . 0.0 106.47 178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -97.67 116.93 30.84 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.087 0.955 . . . . 0.0 108.93 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.84 142.15 30.73 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.656 0.782 . . . . 0.0 111.919 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -107.61 -7.03 32.49 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.849 1.214 . . . . 0.0 113.688 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.92 -96.75 0.04 OUTLIER Glycine 0 CA--C 1.533 1.213 0 O-C-N 120.946 -1.326 . . . . 0.0 114.096 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 96.5 p -156.65 170.72 21.74 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.252 1.021 . . . . 0.0 112.863 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.99 -121.21 5.34 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 126.157 1.837 . . . . 0.0 114.526 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.96 93.26 3.94 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -117.97 166.58 12.34 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.569 1.148 . . . . 0.0 107.923 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.09 143.17 21.23 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.32 160.02 43.77 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.75 135.9 42.24 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 127.117 2.167 . . . . 0.0 108.049 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.27 -55.43 5.66 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.911 -0.875 . . . . 0.0 110.911 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.4 -106.98 2.08 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.883 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.94 100.88 3.56 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 118.737 1.268 . . . . 0.0 111.658 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.53 -152.42 17.77 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 122.724 1.18 . . . . 0.0 112.634 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -121.69 46.48 2.07 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 130.298 3.439 . . . . 0.0 104.132 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.24 164.29 17.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 127.284 2.234 . . . . 0.0 108.658 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -125.16 147.5 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.734 0.778 . . . . 0.0 109.461 -179.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.46 128.93 22.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.4 100.58 10.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.106 1.762 . . . . 0.0 107.227 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -51.56 -34.24 34.85 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 125.244 1.402 . . . . 0.0 115.029 -178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.01 -160.46 29.74 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -102.81 169.09 8.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.81 -165.61 32.14 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.4 ptt-85 -100.45 96.84 7.67 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.32 161.97 14.32 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 124.722 1.209 . . . . 0.0 109.079 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.479 HH21 ' HG ' ' A' ' 73' ' ' LEU . 1.1 tmt_? -126.47 105.22 8.6 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.466 1.506 . . . . 0.0 108.467 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.67 133.45 49.5 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 123.816 0.846 . . . . 0.0 110.26 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.94 89.93 2.34 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.13 -63.37 5.33 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 117.88 168.94 14.61 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -61.82 105.39 0.55 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.247 0.524 . . . . 0.0 110.801 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.34 43.58 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 128.323 2.868 . . . . 0.0 107.008 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.77 82.41 2.0 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p30 -79.29 167.39 20.99 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 126.544 1.937 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.426 ' HB ' HG22 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -135.26 105.82 6.45 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 179.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -83.82 115.34 22.2 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.742 1.156 . . . . 0.0 111.702 -177.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.8 t -90.25 116.74 32.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 122.615 0.366 . . . . 0.0 111.011 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -116.96 105.86 12.79 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.51 1.524 . . . . 0.0 108.38 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' HD13 ' A' ' 87' ' ' LEU . 5.7 t -159.15 72.79 0.57 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.817 0.735 . . . . 0.0 112.414 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.49 164.28 31.35 Favored 'General case' 0 CA--C 1.528 0.11 0 O-C-N 121.403 -0.811 . . . . 0.0 109.012 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -67.61 -59.88 2.99 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.643 -1.285 . . . . 0.0 109.719 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 60' ' ' SER . 4.1 mp0 -67.07 -10.65 52.26 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.86 -178.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -75.43 14.52 0.59 Allowed 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 124.982 2.325 . . . . 0.0 110.877 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 58' ' ' GLU . 7.4 t -123.69 -14.77 7.18 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.152 2.181 . . . . 0.0 112.732 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -165.43 170.2 14.78 Favored 'General case' 0 C--N 1.346 0.417 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.46 167.26 11.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 128.136 2.575 . . . . 0.0 109.233 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.73 165.43 27.52 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.66 -40.74 98.0 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.108 0.956 . . . . 0.0 109.203 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.4 p -53.38 -54.04 42.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 126.35 1.86 . . . . 0.0 109.138 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -156.87 148.7 22.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.31 137.81 28.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -121.26 51.28 1.29 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -73.35 119.21 17.27 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -72.68 153.31 41.26 Favored 'General case' 0 C--O 1.246 0.904 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.6 tp -143.86 105.82 4.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.059 0.944 . . . . 0.0 110.218 -178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -94.18 145.53 7.83 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.479 ' HG ' HH21 ' A' ' 42' ' ' ARG . 4.0 mm? -108.45 163.32 13.32 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.268 1.427 . . . . 0.0 109.434 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 17.38 46.98 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.568 1 C-N-CA 134.274 5.03 . . . . 0.0 115.743 177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -60.65 116.56 4.47 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.034 1.334 . . . . 0.0 113.713 -177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.28 83.2 1.99 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 133' ' ' HIS . . . -50.4 -15.41 0.24 Allowed 'General case' 0 C--O 1.24 0.589 0 N-CA-C 115.51 1.67 . . . . 0.0 115.51 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -60.4 -27.48 67.47 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.39 -35.22 0.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 116.28 -1.819 . . . . 0.0 114.377 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.59 158.87 23.16 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 121.558 1.981 . . . . 0.0 109.937 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.463 ' HG3' HH11 ' A' ' 81' ' ' ARG . 3.1 mmt85 -141.17 157.04 45.8 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 120.079 -1.638 . . . . 0.0 110.149 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.7 mt -134.51 124.73 45.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 124.342 1.057 . . . . 0.0 110.569 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -87.24 147.8 25.4 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.097 -1.002 . . . . 0.0 109.15 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.03 19.68 1.43 Allowed 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 125.455 1.502 . . . . 0.0 111.645 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.1 m -49.71 -41.82 44.33 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 120.71 -1.244 . . . . 0.0 111.214 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.01 -50.38 3.52 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 55' ' ' SER . 9.9 mp -98.91 112.67 24.71 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HD23 ' A' ' 100' ' ' LEU . . . 109.45 82.69 1.39 Allowed Glycine 0 CA--C 1.521 0.426 0 O-C-N 123.596 0.56 . . . . 0.0 111.969 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -64.2 159.93 19.6 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.166 -1.196 . . . . 0.0 111.046 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.4 t -68.67 -33.74 74.51 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.88 128.05 22.87 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 107.421 -2.271 . . . . 0.0 107.421 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.95 162.98 12.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.094 1.358 . . . . 0.0 111.109 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.74 -102.34 0.19 Allowed Glycine 0 CA--C 1.52 0.367 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -137.36 14.63 3.0 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.61 97.9 0.99 Allowed Glycine 0 C--N 1.333 0.407 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.81 -164.37 1.31 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.774 0.83 . . . . 0.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.48 -14.61 5.02 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.361 1.934 . . . . 0.0 116.114 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.0 28.5 0.19 Allowed Glycine 0 CA--C 1.524 0.607 0 C-N-CA 125.884 1.707 . . . . 0.0 109.124 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.15 161.01 35.56 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.456 HD23 ' HA2' ' A' ' 88' ' ' GLY . 3.1 tm? -147.68 138.7 23.48 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.006 1.323 . . . . 0.0 108.483 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.0 133.03 52.9 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.591 1.087 . . . . 0.0 110.122 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.57 140.72 44.87 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.454 1.901 . . . . 0.0 108.205 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -161.26 171.23 18.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.408 1.883 . . . . 0.0 109.674 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 21.4 p -131.71 162.33 30.71 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-O 122.472 1.13 . . . . 0.0 109.415 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -62.32 166.58 4.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.365 -1.289 . . . . 0.0 108.56 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.92 -50.0 58.5 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.857 1.208 . . . . 0.0 112.215 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -90.29 -13.76 34.62 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.164 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.29 12.89 60.9 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 124.228 0.918 . . . . 0.0 112.55 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.76 -26.11 67.88 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.896 1.848 . . . . 0.0 110.605 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -135.01 164.55 27.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.981 1.313 . . . . 0.0 110.464 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 28.1 m -126.31 136.96 53.39 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -123.51 115.52 21.68 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.5 pp -148.57 132.82 17.43 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.483 ' HE2' ' N ' ' A' ' 127' ' ' VAL . 0.6 OUTLIER -151.91 152.81 33.03 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 118.476 0.58 . . . . 0.0 112.117 179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -87.58 159.75 18.46 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 52.45 179.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.735 2.014 . . . . 0.0 114.461 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -165.56 169.39 15.47 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.242 1.417 . . . . 0.0 109.382 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 123' ' ' ARG . . . -173.51 -149.83 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.62 1.968 . . . . 0.0 108.609 178.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.25 157.75 29.62 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 129.232 3.013 . . . . 0.0 106.143 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -32.74 -51.53 0.29 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.771 1.628 . . . . 0.0 113.369 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -79.17 -38.76 35.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.541 1.137 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -68.56 -15.59 68.63 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 116.436 -2.313 . . . . 0.0 116.207 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 118' ' ' ALA . 51.8 mtt-85 105.61 90.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 130.281 3.433 . . . . 0.0 113.609 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.7 mtm180 -93.96 161.04 14.46 Favored 'General case' 0 C--O 1.224 -0.257 0 O-C-N 119.165 -2.209 . . . . 0.0 108.781 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -82.36 149.91 27.46 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 126.683 1.993 . . . . 0.0 114.606 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.72 110.38 1.12 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.736 1.215 . . . . 0.0 112.395 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.483 ' N ' ' HE2' ' A' ' 114' ' ' LYS . 91.6 t -147.18 154.85 11.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -136.53 121.29 18.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.6 tt -111.04 121.11 44.51 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -107.95 107.21 17.82 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.513 1.525 . . . . 0.0 110.564 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -170.2 166.05 39.3 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.04 -41.52 28.64 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.838 2.455 . . . . 0.0 110.514 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 13.8 m-70 -79.26 51.41 1.19 Allowed 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 123.421 1.582 . . . . 0.0 109.336 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t -52.87 107.11 0.19 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.748 2.819 . . . . 0.0 113.16 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.26 23.05 63.86 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 121.154 -0.966 . . . . 0.0 113.089 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.37 105.24 17.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -112.08 154.34 25.56 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 125.324 1.45 . . . . 0.0 110.474 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 64.5 m -153.91 175.18 13.66 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.49 -18.75 20.38 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.37 -40.37 8.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 119.495 1.043 . . . . 0.0 110.306 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -57.96 -17.62 18.25 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 126.508 1.923 . . . . 0.0 112.51 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.34 145.12 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 126.05 1.74 . . . . 0.0 110.019 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 46.0 t -111.34 110.74 33.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.47 -53.88 53.07 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.364 0.666 . . . . 0.0 112.356 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.36 92.77 0.12 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 127.297 2.239 . . . . 0.0 105.18 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -166.69 80.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.576 1.55 . . . . 0.0 108.995 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.4 t -79.08 -3.35 44.9 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 117.422 -1.275 . . . . 0.0 114.001 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.58 -36.5 0.13 Allowed Glycine 0 C--N 1.34 0.801 0 CA-C-N 121.771 2.078 . . . . 0.0 116.434 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -67.94 96.45 0.6 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.094 1.447 . . . . 0.0 109.071 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 161' ' ' THR . 0.3 OUTLIER -66.7 155.29 38.45 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 121.819 -0.55 . . . . 0.0 109.653 179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 t -116.47 4.22 13.29 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.012 1.325 . . . . 0.0 110.229 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -165.68 -159.72 0.42 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.686 3.994 . . . . 0.0 105.899 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 56.59 28.7 14.36 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.445 2.298 . . . . 0.0 110.254 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -80.94 99.69 8.52 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.22 153.51 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.63 1.172 . . . . 0.0 110.231 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.33 87.86 4.99 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.434 1.494 . . . . 0.0 110.822 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 147.6 -31.38 1.38 Allowed Glycine 0 CA--C 1.521 0.458 0 CA-C-O 119.217 -0.769 . . . . 0.0 113.091 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -77.98 172.27 13.75 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 117.966 0.883 . . . . 0.0 110.554 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.9 m -57.49 146.61 29.19 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.8 0.84 . . . . 0.0 110.099 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -91.56 155.32 23.25 Favored Glycine 0 CA--C 1.528 0.848 0 O-C-N 121.503 -0.748 . . . . 0.0 112.228 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 150' ' ' THR . 4.4 p -78.77 172.74 13.31 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 117.731 0.765 . . . . 0.0 112.401 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.1 tp60 61.46 52.99 3.51 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.96 2.104 . . . . 0.0 110.605 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -89.47 100.62 13.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.08 -177.76 52.04 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.715 1.175 . . . . 0.0 112.757 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -128.0 171.11 12.14 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.083 1.753 . . . . 0.0 110.543 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 8.2 tt -142.66 -16.87 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.007 1.323 . . . . 0.0 111.516 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 C--O 1.245 0.85 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 178.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.916 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 t -153.17 163.07 40.54 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.513 1.157 . . . . 0.0 108.467 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 33.0 t70 35.07 59.6 0.72 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 128.197 2.599 . . . . 0.0 113.598 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -68.73 171.16 38.52 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -135.03 144.17 49.11 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 125.447 1.499 . . . . 0.0 107.735 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.06 151.26 27.03 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.318 2.012 . . . . 0.0 112.385 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -125.38 121.95 35.37 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.0 t -102.74 116.89 47.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.12 162.88 42.5 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 121.505 0.503 . . . . 0.0 112.538 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.03 -165.78 30.05 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 125.197 1.38 . . . . 0.0 115.093 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -115.46 -4.6 12.29 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 127.097 2.159 . . . . 0.0 114.384 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.4 p -130.99 143.25 50.58 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 128.243 2.617 . . . . 0.0 104.475 178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -49.39 129.48 18.75 Favored 'General case' 0 C--O 1.238 0.494 0 O-C-N 124.153 0.908 . . . . 0.0 113.052 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -141.26 167.32 22.46 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.431 1.492 . . . . 0.0 107.927 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -111.41 104.4 12.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 102.37 -3.196 . . . . 0.0 102.37 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -102.01 127.15 49.01 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 125.83 1.652 . . . . 0.0 110.405 -177.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -133.71 147.83 51.4 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.844 0.857 . . . . 0.0 112.357 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.78 -43.47 0.87 Allowed Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.947 1.736 . . . . 0.0 109.264 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.94 -174.47 51.25 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.442 1.496 . . . . 0.0 110.037 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 51.0 p -69.03 125.32 26.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 121.32 -1.106 . . . . 0.0 110.231 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 155.42 -146.29 13.99 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.1 94.4 4.25 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 103.598 -2.741 . . . . 0.0 103.598 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -123.62 163.22 21.45 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.549 1.068 . . . . 0.0 109.098 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.9 99.07 2.94 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 120.021 -1.674 . . . . 0.0 106.639 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -109.92 143.49 39.78 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.053 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -119.05 124.91 48.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -40.02 -53.21 3.26 Favored Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 128.806 3.098 . . . . 0.0 114.061 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.13 -116.8 3.63 Favored Glycine 0 C--O 1.241 0.546 0 CA-C-O 118.819 -0.99 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.91 82.31 0.94 Allowed 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.225 1.012 . . . . 0.0 110.549 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.38 -153.65 14.86 Favored Glycine 0 N--CA 1.45 -0.405 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -101.19 53.34 0.84 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.921 2.488 . . . . 0.0 105.874 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -77.37 163.44 26.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 122.709 1.242 . . . . 0.0 110.131 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 pt -135.66 94.42 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pp -101.24 151.07 22.31 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.613 -1.304 . . . . 0.0 112.242 -179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.54 111.31 5.74 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 127.747 2.419 . . . . 0.0 107.966 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.57 -68.64 1.59 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.87 -177.6 16.5 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 125.56 1.553 . . . . 0.0 111.715 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.61 108.27 2.0 Allowed 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.718 -0.872 . . . . 0.0 111.807 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 151.36 170.27 18.03 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 125.332 1.444 . . . . 0.0 110.589 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.404 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -88.15 97.19 10.86 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 177.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.91 162.51 14.75 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.742 0.817 . . . . 0.0 109.275 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -121.07 107.8 13.06 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.734 1.214 . . . . 0.0 108.848 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.48 152.41 24.26 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.76 1.224 . . . . 0.0 108.721 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -149.58 94.87 2.25 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.46 7.89 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.19 -170.84 15.39 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.23 104.22 6.65 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.07 -161.45 20.6 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 128.359 2.885 . . . . 0.0 107.671 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.8 65.46 1.54 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 101.678 -3.452 . . . . 0.0 101.678 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.51 168.6 19.7 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 129.231 3.012 . . . . 0.0 115.734 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -132.13 101.69 5.49 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 126.733 2.013 . . . . 0.0 111.69 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -84.77 101.42 12.22 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 72.6 t -95.49 139.35 19.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 120.968 -1.082 . . . . 0.0 110.932 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -146.26 153.03 40.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.078 1.351 . . . . 0.0 108.037 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.8 p -172.44 9.57 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 119.588 3.181 . . . . 0.0 119.588 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.41 166.81 12.21 Favored 'General case' 0 C--N 1.352 0.706 0 CA-C-N 125.646 3.839 . . . . 0.0 114.439 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -63.71 -21.05 66.2 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 116.755 2.131 . . . . 0.0 116.755 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.68 -38.22 14.95 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 122.23 2.286 . . . . 0.0 106.488 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -88.35 76.04 8.4 Favored 'General case' 0 C--N 1.348 0.507 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.2 m -150.28 -28.56 0.23 Allowed 'General case' 0 N--CA 1.433 -1.302 0 O-C-N 120.932 -1.105 . . . . 0.0 112.59 -178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.9 -179.76 5.43 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 119.391 0.996 . . . . 0.0 109.072 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.0 OUTLIER -114.65 162.34 16.91 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 176.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.589 HG22 ' HG3' ' A' ' 123' ' ' ARG . 56.0 p -129.51 160.42 33.25 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -64.05 -38.75 92.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.9 p -66.67 -34.41 77.8 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.804 1.642 . . . . 0.0 113.662 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -162.22 132.57 4.79 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.221 0.919 . . . . 0.0 111.165 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 69' ' ' ASN . 86.0 t -97.41 149.08 5.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -135.7 21.46 3.33 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.343 1.857 . . . . 0.0 109.553 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.533 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -58.97 116.74 4.0 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.736 1.214 . . . . 0.0 112.693 -179.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.12 151.21 43.19 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.169 1.388 . . . . 0.0 109.79 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.77 110.93 7.34 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.8 mt -100.8 138.95 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.7 tp -109.42 153.42 24.03 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.025 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.8 t0 25.99 73.74 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.355 3.862 . . . . 0.0 113.996 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -85.71 127.97 34.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.666 0.786 . . . . 0.0 110.421 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -104.33 76.21 1.3 Allowed 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -49.28 -28.41 4.73 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.912 1.233 . . . . 0.0 113.239 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -61.3 -26.32 67.71 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.469 1.108 . . . . 0.0 111.256 178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -131.16 -39.99 1.16 Allowed 'General case' 0 N--CA 1.465 0.305 0 O-C-N 120.458 -1.401 . . . . 0.0 114.625 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -64.55 158.95 22.81 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 123.66 1.695 . . . . 0.0 111.732 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -133.66 165.14 25.61 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.343 2.657 . . . . 0.0 108.926 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.4 mt -144.9 121.18 4.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.89 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -106.39 94.78 5.33 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 120.969 1.713 . . . . 0.0 108.357 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -115.95 17.46 15.93 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.223 1.409 . . . . 0.0 110.139 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 65.4 p -52.99 -45.73 68.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.606 -0.684 . . . . 0.0 111.575 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.26 -11.93 36.39 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.1 mt -117.76 68.79 0.77 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 120.164 1.347 . . . . 0.0 109.39 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.81 83.27 0.06 OUTLIER Glycine 0 C--N 1.337 0.62 0 N-CA-C 116.71 1.444 . . . . 0.0 116.71 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -150.17 177.0 10.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.273 1.829 . . . . 0.0 107.121 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.1 t 109.13 -2.48 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.732 1 C-N-CA 136.521 5.928 . . . . 0.0 107.582 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.99 -176.59 20.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 126.404 1.954 . . . . 0.0 110.3 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.21 163.17 12.79 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 119.093 1.446 . . . . 0.0 110.811 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -177.82 -68.85 0.06 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.4 t0 147.98 71.19 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 130.572 3.549 . . . . 0.0 110.741 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.17 42.69 97.28 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -115.69 -160.58 0.75 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.125 1.37 . . . . 0.0 108.592 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.26 74.66 0.01 OUTLIER Glycine 0 C--N 1.332 0.358 0 C-N-CA 130.13 3.729 . . . . 0.0 112.266 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.82 35.66 6.73 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 126.998 2.237 . . . . 0.0 112.346 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.259 6.2 p -135.37 169.57 17.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.273 1.537 . . . . 0.0 112.281 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 115' ' ' SER . 0.5 OUTLIER -163.12 127.18 2.91 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 125.025 1.33 . . . . 0.0 111.695 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.3 tp -146.28 155.09 42.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.124 0.569 . . . . 0.0 110.855 177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.3 mt -89.99 154.95 19.44 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -152.66 171.08 18.73 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.787 1.176 . . . . 0.0 112.063 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -124.55 165.66 17.43 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 121.724 0.773 . . . . 0.0 112.528 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -71.93 174.38 7.06 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.825 1.65 . . . . 0.0 108.707 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.52 -49.28 77.96 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.838 1.199 . . . . 0.0 109.827 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -79.99 -20.38 45.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.449 -0.782 . . . . 0.0 110.122 178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 78.91 12.22 84.38 Favored Glycine 0 CA--C 1.528 0.895 0 CA-C-O 118.773 -1.015 . . . . 0.0 111.337 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.5 m -69.16 -27.43 65.52 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.178 1.489 . . . . 0.0 109.006 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -119.54 160.36 22.55 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.589 1.956 . . . . 0.0 108.146 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 93.6 m -127.22 131.31 50.66 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.766 2.026 . . . . 0.0 108.208 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -134.91 117.82 16.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.88 1.672 . . . . 0.0 107.508 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.534 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.3 pt? -91.98 164.74 13.52 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.147 -0.971 . . . . 0.0 109.153 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -138.94 122.7 17.59 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 123.706 0.803 . . . . 0.0 110.897 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.462 ' HB2' HD23 ' A' ' 100' ' ' LEU . 13.5 t -124.6 141.13 52.32 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 177.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.1 t80 3.68 83.15 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 129.042 2.937 . . . . 0.0 116.343 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -91.39 171.31 9.29 Favored 'General case' 0 N--CA 1.469 0.49 0 O-C-N 121.644 -0.66 . . . . 0.0 110.266 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -141.77 -146.12 0.19 Allowed 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.961 1.705 . . . . 0.0 108.258 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -86.56 148.0 25.7 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.646 1.978 . . . . 0.0 108.334 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.42 -9.84 28.74 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.28 -38.2 12.81 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.869 1.268 . . . . 0.0 109.031 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.08 -72.82 1.09 Allowed Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 107.329 -2.309 . . . . 0.0 107.329 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' HG22 ' A' ' 63' ' ' THR . 4.8 mtp180 -174.83 144.43 0.8 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.591 1.556 . . . . 0.0 109.558 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 152.68 48.91 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.607 0.639 . . . . 0.0 111.226 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -86.31 135.16 33.64 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 118.917 -0.563 . . . . 0.0 111.964 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -160.9 112.73 1.88 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.302 0.641 . . . . 0.0 111.012 176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 69' ' ' ASN . 40.0 t -139.13 142.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.79 127.72 53.06 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.246 1.019 . . . . 0.0 110.965 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 29.3 tp -111.69 132.99 54.23 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.15 1.78 . . . . 0.0 106.941 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -82.71 137.14 34.52 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 121.474 1.943 . . . . 0.0 108.556 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -31.25 130.96 0.17 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 130.093 3.711 . . . . 0.0 116.477 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -106.96 159.52 16.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 130.26 3.424 . . . . 0.0 109.222 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -71.07 -30.32 66.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.342 2.657 . . . . 0.0 110.86 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.4 t -139.04 125.29 20.2 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 33.9 4.92 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -84.82 145.44 27.85 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.817 1.647 . . . . 0.0 114.633 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -130.7 138.77 50.17 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 125.852 1.661 . . . . 0.0 112.36 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.26 -173.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 128.725 2.81 . . . . 0.0 105.108 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.07 -19.56 45.3 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.455 1.902 . . . . 0.0 113.196 -178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.61 -51.57 8.58 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.45 -29.4 59.64 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.6 t -141.45 149.17 20.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 123.157 0.583 . . . . 0.0 110.938 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.6 t -93.01 104.93 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -66.63 -54.53 22.32 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.2 114.15 0.31 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.993 2.917 . . . . 0.0 104.579 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.24 91.38 0.11 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.04 0.936 . . . . 0.0 110.336 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 58.7 p -129.21 -170.91 2.37 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.076 1.351 . . . . 0.0 110.489 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.3 165.8 53.12 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.7 t -149.41 178.63 8.62 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.878 -0.778 . . . . 0.0 110.014 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 21.2 p -66.76 167.27 11.59 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.081 1.352 . . . . 0.0 112.132 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.5 m -163.99 152.29 13.09 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 127.252 2.221 . . . . 0.0 106.457 178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -143.95 113.74 7.18 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 13.4 tp -134.95 10.97 3.62 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.354 1.462 . . . . 0.0 110.623 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.36 172.17 8.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.258 1.423 . . . . 0.0 110.495 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 p -76.44 141.7 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -57.57 130.51 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.577 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 173.0 -51.8 0.16 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -158.24 175.44 13.76 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 129.392 3.077 . . . . 0.0 105.146 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.2 t -148.01 140.03 24.08 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 120.758 1.617 . . . . 0.0 108.776 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -58.0 -25.14 56.12 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.35 -0.694 . . . . 0.0 113.58 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.5 p -118.87 11.26 12.55 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.705 1.202 . . . . 0.0 112.403 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -154.7 96.26 1.86 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 119.11 0.868 . . . . 0.0 110.345 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.59 121.58 10.67 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.582 0.753 . . . . 0.0 111.178 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -102.21 -174.82 27.59 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.564 1.554 . . . . 0.0 111.876 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -157.33 160.47 38.55 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.886 1.675 . . . . 0.0 107.884 179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 39.1 pt -138.87 -155.37 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.066 1.746 . . . . 0.0 108.535 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.249 1.041 0 C-N-CA 127.99 2.516 . . . . 0.0 105.037 179.263 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.445 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -89.42 123.37 33.51 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -90.52 -16.91 27.98 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.43 -146.82 20.73 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.301 1.429 . . . . 0.0 110.946 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -141.83 88.07 9.67 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.874 2.07 . . . . 0.0 108.822 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.14 150.47 37.62 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.08 2.52 . . . . 0.0 110.924 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.97 113.05 16.65 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.01 122.54 68.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' HA3' HD21 ' A' ' 16' ' ' LEU . . . -89.93 -153.51 28.41 Favored Glycine 0 C--O 1.24 0.525 0 C-N-CA 126.734 2.111 . . . . 0.0 109.377 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -163.53 -75.22 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -159.26 -22.55 0.07 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 p -82.11 118.8 23.32 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -58.06 130.92 48.8 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 125.093 1.496 . . . . 0.0 113.094 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -164.31 -166.45 1.12 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.94 1.696 . . . . 0.0 106.803 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.558 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 46.2 mt-30 -116.4 126.94 54.15 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.402 HD21 ' HA3' ' A' ' 9' ' ' GLY . 2.5 mp -117.99 95.47 4.93 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 126.104 1.761 . . . . 0.0 108.608 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.72 112.08 21.52 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 123.766 0.826 . . . . 0.0 110.377 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.56 -45.9 50.8 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.19 146.45 20.93 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.94 1.733 . . . . 0.0 110.436 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -40.15 124.59 1.88 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.451 1.9 . . . . 0.0 112.977 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.13 -147.83 14.93 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 107.077 -2.409 . . . . 0.0 107.077 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 93.25 3.9 Favored 'General case' 0 C--O 1.235 0.298 1 N-CA-C 98.181 -4.748 . . . . 0.0 98.181 175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' H ' ' CG ' ' A' ' 41' ' ' ASP 0.384 58.0 m-20 -126.62 168.05 14.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.467 1.107 . . . . 0.0 113.412 -175.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -127.62 109.21 11.46 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.621 -1.299 . . . . 0.0 113.146 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.405 ' CD1' ' HB2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -98.44 144.09 28.18 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.469 2.308 . . . . 0.0 110.263 -179.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -153.18 109.73 3.4 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.469 1.108 . . . . 0.0 108.426 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.64 -67.04 1.91 Allowed Glycine 0 N--CA 1.449 -0.445 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.78 -74.88 0.35 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 106.96 -2.456 . . . . 0.0 106.96 -177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.67 168.49 16.19 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.501 1.92 . . . . 0.0 108.765 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.14 -158.5 16.83 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 115.139 0.815 . . . . 0.0 115.139 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -125.81 47.08 2.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 131.163 3.785 . . . . 0.0 106.618 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.64 165.8 12.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.917 2.487 . . . . 0.0 108.977 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.558 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 18.9 tt -123.18 116.41 48.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -119.86 147.06 45.15 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.525 0.678 . . . . 0.0 110.862 -179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -146.3 116.39 7.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 125.529 1.532 . . . . 0.0 110.155 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.7 -58.91 12.12 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 105.42 -3.072 . . . . 0.0 105.42 177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.08 172.54 13.12 Favored Glycine 0 N--CA 1.438 -1.22 0 C-N-CA 128.162 2.791 . . . . 0.0 106.97 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.33 107.11 7.22 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 104.525 -2.398 . . . . 0.0 104.525 178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.19 -177.56 31.54 Favored Glycine 0 N--CA 1.435 -1.421 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.555 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -80.69 96.7 6.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -123.13 161.53 24.25 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 123.719 0.808 . . . . 0.0 111.017 -177.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -111.65 115.88 29.85 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.23 144.99 49.03 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 108.488 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.8 t -149.22 118.16 6.7 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.12 -62.5 2.75 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 106.029 -2.829 . . . . 0.0 106.029 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.83 -162.14 12.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 106.842 -2.503 . . . . 0.0 106.842 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.64 102.84 10.94 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.93 174.18 44.02 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.81 59.48 0.74 Allowed 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -76.89 164.7 25.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.346 1.058 . . . . 0.0 109.946 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.0 m -118.83 133.25 55.97 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.317 1.447 . . . . 0.0 108.11 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -114.32 129.62 56.65 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.473 1.109 . . . . 0.0 108.3 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.52 111.81 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 123.699 0.8 . . . . 0.0 109.39 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.55 160.87 34.01 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 128.209 2.604 . . . . 0.0 105.49 179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.741 ' HA ' HD13 ' A' ' 87' ' ' LEU 0.392 77.3 p 87.73 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 128.937 2.895 . . . . 0.0 109.26 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.85 174.71 5.83 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 122.443 1.116 . . . . 0.0 111.897 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -51.04 -71.83 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.878 2.071 . . . . 0.0 113.924 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.81 -13.31 59.93 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.182 -0.949 . . . . 0.0 111.505 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.66 2.61 6.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 125.444 2.545 . . . . 0.0 114.539 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.3 m -74.62 -48.62 25.38 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 117.924 2.565 . . . . 0.0 117.924 -177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -166.87 -179.88 4.95 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 119.94 1.245 . . . . 0.0 111.44 -177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -116.35 158.76 22.94 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.754 1.622 . . . . 0.0 108.877 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.5 p -140.13 162.21 35.79 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -68.1 -12.03 60.13 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.442 -0.786 . . . . 0.0 110.819 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 64.1 p -110.92 -15.13 13.84 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.461 1.504 . . . . 0.0 111.591 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.12 81.49 1.37 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.823 -1.173 . . . . 0.0 111.993 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 69' ' ' ASN . 67.7 t -83.45 131.5 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -124.85 27.84 6.66 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.29 1.436 . . . . 0.0 108.51 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.473 ' H ' HG12 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -65.95 102.4 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.048 1.739 . . . . 0.0 109.647 -179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.96 156.67 39.0 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 127.912 2.485 . . . . 0.0 108.926 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.5 tp -131.26 104.19 6.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.0 mt -91.08 138.66 19.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.26 157.41 18.37 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.279 1.432 . . . . 0.0 110.899 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 20.93 56.45 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.644 1 C-N-CA 132.323 4.249 . . . . 0.0 114.594 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -71.15 142.55 50.72 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 112.008 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -141.4 95.74 2.88 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.277 1.831 . . . . 0.0 110.254 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.26 -14.32 6.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.204 1.402 . . . . 0.0 113.417 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.0 m -64.31 -11.68 34.41 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.517 1.527 . . . . 0.0 112.546 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -155.92 -39.68 0.08 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 120.889 1.677 . . . . 0.0 112.718 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -65.85 158.76 27.02 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -135.91 154.73 51.04 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.99 138.43 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.536 -1.353 . . . . 0.0 111.624 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -87.21 126.49 34.84 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.598 -1.314 . . . . 0.0 110.075 177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 mp -133.28 22.47 4.07 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.674 1.125 . . . . 0.0 109.903 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 t -60.15 -32.2 70.81 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.737 -1.227 . . . . 0.0 112.334 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -15.47 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.741 HD13 ' HA ' ' A' ' 55' ' ' SER . 8.0 mp -126.18 115.45 19.79 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.12 109.93 3.43 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -69.75 174.65 4.92 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.184 0.994 . . . . 0.0 111.515 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -17.99 62.25 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.329 0.652 . . . . 0.0 111.623 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.13 103.46 2.48 Favored Glycine 0 C--N 1.337 0.604 0 O-C-N 121.445 -0.785 . . . . 0.0 113.934 -178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.38 171.24 12.59 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 179.33 -97.74 0.11 Allowed Glycine 0 N--CA 1.462 0.386 0 O-C-N 120.819 -1.176 . . . . 0.0 112.457 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -139.68 -3.49 1.47 Allowed 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.93 50.82 6.16 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.503 -1.165 . . . . 0.0 112.226 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -133.78 -58.36 0.87 Allowed 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -117.06 76.28 0.28 Allowed Glycine 0 C--N 1.31 -0.917 0 C-N-CA 127.272 2.368 . . . . 0.0 112.011 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 66.63 13.5 61.11 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.476 1.036 . . . . 0.0 113.065 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 20.0 p -102.23 173.26 6.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.458 1.503 . . . . 0.0 110.1 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 5.8 tt -151.5 131.55 13.45 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.828 1.651 . . . . 0.0 106.592 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 33.5 tp -145.56 154.84 42.62 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.082 1.353 . . . . 0.0 109.976 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.569 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.1 pt? -122.07 154.71 36.97 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.176 1.79 . . . . 0.0 109.823 178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.4 tptt -145.61 171.85 14.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.124 2.169 . . . . 0.0 107.631 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 61.6 p -122.69 157.18 32.85 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.561 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.9 OUTLIER -65.51 -178.2 0.5 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.271 0.628 . . . . 0.0 111.371 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.74 -47.41 50.76 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.548 1.139 . . . . 0.0 112.106 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.55 -26.13 50.69 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.271 1.028 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.83 71.0 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.309 1.433 . . . . 0.0 114.792 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.9 p -69.66 -42.49 74.14 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 125.251 1.42 . . . . 0.0 111.558 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.561 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 64.2 mtm180 -87.49 138.88 31.09 Favored 'General case' 0 CA--C 1.505 -0.769 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 25.9 m -111.84 137.39 49.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.08 118.64 23.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.75 149.61 50.16 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.066 1.346 . . . . 0.0 110.083 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 0.8 OUTLIER -146.4 137.7 24.48 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.521 0.728 . . . . 0.0 111.566 178.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 27.2 t -106.31 133.45 50.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.194 1.798 . . . . 0.0 106.855 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.3 t80 17.65 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 129.278 3.031 . . . . 0.0 113.328 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -87.36 160.58 18.31 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 121.337 -0.852 . . . . 0.0 111.07 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -119.23 -138.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.255 1.022 . . . . 0.0 110.021 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.1 p-10 -91.95 155.5 18.11 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 127.256 2.223 . . . . 0.0 111.997 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.51 -3.13 4.0 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.376 1.87 . . . . 0.0 112.386 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -111.54 -12.46 13.95 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 124.737 1.215 . . . . 0.0 112.719 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -107.46 -68.69 0.67 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.71 139.25 0.53 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 109.359 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 mtp85 -137.83 135.51 36.3 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 1.3 t80 -81.95 124.16 29.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.5 124.78 12.98 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.76 166.22 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.747 1.219 . . . . 0.0 108.675 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -133.41 122.79 24.24 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 124.146 0.978 . . . . 0.0 110.549 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 62.2 tp -119.04 123.54 44.75 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.885 1.274 . . . . 0.0 109.255 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.72 45.32 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.719 1.608 . . . . 0.0 107.072 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.87 -163.69 27.76 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -134.73 -67.77 0.55 Allowed 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -84.22 64.94 8.55 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.753 2.021 . . . . 0.0 105.603 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 12.2 t -130.94 170.18 14.8 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.476 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 102.89 -43.93 1.59 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -72.15 121.46 19.33 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.409 1.099 . . . . 0.0 109.576 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.87 142.26 50.36 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 125.491 1.517 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.4 m -154.18 -178.42 7.1 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 127.527 2.331 . . . . 0.0 105.532 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -60.41 3.23 0.08 Allowed 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.958 2.903 . . . . 0.0 115.791 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.15 -0.62 5.17 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 125.5 1.52 . . . . 0.0 111.521 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.45 -23.38 9.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 126.625 1.97 . . . . 0.0 108.428 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 75.5 t -134.4 147.95 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 125.005 1.322 . . . . 0.0 109.975 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 28.1 t -98.01 122.4 49.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 122.748 1.261 . . . . 0.0 108.222 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -75.09 -51.29 13.85 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.966 2.506 . . . . 0.0 109.438 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -172.59 118.47 0.36 Allowed 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 130.576 3.55 . . . . 0.0 107.727 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 3.21 107.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 131.479 3.912 . . . . 0.0 115.637 178.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.1 t -121.83 -156.53 0.69 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.721 2.008 . . . . 0.0 108.887 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -179.16 78.88 0.06 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.616 1.103 . . . . 0.0 110.707 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.3 m -132.84 114.77 14.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.176 0.99 . . . . 0.0 108.966 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.5 p -66.61 23.04 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.219 3.408 . . . . 0.0 114.833 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.1 m 67.48 -19.07 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.151 2.181 . . . . 0.0 115.074 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -122.99 179.56 4.61 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 126.687 1.995 . . . . 0.0 110.252 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.92 -11.8 1.28 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.101 1.76 . . . . 0.0 111.08 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -91.32 154.21 19.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.416 1.487 . . . . 0.0 107.045 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 p -95.74 5.44 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 124.719 2.199 . . . . 0.0 114.203 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.1 tt -81.37 84.6 6.61 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 129.004 2.922 . . . . 0.0 105.775 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -152.85 119.19 0.94 Allowed Glycine 0 CA--C 1.52 0.354 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -126.95 148.64 50.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 126.415 1.886 . . . . 0.0 107.743 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t 45.02 45.96 9.07 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.209 2.204 . . . . 0.0 112.63 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 122.51 -168.46 14.95 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.98 1.276 . . . . 0.0 110.092 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 -78.36 0.14 Allowed 'General case' 0 C--O 1.241 0.611 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -70.04 142.79 52.68 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.597 0.713 . . . . 0.0 110.792 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.75 156.72 39.16 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.49 1.516 . . . . 0.0 110.48 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -144.03 -172.19 14.59 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 123.955 0.788 . . . . 0.0 111.686 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.87 172.48 17.96 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.566 1.147 . . . . 0.0 109.064 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 6.0 tt -147.84 -174.33 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.944 1.298 . . . . 0.0 109.393 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 C--O 1.248 1.013 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 179.359 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.576 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -152.25 152.69 32.5 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.143 0.971 . . . . 0.0 108.446 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -84.48 173.33 10.94 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.23 163.0 28.74 Favored Glycine 0 CA--C 1.523 0.532 0 O-C-N 121.76 -0.588 . . . . 0.0 112.77 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -77.8 152.77 80.44 Favored Pre-proline 0 C--O 1.236 0.367 0 CA-C-O 118.902 -0.57 . . . . 0.0 109.692 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.92 139.31 19.37 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.191 1.927 . . . . 0.0 109.611 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.95 106.49 9.67 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.5 t -93.27 115.13 31.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -74.08 -81.11 0.45 Allowed Glycine 0 CA--C 1.521 0.456 0 N-CA-C 106.415 -2.674 . . . . 0.0 106.415 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.6 -177.21 32.86 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-O 123.387 1.548 . . . . 0.0 113.109 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -82.02 -9.58 59.51 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.013 -1.094 . . . . 0.0 108.757 177.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.2 p -104.56 131.07 52.39 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.313 2.645 . . . . 0.0 109.037 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -48.07 140.26 7.27 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 127.802 2.441 . . . . 0.0 113.364 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.42 177.55 2.18 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 178.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.429 ' HG3' HG23 ' A' ' 33' ' ' ILE . 13.4 mt-30 -113.0 144.2 42.99 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -137.58 138.69 39.82 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.853 1.661 . . . . 0.0 108.288 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -143.52 136.48 27.65 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.08 -38.44 2.69 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.154 1.835 . . . . 0.0 109.422 178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.9 -73.22 1.26 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.707 1.146 . . . . 0.0 113.038 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.1 m -164.64 126.93 2.27 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 124.661 1.184 . . . . 0.0 108.919 178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.22 -144.97 14.11 Favored Glycine 0 N--CA 1.436 -1.308 0 CA-C-N 118.773 0.715 . . . . 0.0 112.246 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.66 98.97 6.07 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.65 158.35 43.45 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.076 -2.935 . . . . 0.0 103.076 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -139.78 100.52 3.97 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.03 146.18 39.55 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 120.027 1.285 . . . . 0.0 114.416 -177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -141.37 116.12 9.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 C-N-CA 127.554 2.342 . . . . 0.0 108.122 -177.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.08 -70.89 1.13 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.1 -74.46 0.43 Allowed Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.268 -1.295 . . . . 0.0 114.226 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -97.52 -145.54 0.3 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.298 1.549 . . . . 0.0 111.858 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.16 170.8 21.85 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 127.18 2.324 . . . . 0.0 114.418 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.383 3.5 t70 48.73 44.8 21.81 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 131.254 3.822 . . . . 0.0 114.286 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -101.3 165.93 11.02 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 127.605 2.362 . . . . 0.0 107.104 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.429 HG23 ' HG3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -138.18 97.23 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 pp -119.6 150.16 40.76 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.507 -1.371 . . . . 0.0 111.728 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.46 119.7 9.53 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 125.236 1.414 . . . . 0.0 111.261 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -71.54 -31.72 65.23 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 123.775 0.702 . . . . 0.0 113.971 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.41 166.35 34.33 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.109 0.861 . . . . 0.0 112.059 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.12 106.84 1.38 Allowed 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.46 0.648 . . . . 0.0 110.668 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.99 166.92 17.37 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 127.434 2.445 . . . . 0.0 108.349 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.05 97.61 8.85 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 120.929 -1.336 . . . . 0.0 108.984 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -100.17 161.88 13.32 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.566 1.546 . . . . 0.0 107.06 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.4 ttt180 -125.3 100.62 6.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.86 156.34 23.09 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.759 0.824 . . . . 0.0 112.641 -178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -150.34 98.63 2.69 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.92 -61.93 6.89 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.63 -162.96 12.24 Favored Glycine 0 CA--C 1.519 0.331 0 N-CA-C 110.824 -0.91 . . . . 0.0 110.824 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.83 102.68 12.52 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.94 174.94 30.36 Favored Glycine 0 N--CA 1.448 -0.515 0 O-C-N 121.561 -0.712 . . . . 0.0 111.954 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.49 80.72 4.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.855 0.862 . . . . 0.0 110.692 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -76.63 166.18 23.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.88 1.272 . . . . 0.0 111.42 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.64 97.07 4.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.902 1.681 . . . . 0.0 107.939 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -87.52 112.79 22.59 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.994 -1.067 . . . . 0.0 113.336 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 t -86.76 119.44 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 120.55 1.523 . . . . 0.0 109.342 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -138.28 98.83 3.7 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.062 1.345 . . . . 0.0 108.27 178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.45 ' HA ' HD13 ' A' ' 87' ' ' LEU . 51.7 p -145.49 16.01 1.46 Allowed 'General case' 0 C--O 1.243 0.712 0 N-CA-C 118.796 2.887 . . . . 0.0 118.796 -177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -93.25 163.96 13.41 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 120.441 1.473 . . . . 0.0 110.987 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? -59.71 -51.1 71.22 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -76.18 10.34 2.03 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.564 1.545 . . . . 0.0 111.548 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -127.12 27.1 5.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.233 2.213 . . . . 0.0 107.562 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.9 t -133.23 -14.78 2.59 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.084 -1.635 . . . . 0.0 111.16 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 5.2 p90 -166.56 -178.89 4.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 119.363 0.983 . . . . 0.0 109.899 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.9 ptt85 -118.54 157.37 27.44 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.5 p -135.26 169.64 17.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -65.25 -35.71 81.89 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 p -60.18 -48.52 81.36 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.972 0.909 . . . . 0.0 109.884 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.97 144.16 14.55 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 122.399 1.095 . . . . 0.0 110.139 178.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.6 m -92.24 143.86 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 127.627 2.371 . . . . 0.0 108.0 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -131.53 39.75 3.47 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.575 0.75 . . . . 0.0 109.293 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -68.37 111.54 4.69 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.546 1.139 . . . . 0.0 112.314 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.64 150.34 34.61 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.62 1.568 . . . . 0.0 106.811 177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.7 tp -133.44 105.79 7.12 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.5 mt -98.28 135.86 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.93 123.66 48.96 Favored 'General case' 0 CA--C 1.522 -0.107 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 48.91 77.77 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 129.538 3.135 . . . . 0.0 111.636 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -90.3 143.92 26.31 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.53 91.87 2.41 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 119.631 1.105 . . . . 0.0 109.431 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 133' ' ' HIS . . . -56.17 -15.12 3.3 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.672 1.189 . . . . 0.0 112.976 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -60.92 -41.9 97.08 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.242 0.928 . . . . 0.0 109.33 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -105.01 -53.01 2.74 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -57.51 162.81 2.7 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtt180 -143.02 164.66 29.48 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 126.449 1.899 . . . . 0.0 110.986 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.5 mt -134.85 136.04 52.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.213 0.605 . . . . 0.0 110.345 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -108.36 118.3 36.42 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' H ' HG12 ' A' ' 143' ' ' VAL . 0.0 OUTLIER -144.59 44.39 1.39 Allowed 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.803 1.641 . . . . 0.0 110.782 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 21.8 p -53.13 -25.43 13.23 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.72 -16.57 33.92 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 118.399 -0.81 . . . . 0.0 113.026 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 55' ' ' SER . 2.4 mp -84.16 130.89 34.82 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -70.94 45.61 0.71 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 128.772 3.082 . . . . 0.0 114.423 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -52.88 153.67 3.22 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.123 0.969 . . . . 0.0 111.58 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 t -144.15 -4.53 0.81 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.489 1.115 . . . . 0.0 112.784 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 121.8 179.24 15.95 Favored Glycine 0 C--O 1.242 0.622 0 CA-C-N 119.362 0.983 . . . . 0.0 111.024 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 164.96 25.86 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 122.078 0.942 . . . . 0.0 109.87 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 165.6 -96.61 0.13 Allowed Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.527 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -150.35 12.53 0.73 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.36 17.42 76.08 Favored Glycine 0 CA--C 1.538 1.479 0 O-C-N 121.317 -0.864 . . . . 0.0 111.217 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -88.17 -110.6 0.07 Allowed 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.338 -1.095 . . . . 0.0 110.745 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.84 62.5 0.7 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 128.788 3.089 . . . . 0.0 112.281 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 75.87 23.95 70.82 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-O 119.41 -0.661 . . . . 0.0 113.123 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.8 p -100.7 -177.84 3.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 118.942 1.371 . . . . 0.0 109.595 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.1 tp -133.03 131.22 40.42 Favored 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.922 1.689 . . . . 0.0 108.838 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 49.3 tp -116.72 137.01 52.5 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.2 mp -121.56 126.78 49.97 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 125.656 1.582 . . . . 0.0 108.092 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mmtt -140.18 171.39 14.24 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.151 2.18 . . . . 0.0 109.708 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 39.7 p -127.16 166.42 17.72 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.441 -0.787 . . . . 0.0 110.155 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -62.85 170.85 2.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.551 1.54 . . . . 0.0 108.973 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.03 -47.16 61.73 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.71 0.687 . . . . 0.0 111.217 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -94.39 -9.67 34.97 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.419 0.688 . . . . 0.0 111.948 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.2 17.73 68.67 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 120.92 -1.112 . . . . 0.0 110.811 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 p -69.25 -29.59 67.54 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 126.594 1.957 . . . . 0.0 110.24 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.7 mtt85 -134.08 167.26 20.97 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 125.815 1.646 . . . . 0.0 108.068 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.401 ' HB ' HD22 ' A' ' 129' ' ' LEU . 53.4 m -123.63 138.2 54.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.63 116.41 16.63 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.213 1.405 . . . . 0.0 107.966 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.1 pp -117.64 164.57 14.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.879 1.672 . . . . 0.0 107.83 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -139.95 136.31 33.7 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.704 1.202 . . . . 0.0 109.145 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 26.4 t -126.56 118.7 25.4 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 7.1 t80 34.42 57.03 0.68 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.678 2.391 . . . . 0.0 112.553 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pm0 -70.63 178.14 3.17 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.508 -0.745 . . . . 0.0 109.686 178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -139.54 -153.19 0.45 Allowed 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.721 0.809 . . . . 0.0 110.216 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.28 154.08 35.42 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.77 1.228 . . . . 0.0 108.209 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -61.14 -16.56 45.75 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.719 0.808 . . . . 0.0 112.818 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -92.39 -35.31 13.77 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.783 2.033 . . . . 0.0 110.542 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.93 -64.22 2.07 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 124.163 0.887 . . . . 0.0 110.955 -179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 0.0 OUTLIER 174.74 144.26 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.354 1.862 . . . . 0.0 110.615 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.09 150.26 46.72 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.986 -1.072 . . . . 0.0 109.57 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -81.01 132.82 35.39 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -156.23 112.16 3.02 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.16 159.75 13.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 127.44 2.296 . . . . 0.0 104.861 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -131.92 130.23 41.3 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.401 HD22 ' HB ' ' A' ' 111' ' ' THR . 7.9 tt -115.82 118.95 34.42 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -83.63 107.67 16.23 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.8 -160.84 19.41 Favored Glycine 0 CA--C 1.533 1.161 0 N-CA-C 107.976 -2.05 . . . . 0.0 107.976 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -147.71 177.21 9.48 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.59 2.356 . . . . 0.0 107.635 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 0.3 OUTLIER -152.37 88.23 1.36 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 120.15 1.341 . . . . 0.0 109.684 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.25 153.59 43.44 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.27 34.16 87.11 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.831 -0.983 . . . . 0.0 111.486 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -56.51 157.08 5.43 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.071 1.415 . . . . 0.0 114.282 -178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 mt -131.46 158.19 41.49 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 126.332 1.853 . . . . 0.0 112.934 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 41.2 m -144.79 -71.34 0.27 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.586 1.555 . . . . 0.0 108.561 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.49 -7.51 0.16 Allowed 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 127.228 2.211 . . . . 0.0 113.981 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.4 -38.64 1.18 Allowed 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.99 1.316 . . . . 0.0 111.407 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 -76.63 -11.32 59.84 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.453 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.7 t -122.23 150.12 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 O-C-N 121.077 -1.014 . . . . 0.0 111.107 -174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 84' ' ' LEU . 7.4 p -58.62 143.11 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.56 -28.74 65.8 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 58.39 63.26 1.76 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.283 1.833 . . . . 0.0 108.838 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -53.34 124.23 14.11 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.418 1.487 . . . . 0.0 109.079 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 72.1 p -84.67 -166.11 1.37 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 126.11 1.764 . . . . 0.0 109.43 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.05 -105.4 3.02 Favored Glycine 0 CA--C 1.52 0.384 0 N-CA-C 103.648 -3.781 . . . . 0.0 103.648 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.5 p -142.13 94.44 2.66 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 6.5 t -147.01 46.07 1.17 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.593 0.757 . . . . 0.0 109.714 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.9 t -111.72 135.72 51.93 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 121.507 -0.746 . . . . 0.0 109.879 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -83.3 161.77 21.34 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.034 1.334 . . . . 0.0 108.194 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 18.3 tp -153.82 -0.14 0.22 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.062 0.945 . . . . 0.0 112.313 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -126.85 -178.74 4.51 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.914 2.086 . . . . 0.0 108.972 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.4 t -127.85 26.06 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 123.492 1.615 . . . . 0.0 111.633 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.7 164.29 10.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.815 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.46 -31.18 14.02 Favored Glycine 0 CA--C 1.527 0.844 0 O-C-N 121.513 -0.742 . . . . 0.0 112.172 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.8 153.91 42.18 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 128.021 2.529 . . . . 0.0 110.236 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 37.4 m -133.91 100.01 4.62 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.919 0.887 . . . . 0.0 109.258 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.67 -21.35 69.22 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.943 1.259 . . . . 0.0 115.433 -178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 3.3 p -80.7 174.76 11.3 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 120.44 2.12 . . . . 0.0 110.705 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -69.28 168.73 13.62 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.814 -1.179 . . . . 0.0 110.35 178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . 37.99 57.58 1.55 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.475 2.71 . . . . 0.0 116.864 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.89 -25.94 30.65 Favored Glycine 0 CA--C 1.532 1.114 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 71.06 4.97 5.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.424 2.29 . . . . 0.0 112.786 -179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 23.0 pt -78.58 179.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 124.142 0.977 . . . . 0.0 108.594 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--O 1.246 0.896 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 179.068 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.647 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -138.19 46.13 2.06 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.009 1.724 . . . . 0.0 107.083 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -85.04 9.84 13.61 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.35 1.46 . . . . 0.0 111.476 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.19 169.85 36.85 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.377 1.465 . . . . 0.0 110.051 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -143.05 133.25 12.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 128.557 2.743 . . . . 0.0 106.911 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.36 151.11 37.56 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.728 2.285 . . . . 0.0 112.217 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.23 134.91 51.08 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.3 t -127.41 127.33 68.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.37 167.34 2.05 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 126.099 1.809 . . . . 0.0 113.874 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.28 1.98 68.19 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-O 117.705 -1.608 . . . . 0.0 113.9 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 54.66 30.47 13.4 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 123.955 1.836 . . . . 0.0 108.952 -177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 p -144.08 -141.3 0.12 Allowed 'General case' 0 CA--C 1.54 0.574 1 C-N-CA 133.324 4.65 . . . . 0.0 106.004 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.64 134.92 34.32 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.892 1.677 . . . . 0.0 107.803 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -168.61 -164.4 0.5 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 129.923 3.289 . . . . 0.0 105.078 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.453 ' CG ' HG23 ' A' ' 33' ' ' ILE . 22.1 mt-30 -128.67 144.07 51.08 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' N ' HD12 ' A' ' 16' ' ' LEU . 2.2 mp -122.98 113.62 19.31 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 127.328 2.251 . . . . 0.0 106.516 -179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -125.06 110.0 13.62 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.112 0.869 . . . . 0.0 108.993 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.99 -46.36 36.92 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -65.42 3.88 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.3 p -154.45 179.53 8.93 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.918 1.359 . . . . 0.0 112.416 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.21 -169.9 55.0 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.031 1.3 . . . . 0.0 109.907 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.21 95.06 4.81 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -125.13 130.4 52.13 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -91.78 115.81 28.37 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.22 143.93 36.37 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -134.96 120.06 18.75 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 122.934 0.493 . . . . 0.0 110.663 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.73 -52.37 46.29 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 126.459 1.981 . . . . 0.0 114.198 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.65 -70.72 2.97 Favored Glycine 0 CA--C 1.533 1.165 0 O-C-N 120.866 -1.373 . . . . 0.0 110.689 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.37 159.77 17.69 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.175 1.39 . . . . 0.0 109.138 177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.74 -174.63 46.85 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.894 1.235 . . . . 0.0 115.595 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.271 6.8 t70 45.78 38.86 4.65 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 128.807 2.843 . . . . 0.0 112.322 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -120.6 166.96 12.94 Favored 'General case' 0 C--O 1.241 0.62 1 C-N-CA 133.723 4.809 . . . . 0.0 107.002 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.453 HG23 ' CG ' ' A' ' 15' ' ' GLN . 1.8 tt -137.54 108.93 6.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 N-CA-C 116.409 2.003 . . . . 0.0 116.409 -176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.81 146.97 37.91 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.706 -1.246 . . . . 0.0 111.566 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -139.77 105.14 5.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.372 2.669 . . . . 0.0 105.346 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.55 -27.01 47.27 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.864 1.221 . . . . 0.0 114.032 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.85 -177.91 51.11 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.332 0.967 . . . . 0.0 111.892 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 58' ' ' GLU . . . -75.93 107.77 8.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.775 1.23 . . . . 0.0 109.994 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.98 165.84 11.97 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 125.426 1.488 . . . . 0.0 110.323 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.84 97.03 8.42 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.807 -0.819 . . . . 0.0 109.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -108.42 162.05 14.47 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 128.524 2.729 . . . . 0.0 107.658 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 -122.48 98.58 5.99 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.97 150.43 20.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.721 0.772 . . . . 0.0 110.624 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -150.8 118.83 6.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 178.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.85 -62.72 2.74 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 106.414 -2.674 . . . . 0.0 106.414 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.59 -158.89 14.1 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.23 103.96 8.5 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 166.98 177.77 38.94 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-O 122.039 0.8 . . . . 0.0 112.577 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -97.78 66.68 1.94 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.57 165.24 25.06 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 123.989 0.916 . . . . 0.0 109.489 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.65 106.44 9.4 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.867 0.867 . . . . 0.0 108.718 -178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.79 100.41 12.9 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.3 t -88.3 139.11 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 O-C-N 120.896 -1.128 . . . . 0.0 108.17 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -136.81 104.85 5.63 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -154.14 67.62 0.73 Allowed 'General case' 0 C--O 1.24 0.592 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.28 46.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 122.177 0.989 . . . . 0.0 110.676 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -61.79 -51.05 69.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.774 0.83 . . . . 0.0 109.329 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.525 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 2.7 mp0 -67.22 -31.71 72.26 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.99 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -75.79 4.15 8.54 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 123.905 1.812 . . . . 0.0 115.357 -178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.4 m -73.29 -45.36 55.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 124.781 1.233 . . . . 0.0 113.549 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 6.0 p90 -165.54 -178.84 5.11 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 119.464 1.029 . . . . 0.0 110.426 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.1 154.54 31.92 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 125.419 1.488 . . . . 0.0 108.787 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.9 p -140.25 -179.14 5.82 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.252 1.021 . . . . 0.0 111.264 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -62.01 -48.06 82.01 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.699 2.0 . . . . 0.0 108.244 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.5 p -71.73 -31.78 67.06 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.783 1.233 . . . . 0.0 114.204 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -159.12 139.35 12.15 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.678 1.126 . . . . 0.0 111.099 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.1 t -112.19 134.45 54.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 125.424 1.49 . . . . 0.0 108.52 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -128.9 51.1 2.06 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -75.6 118.23 18.22 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.68 1.192 . . . . 0.0 113.128 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.49 151.73 23.73 Favored 'General case' 0 C--O 1.246 0.888 0 C-N-CA 124.965 1.306 . . . . 0.0 109.087 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.1 tp -137.68 105.03 5.48 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.296 1.839 . . . . 0.0 108.428 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.5 mp -88.9 125.38 42.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.08 163.04 13.49 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.226 1.81 . . . . 0.0 106.233 176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 44.63 65.34 1.09 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.664 1.986 . . . . 0.0 112.702 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -96.45 124.5 40.47 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -129.64 86.69 2.44 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.35 2.26 . . . . 0.0 108.248 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.47 -4.63 4.16 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.616 -1.303 . . . . 0.0 112.751 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -19.7 65.83 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.002 -1.061 . . . . 0.0 108.755 177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -142.23 -25.16 0.66 Allowed 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.499 -1.715 . . . . 0.0 113.506 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -61.25 145.86 49.83 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 120.64 1.564 . . . . 0.0 112.088 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 82' ' ' ILE . 0.8 OUTLIER -122.69 153.73 39.03 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.781 1.232 . . . . 0.0 108.963 178.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.564 HD12 ' C ' ' A' ' 81' ' ' ARG . 3.8 mp -138.3 113.12 8.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.01 0.924 . . . . 0.0 109.23 -179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -101.46 97.0 7.52 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.03 9.67 3.84 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -51.13 -28.3 10.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.08 -30.31 71.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.21 1.004 . . . . 0.0 112.753 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.06 30.03 0.11 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.35 73.23 1.25 Allowed Glycine 0 C--N 1.335 0.498 0 C-N-CA 125.438 1.494 . . . . 0.0 114.726 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -133.14 130.18 38.88 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.041 0.921 . . . . 0.0 111.053 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.37 -19.59 3.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 128.001 2.52 . . . . 0.0 108.954 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 153.88 -164.32 31.23 Favored Glycine 0 C--N 1.339 0.748 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.85 164.58 23.48 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -173.15 -67.3 0.05 OUTLIER Glycine 0 C--O 1.228 -0.262 0 CA-C-O 117.328 -1.818 . . . . 0.0 109.839 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 21.1 t70 138.44 48.27 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 131.615 3.966 . . . . 0.0 112.858 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.11 46.56 10.18 Favored Glycine 0 N--CA 1.47 0.922 0 O-C-N 120.789 -1.194 . . . . 0.0 115.451 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -118.59 -166.32 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.047 1.339 . . . . 0.0 108.202 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.08 65.97 0.01 OUTLIER Glycine 0 CA--C 1.521 0.42 1 C-N-CA 131.693 4.473 . . . . 0.0 115.013 -179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.39 23.15 6.43 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 127.041 2.258 . . . . 0.0 111.742 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 p -131.89 176.14 8.61 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.321 1.56 . . . . 0.0 111.552 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.6 tt -142.99 151.81 41.26 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.367 -0.833 . . . . 0.0 111.743 -177.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.9 tp -113.61 146.14 40.2 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 128.623 2.769 . . . . 0.0 106.8 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.41 133.6 48.62 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 127.692 2.397 . . . . 0.0 105.473 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -146.67 131.13 17.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.772 0.829 . . . . 0.0 108.912 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.3 p -92.81 154.16 18.43 Favored 'General case' 0 C--O 1.241 0.618 0 O-C-N 120.45 -1.406 . . . . 0.0 108.122 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -62.49 169.26 3.07 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.119 -0.988 . . . . 0.0 109.468 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.26 -41.05 36.53 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.445 1.021 . . . . 0.0 110.934 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -95.24 -25.31 16.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.436 0.695 . . . . 0.0 111.776 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 96.68 -5.28 64.25 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.022 -1.432 . . . . 0.0 114.91 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.6 m -62.03 -31.29 71.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.762 1.625 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtm-85 -115.91 152.02 34.22 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 27.3 m -127.32 142.89 51.33 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -136.08 117.38 14.59 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 126.3 1.84 . . . . 0.0 108.244 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.69 156.31 32.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.9 mtmp? -140.37 121.92 15.17 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -96.94 149.94 21.33 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 32.7 t80 16.55 80.51 0.01 OUTLIER 'General case' 0 C--O 1.237 0.425 0 C-N-CA 128.47 2.708 . . . . 0.0 111.872 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.59 -169.8 2.41 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.118 0.567 . . . . 0.0 109.726 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -157.78 -137.36 0.05 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -85.0 139.43 31.79 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -50.54 -19.63 0.94 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.525 1.93 . . . . 0.0 115.862 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -105.07 -38.04 6.72 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 119.535 1.061 . . . . 0.0 109.809 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -57.86 -65.68 3.36 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 125.139 1.352 . . . . 0.0 110.217 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.62 116.16 0.14 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.163 0.585 . . . . 0.0 110.932 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -138.4 138.35 38.14 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 4.4 t80 -80.2 152.72 29.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -151.02 113.92 4.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.192 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.65 147.09 33.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 125.709 1.604 . . . . 0.0 109.252 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -115.81 137.19 52.33 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.4 tt -128.1 119.39 25.25 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.97 107.71 16.5 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 103.148 -2.908 . . . . 0.0 103.148 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.97 132.88 11.88 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.94 -73.2 0.68 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 117.803 -1.094 . . . . 0.0 108.536 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -83.07 -100.32 0.04 OUTLIER 'General case' 0 C--N 1.344 0.362 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.23 157.42 42.53 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 127.2 2.2 . . . . 0.0 106.785 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -122.9 43.79 1.4 Allowed Glycine 0 C--N 1.333 0.405 0 CA-C-O 117.966 -1.463 . . . . 0.0 114.11 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.01 153.59 36.38 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 119.03 1.415 . . . . 0.0 107.738 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.8 155.38 47.88 Favored 'General case' 0 C--O 1.232 0.163 0 O-C-N 120.294 -1.504 . . . . 0.0 110.761 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.9 m -168.49 172.08 8.5 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 129.163 2.985 . . . . 0.0 104.109 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -53.12 -30.94 39.56 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.395 1.878 . . . . 0.0 113.816 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.21 -39.06 68.83 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.763 0.825 . . . . 0.0 109.877 178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -72.08 -71.64 0.27 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.615 1.566 . . . . 0.0 107.644 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -95.6 124.94 48.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 C-N-CA 126.592 1.957 . . . . 0.0 111.894 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t -71.14 105.99 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -51.16 9.49 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.585 0.754 . . . . 0.0 109.531 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.61 116.46 0.06 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.47 1.508 . . . . 0.0 108.754 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.9 179.85 0.82 Allowed 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 125.467 1.507 . . . . 0.0 107.437 176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . 0.273 5.8 t 53.46 7.65 0.1 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 127.412 2.285 . . . . 0.0 115.603 179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.02 -176.18 30.56 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 119.924 -1.735 . . . . 0.0 113.63 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.0 t -114.45 162.65 16.4 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.382 1.473 . . . . 0.0 109.678 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.4 p -125.69 50.96 1.78 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.492 1.517 . . . . 0.0 109.62 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 t -154.99 172.19 18.51 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -57.34 150.81 17.38 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.668 1.187 . . . . 0.0 108.084 178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.7 mp -70.1 -72.43 0.2 Allowed 'General case' 0 CA--C 1.514 -0.438 0 C-N-CA 123.712 0.805 . . . . 0.0 111.747 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -133.81 53.83 1.98 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 127.187 2.195 . . . . 0.0 110.453 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -141.09 168.3 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 58.3 tp -152.52 106.67 3.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.809 -1.922 . . . . 0.0 105.809 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -167.82 59.17 0.21 Allowed Glycine 0 C--N 1.334 0.421 0 CA-C-O 118.312 -1.271 . . . . 0.0 111.41 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.4 t0 15.72 72.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 129.019 2.928 . . . . 0.0 113.637 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 66.2 m -133.28 -175.4 3.79 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.613 1.565 . . . . 0.0 108.888 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -166.39 -173.16 34.51 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 12.5 t -113.12 -19.03 12.0 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.693 1.197 . . . . 0.0 110.216 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -78.2 122.71 26.02 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -88.12 -173.45 4.24 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.331 1.052 . . . . 0.0 109.512 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.48 135.51 3.12 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 125.052 1.311 . . . . 0.0 112.994 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.75 171.68 14.4 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.442 1.897 . . . . 0.0 107.767 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 49.0 mt -142.64 126.59 15.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.247 0.928 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 178.164 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.631 0 CA-C-O 118.844 -0.975 . . . . 0.0 111.289 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m -114.03 143.49 44.66 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.813 1.245 . . . . 0.0 110.787 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.4 52.38 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 126.494 1.918 . . . . 0.0 105.855 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -177.37 170.43 42.96 Favored Glycine 0 N--CA 1.449 -0.478 0 O-C-N 121.721 -0.612 . . . . 0.0 112.351 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -138.07 147.0 54.45 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.144 1.378 . . . . 0.0 110.532 -178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -86.04 157.27 9.96 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.771 2.314 . . . . 0.0 111.437 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.3 tt -125.37 106.04 9.53 Favored 'General case' 0 C--O 1.228 -0.057 0 C-N-CA 126.312 1.845 . . . . 0.0 106.386 178.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -100.22 122.13 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -65.7 -76.13 0.36 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.875 1.226 . . . . 0.0 110.048 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.74 -98.85 0.19 Allowed Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.695 1.141 . . . . 0.0 110.521 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -152.21 16.39 0.63 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.204 1.401 . . . . 0.0 109.547 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.0 p -122.22 126.3 47.94 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.122 2.169 . . . . 0.0 108.662 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.65 132.28 50.63 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.339 1.456 . . . . 0.0 110.692 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.21 -164.59 1.95 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.11 128.88 45.68 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 103.366 -2.827 . . . . 0.0 103.366 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.9 mt -120.31 148.9 43.13 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -126.86 133.03 50.81 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.293 1.037 . . . . 0.0 109.648 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -84.76 -78.27 1.15 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 104.479 -3.448 . . . . 0.0 104.479 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 165.42 35.17 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.23 128.34 35.21 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.806 0.442 . . . . 0.0 110.679 -179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 129.93 -140.44 11.74 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 106.687 -2.565 . . . . 0.0 106.687 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.52 92.37 3.7 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 102.607 -3.109 . . . . 0.0 102.607 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -131.87 104.34 6.82 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 102.693 -3.076 . . . . 0.0 102.693 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 145.95 26.04 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.822 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -136.13 152.98 51.4 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -148.54 109.75 4.36 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.65 -51.24 59.1 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.26 -80.5 0.34 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.166 -2.374 . . . . 0.0 107.166 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -162.16 85.54 0.59 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 125.113 1.125 . . . . 0.0 109.133 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.03 -177.81 39.52 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-O 121.95 0.75 . . . . 0.0 111.999 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -92.79 52.5 1.87 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -77.45 165.69 24.05 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 123.799 1.762 . . . . 0.0 112.467 -178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 tt -131.75 100.89 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 112.435 -2.166 . . . . 0.0 108.481 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.45 ' HB3' HD13 ' A' ' 25' ' ' LEU . 7.1 mp -101.86 117.6 35.19 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 125.612 1.565 . . . . 0.0 110.033 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -108.24 101.86 11.04 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.694 1.197 . . . . 0.0 108.059 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.54 -21.69 67.1 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.94 -0.922 . . . . 0.0 115.185 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.55 -152.2 51.57 Favored Glycine 0 CA--C 1.535 1.294 0 CA-C-N 119.896 1.848 . . . . 0.0 110.394 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.69 169.18 17.29 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.915 0.886 . . . . 0.0 109.673 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.84 177.78 46.45 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.653 ' HG3' ' HA ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -107.96 98.78 8.31 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.921 -2.251 . . . . 0.0 104.921 -179.098 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.92 162.19 13.51 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.777 1.631 . . . . 0.0 109.525 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.7 ttt-85 -115.19 100.61 8.28 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 102.44 -3.17 . . . . 0.0 102.44 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.53 146.17 30.95 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.943 0.897 . . . . 0.0 112.208 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 t -151.16 138.71 19.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.27 -48.46 3.53 Favored Glycine 0 CA--C 1.522 0.48 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.76 -170.07 17.66 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 106.26 -2.736 . . . . 0.0 106.26 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.64 103.12 6.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.67 -139.42 2.65 Favored Glycine 0 CA--C 1.503 -0.686 0 C-N-CA 126.414 1.959 . . . . 0.0 108.592 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.83 66.12 0.67 Allowed 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 127.8 2.44 . . . . 0.0 105.311 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.21 166.22 23.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -176.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 56.3 m -142.04 93.36 2.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.737 2.815 . . . . 0.0 108.8 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -78.95 110.27 14.01 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 125.028 1.331 . . . . 0.0 107.883 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 t -80.74 150.69 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 121.037 -1.04 . . . . 0.0 113.296 -177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -124.23 116.49 22.77 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.02 2.128 . . . . 0.0 106.133 177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -77.7 -56.9 4.14 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.68 176.28 11.54 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.646 1.112 . . . . 0.0 111.733 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' HA ' HD21 ' A' ' 87' ' ' LEU . 25.5 ttp180 -64.47 -26.07 68.28 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -64.56 -37.64 88.25 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.893 1.679 . . . . 0.0 111.742 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.32 34.64 0.37 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.548 2.339 . . . . 0.0 110.416 -178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.9 m -145.85 -4.83 0.64 Allowed 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -132.22 168.28 18.33 Favored 'General case' 0 CA--C 1.497 -1.058 0 O-C-N 120.415 -1.428 . . . . 0.0 110.041 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' HB2' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -115.81 156.51 25.93 Favored 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.6 p -121.84 176.8 5.56 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -55.96 -33.72 65.03 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.789 0.835 . . . . 0.0 113.213 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.9 p -129.9 10.42 5.49 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.17 93.93 2.64 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 120.268 1.395 . . . . 0.0 109.871 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.88 121.98 38.99 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 C-N-CA 124.001 0.92 . . . . 0.0 110.021 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.653 ' HA ' ' HG3' ' A' ' 40' ' ' ARG . 13.3 m-30 -106.94 24.56 12.58 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -52.54 109.9 0.45 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 119.38 0.991 . . . . 0.0 113.045 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -81.52 157.37 24.85 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 131.515 3.926 . . . . 0.0 112.016 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.6 tp -136.72 113.24 10.08 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.35 121.42 41.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.85 150.6 27.43 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.671 1.588 . . . . 0.0 111.071 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.4 t0 40.03 64.57 0.87 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 128.356 2.662 . . . . 0.0 113.957 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -94.45 139.58 30.95 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.154 0.982 . . . . 0.0 113.275 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -130.6 90.56 2.94 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.007 2.123 . . . . 0.0 107.79 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.57 -16.43 10.17 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.4 m -62.12 -30.49 71.07 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.519 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -126.75 -39.03 2.01 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 111.759 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -67.03 157.76 32.7 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 122.506 1.146 . . . . 0.0 111.305 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -151.43 171.89 16.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.185 1.394 . . . . 0.0 112.967 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 133.52 62.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -102.91 113.69 27.35 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.1 mt -94.44 -88.4 0.24 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.009 0.524 . . . . 0.0 110.948 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 145' ' ' ALA . 4.0 t 71.46 -68.03 0.23 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.322 2.249 . . . . 0.0 108.249 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.78 -22.44 66.91 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 HD21 ' HA ' ' A' ' 57' ' ' ARG . 3.7 mp -128.72 104.48 7.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 120.14 1.336 . . . . 0.0 110.996 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.05 102.73 0.18 Allowed Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -75.6 165.66 24.75 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.9 m -71.09 -0.1 8.83 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.2 -0.937 . . . . 0.0 112.222 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -136.88 167.95 24.43 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 119.54 1.063 . . . . 0.0 113.5 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 pp -126.28 177.21 6.56 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.552 2.741 . . . . 0.0 109.607 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 157.84 -83.07 0.14 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-O 119.23 -0.761 . . . . 0.0 113.086 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -132.92 2.73 3.69 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.74 15.9 67.25 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.845 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -84.73 -125.24 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.387 1.875 . . . . 0.0 108.111 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.96 24.95 0.01 OUTLIER Glycine 0 CA--C 1.529 0.919 1 C-N-CA 130.953 4.12 . . . . 0.0 118.85 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 123.33 26.76 1.59 Allowed Glycine 0 CA--C 1.522 0.495 0 CA-C-N 119.641 1.721 . . . . 0.0 112.269 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.287 41.5 p -113.36 -166.78 1.12 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.247 1.019 . . . . 0.0 110.764 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 134.65 22.93 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.39 1.476 . . . . 0.0 108.896 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.519 HD23 ' N ' ' A' ' 102' ' ' LEU . 6.1 tt -134.66 139.05 44.98 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.99 1.316 . . . . 0.0 108.078 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -132.17 133.76 44.61 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -138.7 165.88 25.81 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.524 1.154 . . . . 0.0 108.401 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.7 p -118.62 162.96 17.53 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.18 -172.93 0.97 Allowed 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.19 -62.64 1.53 Allowed 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.083 -1.011 . . . . 0.0 112.088 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -67.58 -43.66 80.05 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.01 4.22 18.9 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 127.393 2.425 . . . . 0.0 109.598 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 95.6 m -65.03 -35.04 79.89 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.191 1.796 . . . . 0.0 109.661 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 45.2 mtt180 -116.34 153.5 31.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.067 0.947 . . . . 0.0 108.586 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 87.8 m -127.33 141.77 51.62 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 123.706 0.802 . . . . 0.0 110.185 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -134.46 117.93 16.8 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.212 1.405 . . . . 0.0 107.949 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 pp -122.78 160.44 25.98 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.708 1.203 . . . . 0.0 107.828 178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 90.2 mttt -136.27 122.43 20.36 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 21.8 t -105.75 107.52 18.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 68.4 t80 40.92 73.46 0.12 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.12 2.168 . . . . 0.0 110.977 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -79.89 174.96 11.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.314 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -144.29 -143.47 0.14 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.431 1.092 . . . . 0.0 108.388 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -86.84 153.53 21.57 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.45 ' HB2' ' HE ' ' A' ' 124' ' ' ARG . . . -57.51 -26.54 61.48 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.827 0.451 . . . . 0.0 111.992 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -89.69 -38.78 13.63 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.679 1.191 . . . . 0.0 111.976 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -73.43 -50.59 11.58 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.269 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 166.45 79.31 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.445 1.498 . . . . 0.0 110.636 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.45 ' HE ' ' HB2' ' A' ' 120' ' ' ALA . 14.7 ttp85 -95.53 127.37 41.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 7.8 t80 -80.94 123.16 28.08 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.471 1.109 . . . . 0.0 110.249 -178.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -153.87 122.15 6.15 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -144.53 160.95 14.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 105.458 -2.053 . . . . 0.0 105.458 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.79 139.17 52.82 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.5 tt -120.58 125.87 48.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -107.28 106.6 17.13 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.79 175.85 29.21 Favored Glycine 0 N--CA 1.452 -0.24 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.98 -48.0 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -92.74 -83.49 0.31 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.818 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 13.2 t -150.86 172.98 14.79 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.693 1.133 . . . . 0.0 109.526 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.57 26.13 3.7 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.8 2.143 . . . . 0.0 111.227 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -80.06 104.85 10.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.111 1.455 . . . . 0.0 111.312 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -92.87 156.78 16.74 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.107 0.963 . . . . 0.0 112.625 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.5 t -148.51 -100.71 0.08 Allowed 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.797 0.439 . . . . 0.0 111.458 178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.78 6.14 9.4 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.93 -23.36 1.55 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.762 1.165 . . . . 0.0 112.958 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -9.69 58.82 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.572 1.549 . . . . 0.0 111.369 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 61.1 t -150.39 124.5 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.97 105.79 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 104.17 -2.529 . . . . 0.0 104.17 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -54.2 -48.38 71.06 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.851 0.86 . . . . 0.0 111.026 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 85' ' ' SER . . . -170.01 115.79 0.53 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 129.011 2.924 . . . . 0.0 105.02 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -62.07 95.82 0.06 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.548 1.139 . . . . 0.0 111.444 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 t -155.92 -172.53 4.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.685 1.594 . . . . 0.0 109.073 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.21 68.38 0.3 Allowed Glycine 0 C--N 1.333 0.364 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.0 p -124.11 137.88 54.5 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 105.08 -2.193 . . . . 0.0 105.08 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 19.5 p -134.09 -177.58 4.64 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.379 1.071 . . . . 0.0 110.382 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 t -144.22 -161.53 1.3 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 129.229 3.012 . . . . 0.0 103.435 179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 8.83 101.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 131.379 3.872 . . . . 0.0 113.677 177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.69 31.19 6.36 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.294 1.838 . . . . 0.0 111.201 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -73.42 152.2 40.88 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.094 -1.004 . . . . 0.0 108.99 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 20.3 t -68.06 149.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . 0.349 1.5 pp 50.89 -0.81 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 130.68 3.592 . . . . 0.0 118.503 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.34 90.75 0.37 Allowed Glycine 0 CA--C 1.522 0.507 0 N-CA-C 108.543 -1.823 . . . . 0.0 108.543 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.28 129.89 43.48 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m 57.27 34.59 24.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.092 0.957 . . . . 0.0 110.054 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -40.07 -46.75 3.31 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.621 2.057 . . . . 0.0 115.506 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -65.72 26.46 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.03 122.88 16.52 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 119.766 -1.834 . . . . 0.0 111.564 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -64.96 170.4 4.37 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 141.44 139.54 3.68 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -130.9 -178.32 4.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.147 0.979 . . . . 0.0 110.422 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.8 pt -109.1 -145.74 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 126.066 1.746 . . . . 0.0 108.518 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 C--O 1.246 0.884 0 C-N-CA 128.671 2.788 . . . . 0.0 105.976 179.145 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.055 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.8 65.85 0.8 Allowed 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.06 -28.72 68.43 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.299 1.039 . . . . 0.0 113.635 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.62 -173.03 45.66 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 128.931 3.157 . . . . 0.0 106.735 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 59.6 tt0 -128.33 140.9 39.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 118.612 1.206 . . . . 0.0 109.436 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.93 136.15 22.35 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.332 2.021 . . . . 0.0 110.9 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.48 101.76 7.08 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.77 122.81 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.51 -99.52 0.06 OUTLIER Glycine 0 CA--C 1.521 0.42 0 N-CA-C 107.213 -2.355 . . . . 0.0 107.213 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.57 27.17 0.03 OUTLIER Glycine 0 C--N 1.333 0.376 0 CA-C-O 117.127 -1.93 . . . . 0.0 115.187 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 64.74 44.04 3.91 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 123.507 1.623 . . . . 0.0 108.255 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.4 p -132.84 126.44 32.27 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.194 3.398 . . . . 0.0 110.136 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.75 123.59 20.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -164.32 -178.5 5.52 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -119.65 96.49 5.21 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.899 0.88 . . . . 0.0 110.306 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 34' ' ' LEU . 31.2 mt -87.93 104.05 16.26 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -100.62 161.71 13.42 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.4 0.68 . . . . 0.0 110.079 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.58 -147.81 7.54 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 125.703 1.621 . . . . 0.0 110.099 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.71 -69.68 0.06 OUTLIER Glycine 0 CA--C 1.523 0.553 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.8 p -171.14 174.92 4.47 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.351 1.06 . . . . 0.0 111.417 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 103.66 -153.46 17.9 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 129.294 3.33 . . . . 0.0 105.674 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.58 91.6 3.55 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 101.798 -3.408 . . . . 0.0 101.798 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -105.2 168.23 9.21 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.688 1.595 . . . . 0.0 110.387 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -145.21 102.36 3.73 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 120.641 -1.287 . . . . 0.0 111.65 -179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.43 152.88 23.04 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 120.624 1.556 . . . . 0.0 111.121 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -151.27 113.14 4.48 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.164 0.985 . . . . 0.0 109.404 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.89 -64.58 2.86 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.741 -0.943 . . . . 0.0 110.741 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.47 -58.41 0.7 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.02 -1.433 . . . . 0.0 113.344 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 171.7 116.38 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 127.148 2.179 . . . . 0.0 110.427 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.3 175.79 34.64 Favored Glycine 0 CA--C 1.52 0.345 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.6 55.34 2.31 Favored 'General case' 0 N--CA 1.419 -1.995 0 C-N-CA 126.697 1.999 . . . . 0.0 106.594 177.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.17 164.49 24.9 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 123.591 1.663 . . . . 0.0 111.332 -178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.91 110.0 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 16' ' ' LEU . 46.2 mt -116.79 136.44 52.95 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.156 0.982 . . . . 0.0 110.095 -176.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.6 144.75 32.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.156 1.783 . . . . 0.0 110.403 -179.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -118.15 -24.52 3.24 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.265 0.936 . . . . 0.0 114.781 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.96 -127.34 9.22 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 119.076 1.438 . . . . 0.0 111.846 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.38 107.32 13.22 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.256 1.822 . . . . 0.0 108.318 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.54 166.68 15.99 Favored Glycine 0 N--CA 1.427 -1.911 0 CA-C-O 122.998 1.332 . . . . 0.0 113.776 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.43 96.65 4.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . 0.342 0.9 OUTLIER -115.2 159.99 20.27 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -118.05 102.5 9.08 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.03 142.33 36.84 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.445 1.498 . . . . 0.0 112.637 -178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.2 t -150.67 130.08 12.92 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 126.371 1.868 . . . . 0.0 106.121 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.63 -59.1 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 106.739 -2.544 . . . . 0.0 106.739 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 121.06 -167.31 14.03 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.26 102.79 7.81 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.57 172.11 40.91 Favored Glycine 0 N--CA 1.45 -0.383 0 O-C-N 121.539 -0.726 . . . . 0.0 112.22 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.2 67.3 8.75 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.525 1.13 . . . . 0.0 108.579 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.38 166.84 22.86 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 124.912 1.285 . . . . 0.0 110.54 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.8 m -136.09 114.54 11.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -101.82 143.04 32.22 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.62 139.1 51.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-O 121.601 0.715 . . . . 0.0 110.548 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -101.87 144.63 30.28 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.5 t -80.05 -83.36 0.1 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.146 1.378 . . . . 0.0 113.507 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.23 173.87 14.47 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.421 1.489 . . . . 0.0 110.471 -177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.56 -30.5 1.49 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.386 1.874 . . . . 0.0 115.55 -178.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -64.09 -13.51 48.0 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 119.977 1.262 . . . . 0.0 111.47 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -102.71 1.22 34.15 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 124.709 2.195 . . . . 0.0 114.573 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.573 ' OG ' HD22 ' A' ' 87' ' ' LEU . 69.4 m -89.08 -30.26 18.79 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 125.69 1.596 . . . . 0.0 113.458 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.458 ' CG ' ' HB2' ' A' ' 123' ' ' ARG . 7.3 p90 -138.86 -178.71 5.44 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 123.422 1.582 . . . . 0.0 111.859 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.4 162.31 16.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 112.955 -1.93 . . . . 0.0 107.569 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.0 p -125.76 -179.53 4.7 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.98 85.97 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 127.386 2.274 . . . . 0.0 111.063 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.257 30.6 p 86.92 -15.7 0.42 Allowed 'General case' 0 C--N 1.325 -0.462 1 C-N-CA 132.98 4.512 . . . . 0.0 113.651 -179.902 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.03 86.3 4.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 121.123 1.783 . . . . 0.0 108.148 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.5 124.42 39.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -108.48 26.71 10.17 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.734 1.214 . . . . 0.0 108.622 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.79 135.74 57.71 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.06 -1.65 . . . . 0.0 112.076 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.07 155.54 20.1 Favored 'General case' 0 C--O 1.248 1.001 0 C-N-CA 127.544 2.337 . . . . 0.0 106.578 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.3 tp -140.62 105.47 4.95 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.4 mt -91.52 132.67 35.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.11 161.58 14.84 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 125.154 1.382 . . . . 0.0 109.026 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 38.16 47.35 0.96 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.635 2.774 . . . . 0.0 112.954 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.79 132.62 50.03 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.434 1.093 . . . . 0.0 109.032 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.14 80.86 1.9 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.738 1.215 . . . . 0.0 109.954 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.59 -5.72 0.09 Allowed 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 116.641 2.089 . . . . 0.0 116.641 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.4 t -69.58 -43.0 73.74 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.945 -1.097 . . . . 0.0 110.015 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -127.02 -25.17 3.34 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.588 1.699 . . . . 0.0 115.588 -178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.66 160.94 8.43 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 49.7 mtt-85 -139.36 158.02 44.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.025 1.73 . . . . 0.0 114.971 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.9 mt -138.91 128.8 31.85 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 120.11 -1.619 . . . . 0.0 107.473 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 9.8 t0 -83.29 99.77 10.21 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.47 12.58 4.38 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.641 1.176 . . . . 0.0 110.201 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 92.8 p -60.76 -55.62 31.02 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 119.679 -1.888 . . . . 0.0 111.699 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -66.99 -39.86 87.25 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.573 HD22 ' OG ' ' A' ' 60' ' ' SER . 6.0 mt -123.55 105.15 9.51 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.679 -1.601 . . . . 0.0 106.679 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.94 117.2 1.71 Allowed Glycine 0 C--N 1.338 0.643 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -104.61 151.8 23.22 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.77 -25.39 63.79 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -53.8 -53.1 38.24 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 115.048 0.779 . . . . 0.0 115.048 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.449 ' HG ' ' H ' ' A' ' 93' ' ' GLY . 1.8 tt 54.74 174.19 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.386 2.275 . . . . 0.0 111.018 -178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . . . 158.92 -90.45 0.11 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.799 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -151.59 21.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 117.117 2.265 . . . . 0.0 117.117 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.84 1.5 65.5 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 117.248 -1.862 . . . . 0.0 116.622 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -73.7 -162.36 0.13 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.823 1.811 . . . . 0.0 107.624 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -28.65 7.65 0.0 OUTLIER Glycine 0 CA--C 1.545 1.937 2 C-N-CA 134.44 5.781 . . . . 0.0 123.133 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 155.93 12.16 0.05 OUTLIER Glycine 0 CA--C 1.531 1.068 0 C-N-CA 130.144 3.735 . . . . 0.0 110.853 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.291 39.5 p -102.35 -174.64 2.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.753 1.776 . . . . 0.0 111.445 -177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.446 HD23 ' N ' ' A' ' 101' ' ' LEU . 5.3 tt -150.17 144.38 25.63 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 120.865 -1.147 . . . . 0.0 109.473 -178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.446 ' N ' HD23 ' A' ' 100' ' ' LEU . 11.8 tp -134.74 139.11 44.93 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.5 1.52 . . . . 0.0 108.453 177.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.1 pt? -128.83 148.46 50.89 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 126.577 1.951 . . . . 0.0 106.86 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmmm -146.46 154.0 41.08 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 43.5 p -93.52 162.29 14.03 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 178.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -61.22 166.01 4.06 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.942 1.297 . . . . 0.0 108.295 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -52.5 -38.24 59.1 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 119.174 0.897 . . . . 0.0 111.664 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -95.33 -7.44 38.66 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.822 1.649 . . . . 0.0 112.363 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.79 0.19 73.7 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.048 1.309 . . . . 0.0 113.603 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.27 -16.82 63.07 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 126.282 1.833 . . . . 0.0 111.83 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -138.78 163.53 31.95 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.568 1.147 . . . . 0.0 109.778 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.9 m -127.92 146.88 50.5 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.552 0.741 . . . . 0.0 110.175 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.45 121.25 21.96 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.21 2.604 . . . . 0.0 108.893 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.0 OUTLIER -121.67 161.64 22.15 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.58 178.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 125' ' ' PHE . 42.4 mtmt -144.44 122.85 12.36 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.924 1.689 . . . . 0.0 108.123 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.9 t -114.12 121.78 44.85 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.4 t80 39.67 65.06 0.76 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.562 1.945 . . . . 0.0 111.354 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.65 177.74 5.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.806 0.843 . . . . 0.0 111.876 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -150.68 -140.97 0.1 Allowed 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 124.322 1.049 . . . . 0.0 111.125 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.48 155.52 19.97 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.24 1.816 . . . . 0.0 106.852 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.25 -3.17 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -105.12 -14.49 15.37 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.638 1.975 . . . . 0.0 111.746 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -116.11 -70.11 0.45 Allowed Glycine 0 N--CA 1.442 -0.953 0 CA-C-O 118.686 -1.063 . . . . 0.0 111.857 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.458 ' HB2' ' CG ' ' A' ' 61' ' ' TYR . 6.6 ptt-85 -171.18 83.19 0.08 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 -178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.4 mmm-85 -86.07 132.69 33.99 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 119.642 -1.911 . . . . 0.0 109.119 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -92.78 114.69 27.32 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.187 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -150.97 110.94 4.09 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.2 t -130.85 160.59 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.33 1.852 . . . . 0.0 109.824 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.76 151.16 48.59 Favored 'General case' 0 C--N 1.343 0.315 0 C-N-CA 123.804 0.842 . . . . 0.0 111.459 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 14.0 tp -115.07 149.11 38.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 125.424 1.489 . . . . 0.0 108.209 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -93.98 106.85 18.8 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 118.903 0.774 . . . . 0.0 110.507 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.3 -170.99 54.02 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -151.46 140.32 20.94 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.673 2.389 . . . . 0.0 105.808 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -116.57 -102.88 0.42 Allowed 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.948 0.899 . . . . 0.0 109.594 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 14.8 t -165.51 146.3 7.05 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.7 59.64 6.93 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.72 167.83 1.02 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.99 1.716 . . . . 0.0 110.3 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.42 124.64 23.75 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.355 -0.84 . . . . 0.0 112.342 -176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 m -134.62 -75.75 0.46 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.529 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.07 -8.82 0.6 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.894 0.877 . . . . 0.0 112.67 179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.94 -25.64 18.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 119.261 0.937 . . . . 0.0 110.863 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -113.46 -12.82 12.9 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.65 159.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 125.785 1.634 . . . . 0.0 108.849 179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.415 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 2.5 t -136.07 147.37 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -107.87 -43.05 4.54 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.09 1.756 . . . . 0.0 110.862 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.39 103.54 0.35 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.812 2.045 . . . . 0.0 107.039 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' HB3' HG11 ' A' ' 143' ' ' VAL . . . -159.19 -162.49 1.07 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 119.749 1.159 . . . . 0.0 112.031 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.0 t -134.71 161.92 33.79 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 128.129 2.572 . . . . 0.0 106.138 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.08 97.95 1.69 Allowed Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.0 p -143.23 85.44 1.86 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.445 1.098 . . . . 0.0 108.103 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.89 -12.22 60.02 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.558 2.343 . . . . 0.0 115.805 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . 0.295 0.5 OUTLIER 106.21 18.61 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 131.518 3.927 . . . . 0.0 109.61 -178.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -25.27 132.61 0.02 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 130.837 3.655 . . . . 0.0 113.314 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.4 8.48 19.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.847 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 44.26 43.09 5.66 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.057 1.743 . . . . 0.0 113.513 178.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.9 t -70.67 168.62 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.163 2.185 . . . . 0.0 111.695 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -119.91 47.4 1.74 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.226 1.41 . . . . 0.0 107.972 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -171.9 155.49 23.92 Favored Glycine 0 C--N 1.331 0.295 0 O-C-N 120.753 -1.217 . . . . 0.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.74 141.22 58.85 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.696 0.798 . . . . 0.0 111.129 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.1 t -172.87 -176.58 1.46 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 128.08 2.552 . . . . 0.0 107.707 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -147.97 160.81 28.44 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.308 1.432 . . . . 0.0 110.757 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 95.5 m -78.66 -15.93 57.91 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.371 1.068 . . . . 0.0 112.915 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -133.85 -65.02 0.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 121.043 1.747 . . . . 0.0 114.105 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -170.83 110.4 0.35 Allowed 'General case' 0 C--O 1.232 0.171 0 C-N-CA 125.968 1.707 . . . . 0.0 110.024 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.36 99.39 1.17 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.03 27.42 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.571 1.148 . . . . 0.0 108.823 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 25.1 mm 109.0 151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.659 1 C-N-CA 132.93 4.492 . . . . 0.0 105.82 -178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--O 1.254 1.294 0 N-CA-C 104.149 -2.538 . . . . 0.0 104.149 179.313 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.63 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -65.47 172.38 3.33 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 122.664 1.221 . . . . 0.0 111.816 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -74.2 173.0 10.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.275 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.63 159.17 40.09 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.83 89.23 9.04 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 126.548 1.939 . . . . 0.0 107.721 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -78.17 148.53 24.42 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.12 1.88 . . . . 0.0 112.286 -179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD13 ' N ' ' A' ' 8' ' ' VAL . 1.2 tm? -125.68 124.33 40.88 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.413 ' N ' HD13 ' A' ' 7' ' ' LEU . 59.1 t -122.14 99.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -61.51 163.65 22.32 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.266 0.936 . . . . 0.0 112.112 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.56 -76.38 0.97 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 124.766 1.174 . . . . 0.0 111.644 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -163.11 -23.46 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.5 p -89.2 121.76 31.81 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 124.64 1.176 . . . . 0.0 108.893 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.03 134.33 8.26 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 127.858 2.463 . . . . 0.0 113.501 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -151.44 -172.51 4.23 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.177 1.391 . . . . 0.0 109.083 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -123.85 134.88 53.5 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.6 mp -124.47 139.69 53.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -138.92 153.41 48.24 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 121.432 -0.793 . . . . 0.0 111.377 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.48 -60.23 0.38 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 107.328 -2.309 . . . . 0.0 107.328 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.91 -41.13 0.7 Allowed Glycine 0 CA--C 1.532 1.109 0 C-N-CA 125.931 1.729 . . . . 0.0 114.72 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 p -169.21 -173.62 1.79 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.694 1.598 . . . . 0.0 108.51 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.45 -163.22 49.31 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.234 -0.917 . . . . 0.0 112.123 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.62 94.6 4.33 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -114.03 169.52 8.95 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.596 1.958 . . . . 0.0 110.068 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -140.1 99.78 3.76 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 120.008 -1.682 . . . . 0.0 107.232 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.22 150.99 21.97 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -145.69 117.38 8.12 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.12 -50.25 62.91 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.204 1.383 . . . . 0.0 112.066 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 110.01 -92.71 0.7 Allowed Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -165.59 107.88 0.79 Allowed 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.96 -148.48 11.83 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -124.56 57.12 1.26 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.134 3.374 . . . . 0.0 104.045 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.58 165.64 12.06 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.896 2.078 . . . . 0.0 108.959 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.598 HG22 ' HB ' ' A' ' 51' ' ' THR . 40.2 pt -134.29 135.25 54.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.515 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.0 165.66 20.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.731 1.213 . . . . 0.0 112.123 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -145.02 109.16 4.8 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.648 1.979 . . . . 0.0 107.242 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.88 -44.38 97.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.736 -0.48 . . . . 0.0 111.942 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.24 -176.87 46.7 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.134 1.349 . . . . 0.0 111.828 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.27 169.37 10.61 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 88.49 -166.78 34.86 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 105.704 -2.959 . . . . 0.0 105.704 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 126.86 54.01 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.11 162.63 33.71 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 124.452 1.101 . . . . 0.0 109.355 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -120.27 101.84 8.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.96 149.98 24.0 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.113 0.565 . . . . 0.0 111.634 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -150.89 122.89 8.19 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.17 -59.29 3.98 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 105.689 -2.965 . . . . 0.0 105.689 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.16 -168.45 13.39 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 107.79 -2.124 . . . . 0.0 107.79 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.74 103.52 5.87 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.5 -162.84 36.01 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -113.45 82.03 1.61 Allowed 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.007 2.123 . . . . 0.0 107.256 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -97.56 164.74 12.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.439 1.114 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.598 ' HB ' HG22 ' A' ' 33' ' ' ILE . 55.5 m -124.39 117.65 24.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.588 1.155 . . . . 0.0 108.138 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -101.93 107.68 18.91 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.093 1.357 . . . . 0.0 110.307 -179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.7 t -87.21 132.98 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 O-C-N 121.008 -1.057 . . . . 0.0 109.271 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -139.82 114.55 9.41 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.879 2.072 . . . . 0.0 107.81 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 89.5 p -156.27 2.64 0.15 Allowed 'General case' 0 C--O 1.24 0.556 0 N-CA-C 117.364 2.357 . . . . 0.0 117.364 -178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.11 169.32 18.36 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.5 mmt-85 -66.79 -54.69 20.07 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 113.436 -1.711 . . . . 0.0 107.512 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -69.98 -27.59 64.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -70.37 -8.18 48.65 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 125.917 2.77 . . . . 0.0 114.063 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 t -73.65 -45.39 53.02 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.227 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -164.23 -179.98 6.47 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 119.741 1.155 . . . . 0.0 110.058 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB2' ' HA ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -115.4 157.69 23.56 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -131.52 179.9 5.77 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -73.52 -40.82 63.74 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.348 -0.845 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.2 t -70.07 -31.07 68.49 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.699 0.682 . . . . 0.0 111.336 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -158.82 135.03 9.12 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 119.446 1.021 . . . . 0.0 112.157 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 62' ' ' ARG . 60.8 t -105.4 140.96 21.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -133.51 29.08 3.95 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 145.6 55.26 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -177.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.03 151.28 21.1 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.721 2.408 . . . . 0.0 107.666 177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.38 104.75 4.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 mt -92.25 134.73 29.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.55 145.36 34.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.435 1.094 . . . . 0.0 110.907 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 39.02 43.14 0.76 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 131.259 3.823 . . . . 0.0 115.526 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -54.09 144.24 20.1 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.728 1.611 . . . . 0.0 111.204 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -136.91 83.55 2.01 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.012 1.325 . . . . 0.0 110.142 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.48 -16.71 0.63 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 -179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -61.59 -44.2 97.45 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 118.763 0.711 . . . . 0.0 110.219 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . 0.275 6.4 mt-10 -122.18 -13.54 8.11 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.149 0.886 . . . . 0.0 112.573 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -73.83 152.58 40.22 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.15 0.976 . . . . 0.0 110.667 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 72.5 mtt85 -135.6 158.22 44.93 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.432 1.493 . . . . 0.0 109.275 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.85 124.16 26.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -101.9 95.88 6.67 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 177.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.13 33.23 4.77 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.455 1.102 . . . . 0.0 110.047 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.27 -16.69 22.98 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.24 -0.913 . . . . 0.0 112.36 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.72 -29.9 13.12 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.154 0.981 . . . . 0.0 112.494 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mt -114.33 86.55 2.45 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.644 1.177 . . . . 0.0 111.368 -177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.6 103.41 0.88 Allowed Glycine 0 CA--C 1.525 0.699 0 O-C-N 121.54 -0.725 . . . . 0.0 111.363 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.92 178.05 5.85 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.363 -1.08 . . . . 0.0 109.105 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.2 m -83.31 -41.39 18.33 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 120.559 -1.338 . . . . 0.0 109.032 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.52 -57.37 6.05 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HG22 ' A' ' 99' ' ' THR . 6.7 mp -117.41 169.22 9.68 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.816 1.646 . . . . 0.0 113.156 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.29 13.33 0.03 OUTLIER Glycine 0 C--O 1.224 -0.498 0 N-CA-C 117.555 1.782 . . . . 0.0 117.555 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.273 17.1 t0 43.53 25.6 0.08 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.707 4.403 . . . . 0.0 114.316 179.767 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -41.24 -40.6 2.6 Favored Glycine 0 N--CA 1.469 0.886 0 C-N-CA 129.05 3.214 . . . . 0.0 114.513 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.409 ' H ' ' H ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -169.54 -17.16 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 96' ' ' TYR . . . -153.9 54.69 0.44 Allowed Glycine 0 CA--C 1.507 -0.42 0 C-N-CA 126.688 2.089 . . . . 0.0 111.601 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 73.56 -13.54 3.85 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 118.593 1.197 . . . . 0.0 111.383 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 92' ' ' LEU . 67.6 p -126.09 158.43 35.47 Favored 'General case' 0 CA--C 1.501 -0.932 0 O-C-N 120.305 -1.703 . . . . 0.0 111.271 -177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.566 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 1.1 pp -106.45 154.17 21.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 122.23 1.014 . . . . 0.0 110.617 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 130.46 38.4 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.464 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 pp -89.66 156.61 18.45 Favored 'General case' 0 C--N 1.331 -0.224 0 O-C-N 120.676 -1.265 . . . . 0.0 108.557 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -153.36 170.21 21.22 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.108 0.963 . . . . 0.0 109.4 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.7 p -127.82 158.01 38.89 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 125.739 1.615 . . . . 0.0 110.198 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.516 ' ND2' ' H ' ' A' ' 110' ' ' ARG . 0.7 OUTLIER -75.67 175.12 8.93 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.18 -38.96 69.02 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.15 -22.3 45.27 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.157 0.89 . . . . 0.0 112.577 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.03 -10.01 59.04 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 127.203 2.335 . . . . 0.0 114.127 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.6 m -71.93 -19.8 61.85 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.786 1.293 . . . . 0.0 111.211 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.516 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 31.2 mtm180 -113.68 135.52 53.84 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.706 1.202 . . . . 0.0 108.401 178.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.8 m -116.67 125.68 52.1 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.402 1.881 . . . . 0.0 108.198 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -130.25 116.83 18.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.1 165.71 12.11 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.074 0.95 . . . . 0.0 110.312 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -119.97 121.22 38.49 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 103.194 -2.891 . . . . 0.0 103.194 177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.22 168.22 17.19 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 103.611 -2.737 . . . . 0.0 103.611 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -27.01 107.42 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 126.181 1.792 . . . . 0.0 113.554 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -104.26 176.22 5.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 127.243 2.217 . . . . 0.0 112.031 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.406 ' H ' ' HG3' ' A' ' 124' ' ' ARG . . . -161.27 -150.24 0.19 Allowed 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.137 1.775 . . . . 0.0 106.817 178.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -69.63 140.45 53.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.72 1.608 . . . . 0.0 107.893 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.67 -11.15 0.53 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 127.744 2.417 . . . . 0.0 115.452 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -114.51 -38.42 4.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.225 1.41 . . . . 0.0 110.983 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -63.59 -68.74 1.54 Allowed Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 125.767 1.651 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -168.65 128.58 1.17 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 122.469 0.308 . . . . 0.0 111.535 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.406 ' HG3' ' H ' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -138.7 123.98 19.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.47 112.5 18.77 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.425 1.49 . . . . 0.0 109.112 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -156.32 123.19 5.23 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -119.78 171.84 7.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 127.132 2.173 . . . . 0.0 110.923 -178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -132.81 128.71 37.31 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.136 1.375 . . . . 0.0 110.361 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.1 tt -126.09 131.17 52.16 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.425 1.09 . . . . 0.0 108.361 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -107.67 111.78 24.16 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 177.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -173.33 128.07 1.45 Allowed Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -84.32 -45.52 12.72 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.657 0.783 . . . . 0.0 112.46 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -79.85 50.72 1.22 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.384 1.874 . . . . 0.0 109.798 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.8 t -118.23 -177.44 3.28 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.699 1.238 . . . . 0.0 111.114 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.22 -27.97 17.11 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 125.332 1.444 . . . . 0.0 109.67 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -85.26 105.66 16.11 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.6 mp -124.3 116.25 22.32 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.941 -3.355 . . . . 0.0 101.941 178.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.2 m -147.02 -176.98 5.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.59 -19.23 2.17 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 127.025 2.13 . . . . 0.0 115.356 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.1 -50.7 8.23 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 121.183 1.811 . . . . 0.0 108.036 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -67.65 -37.56 82.58 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.106 1.363 . . . . 0.0 112.519 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 3.5 t -107.31 134.9 47.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -177.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.08 154.16 6.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.506 1.922 . . . . 0.0 111.873 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -91.63 -47.82 7.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.3 116.25 0.08 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 127.921 2.488 . . . . 0.0 108.593 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -159.34 172.59 17.69 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 127.266 2.226 . . . . 0.0 108.993 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.4 p -145.28 1.49 0.95 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.839 1.255 . . . . 0.0 111.821 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.49 164.13 10.93 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -177.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 39.2 m -69.23 143.77 53.86 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 23.9 p -60.3 139.95 57.34 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.341 1.057 . . . . 0.0 110.583 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.4 t -69.0 165.41 20.21 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.764 0.792 . . . . 0.0 109.824 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -61.38 164.63 5.4 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 128.373 2.669 . . . . 0.0 115.364 -178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.96 -0.43 16.74 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 127.122 2.169 . . . . 0.0 112.59 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -126.52 82.94 2.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 24.7 t -143.49 151.61 16.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 C-N-CA 125.39 1.476 . . . . 0.0 107.384 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.55 79.0 0.41 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.864 1.266 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.56 159.27 13.82 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-O 122.856 1.253 . . . . 0.0 114.617 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -71.23 -7.8 49.27 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.972 2.509 . . . . 0.0 114.239 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.9 t -62.5 155.57 25.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.628 0.728 . . . . 0.0 111.266 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -142.32 28.63 2.2 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 126.482 1.992 . . . . 0.0 110.155 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.2 m 68.35 1.06 2.75 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.527 1.531 . . . . 0.0 112.24 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -78.62 -66.06 0.91 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.604 1.562 . . . . 0.0 108.025 178.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -163.59 172.6 14.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 128.829 2.852 . . . . 0.0 107.328 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.15 157.84 11.59 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -171.05 173.46 5.05 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.859 1.664 . . . . 0.0 109.326 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.22 146.3 18.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.326 1.05 . . . . 0.0 108.71 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--O 1.245 0.855 0 C-N-CA 125.098 1.359 . . . . 0.0 111.142 -179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.511 0 CA-C-O 119.505 -0.609 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -37.07 134.75 0.52 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 128.12 2.568 . . . . 0.0 113.293 -178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.12 160.26 28.19 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 126.89 2.076 . . . . 0.0 107.992 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.97 142.58 16.19 Favored Glycine 0 C--N 1.337 0.634 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.6 135.12 78.55 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 124.414 1.085 . . . . 0.0 109.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.42 146.84 40.4 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 CA-C-N 121.346 1.516 . . . . 0.0 109.728 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.57 149.87 47.97 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 102.153 -3.277 . . . . 0.0 102.153 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.21 123.28 47.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 C-N-CA 125.185 1.394 . . . . 0.0 108.664 -179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.57 176.31 53.71 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.99 -157.86 23.23 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 124.705 1.145 . . . . 0.0 110.273 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -100.36 -15.76 17.87 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.448 1.499 . . . . 0.0 109.002 177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -94.54 126.33 39.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 130.954 3.702 . . . . 0.0 102.585 177.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -56.9 151.26 14.95 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 124.315 1.009 . . . . 0.0 112.368 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -151.38 174.07 13.78 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -129.41 105.27 7.99 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.5 mp -106.46 104.54 14.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.335 0.654 . . . . 0.0 111.793 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.54 144.94 25.63 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.218 1.407 . . . . 0.0 107.857 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -87.66 -81.65 1.23 Allowed Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.54 ' H ' ' HA3' ' A' ' 37' ' ' GLY . . . 105.7 -173.05 19.85 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.626 2.06 . . . . 0.0 109.74 -178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 p -72.91 123.39 23.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.139 -1.212 . . . . 0.0 107.953 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 -161.87 28.48 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.88 101.14 7.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 102.208 -3.256 . . . . 0.0 102.208 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.67 156.88 27.45 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -135.98 125.98 26.01 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 106.314 -1.736 . . . . 0.0 106.314 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.76 161.33 37.47 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 123.285 0.634 . . . . 0.0 109.761 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' SER . 9.9 t70 -143.56 118.36 9.91 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.957 1.303 . . . . 0.0 108.438 -178.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.01 -48.97 30.58 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.608 1.575 . . . . 0.0 115.023 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.61 -107.87 2.55 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 107.275 -2.33 . . . . 0.0 107.275 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.9 89.21 0.93 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -162.86 -148.09 5.25 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-O 122.274 0.93 . . . . 0.0 114.485 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -121.88 56.19 1.09 Allowed 'General case' 0 N--CA 1.449 -0.491 1 C-N-CA 133.332 4.653 . . . . 0.0 103.771 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.65 166.6 11.25 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 128.26 2.624 . . . . 0.0 115.605 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 tt -133.62 127.61 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.888 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.5 mp -134.34 151.13 51.06 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.34 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.5 142.52 32.28 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.668 1.587 . . . . 0.0 109.891 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.11 -9.07 68.02 Favored Glycine 0 CA--C 1.523 0.533 0 CA-C-O 118.961 -0.91 . . . . 0.0 114.306 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 19' ' ' GLY . . . 71.06 -137.63 26.9 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 119.568 1.684 . . . . 0.0 109.959 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.65 107.96 13.44 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.589 1.156 . . . . 0.0 108.603 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.66 -177.04 21.54 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.305 1.431 . . . . 0.0 111.182 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.1 112.73 12.85 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 122.021 -0.694 . . . . 0.0 109.713 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -115.79 160.96 19.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -134.3 100.62 4.74 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.866 -3.013 . . . . 0.0 102.866 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD11 HG23 ' A' ' 72' ' ' ILE . 3.6 pp -94.22 149.88 20.83 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 36.3 t -150.02 97.32 2.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 104.218 -2.512 . . . . 0.0 104.218 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -61.8 -57.23 18.51 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.176 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.33 -174.1 29.37 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 105.949 -2.86 . . . . 0.0 105.949 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -75.25 102.72 5.13 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.46 173.99 46.29 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -106.52 72.92 0.94 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.16 168.35 20.15 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 128.337 2.655 . . . . 0.0 110.2 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.42 103.44 4.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.556 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -87.52 114.32 24.02 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.99 131.62 57.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.416 0.626 . . . . 0.0 110.127 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.538 ' HB3' HD23 ' A' ' 87' ' ' LEU . 61.5 m-85 -90.9 140.93 29.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.2 m -72.83 -79.91 0.07 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.716 0.806 . . . . 0.0 110.783 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.63 -178.78 7.34 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.318 1.047 . . . . 0.0 109.975 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -54.87 -7.61 0.19 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.287 1.835 . . . . 0.0 114.562 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -73.97 -13.45 60.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.495 1.118 . . . . 0.0 109.545 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -124.97 -179.83 4.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 127.776 2.43 . . . . 0.0 111.875 -178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 t 79.73 28.16 0.33 Allowed 'General case' 0 CA--C 1.537 0.459 1 C-N-CA 133.215 4.606 . . . . 0.0 115.427 177.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -152.36 -178.57 6.9 Favored 'General case' 0 CA--C 1.518 -0.286 0 O-C-N 119.851 -1.78 . . . . 0.0 114.065 -177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.516 ' HB3' HG13 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -130.29 153.9 48.17 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 126.462 1.905 . . . . 0.0 106.494 177.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 19.4 p -126.5 -178.93 4.53 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -69.46 -45.61 68.65 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 119.965 -1.709 . . . . 0.0 110.105 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 44.9 p -83.86 -22.64 31.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.39 174.61 10.42 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.189 0.904 . . . . 0.0 111.539 -178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG13 ' HB3' ' A' ' 62' ' ' ARG . 4.7 t -142.51 130.61 20.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -122.15 11.22 10.14 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 134.21 33.22 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.15 155.07 20.91 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 127.874 2.47 . . . . 0.0 107.951 178.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.25 105.64 4.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.507 1.523 . . . . 0.0 107.196 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.448 HG23 HD11 ' A' ' 43' ' ' LEU . 3.3 mt -85.98 127.38 40.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.059 1.344 . . . . 0.0 110.089 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.07 161.98 14.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.972 2.109 . . . . 0.0 109.886 177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 36.24 40.22 0.1 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 130.189 3.396 . . . . 0.0 114.867 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -69.95 132.43 45.95 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.42 1.088 . . . . 0.0 113.395 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.8 tp10 -141.25 94.86 2.75 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.477 1.111 . . . . 0.0 108.996 178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -50.12 -22.26 1.6 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.729 1.611 . . . . 0.0 114.506 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.9 t -56.42 -23.65 39.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.207 1.403 . . . . 0.0 110.421 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -144.06 -27.84 0.52 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 116.456 -1.735 . . . . 0.0 113.597 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -63.43 147.12 52.12 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.698 1.59 . . . . 0.0 111.768 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.0 mtm180 -134.98 154.17 51.82 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 110.794 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.4 mp -137.27 130.09 43.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 120.012 -1.68 . . . . 0.0 111.125 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -99.39 96.06 7.45 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.482 -0.762 . . . . 0.0 109.598 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 5.38 46.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.951 1.3 . . . . 0.0 112.772 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 87.8 p -56.71 -34.74 67.76 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 120.65 1.568 . . . . 0.0 113.143 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -84.36 -29.55 26.17 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.165 0.586 . . . . 0.0 112.554 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 54' ' ' PHE . 3.4 mm? -122.0 63.21 0.93 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.474 1.51 . . . . 0.0 110.075 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.68 -118.37 0.79 Allowed Glycine 0 N--CA 1.437 -1.283 0 O-C-N 120.139 -1.601 . . . . 0.0 109.745 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 166.18 -165.8 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.711 1 C-N-CA 132.731 4.413 . . . . 0.0 103.837 -178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 66.7 m -127.88 4.46 5.99 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.703 1.601 . . . . 0.0 111.566 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.2 166.09 12.12 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.431 1.967 . . . . 0.0 110.786 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -112.6 165.15 12.52 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.164 0.982 . . . . 0.0 111.725 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 161.13 -97.49 0.16 Allowed Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.775 -0.93 . . . . 0.0 110.775 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -162.23 40.47 0.12 Allowed 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.793 1.237 . . . . 0.0 112.446 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.23 70.41 1.12 Allowed Glycine 0 N--CA 1.48 1.629 0 O-C-N 119.929 -1.732 . . . . 0.0 112.142 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -143.81 -159.24 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.577 1.951 . . . . 0.0 110.836 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.95 71.05 0.13 Allowed Glycine 0 CA--C 1.521 0.455 0 C-N-CA 129.834 3.588 . . . . 0.0 110.768 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 105.45 22.8 7.93 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 125.234 1.397 . . . . 0.0 111.604 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.7 p -133.62 160.01 38.78 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.088 1.444 . . . . 0.0 109.543 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.52 123.23 3.3 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.514 HD13 ' H ' ' A' ' 102' ' ' LEU . 0.2 OUTLIER -146.32 155.15 42.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.948 1.299 . . . . 0.0 110.183 179.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.514 ' H ' HD13 ' A' ' 101' ' ' LEU . 1.5 pt? -121.48 152.5 39.06 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.793 1.237 . . . . 0.0 109.8 177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 161.3 37.85 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 123.039 1.399 . . . . 0.0 109.007 179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 36.7 p -92.8 159.76 15.25 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -72.97 -172.07 0.98 Allowed 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.25 -55.36 18.56 Favored 'General case' 0 C--O 1.213 -0.859 0 O-C-N 120.076 -1.64 . . . . 0.0 111.651 178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -95.91 -4.2 43.92 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.039 1.336 . . . . 0.0 113.354 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.64 -0.19 71.46 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.38 0.99 . . . . 0.0 114.055 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.82 -11.13 54.29 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.144 2.177 . . . . 0.0 110.54 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.9 mtm180 -142.67 157.73 44.38 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.391 3.076 . . . . 0.0 105.869 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 35.3 m -123.5 148.0 46.68 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -139.2 117.16 11.67 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 113' ' ' LEU . 2.1 pt? -119.79 162.19 19.5 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.738 1.615 . . . . 0.0 109.502 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -145.57 132.32 20.02 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 122.1 0.953 . . . . 0.0 111.306 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.0 t -108.63 147.49 31.79 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 101.924 -3.361 . . . . 0.0 101.924 176.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -2.19 79.01 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 128.984 2.914 . . . . 0.0 115.604 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.71 161.34 29.15 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.007 -1.058 . . . . 0.0 112.159 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.7 -127.31 0.17 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.799 1.24 . . . . 0.0 109.873 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -122.39 155.51 35.9 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.924 2.89 . . . . 0.0 107.067 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.0 -14.25 61.3 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 120.101 1.319 . . . . 0.0 111.264 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -70.65 -24.83 62.77 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.202 -0.936 . . . . 0.0 109.49 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -121.47 -50.58 0.25 Allowed Glycine 0 C--N 1.338 0.674 0 CA-C-O 118.259 -1.3 . . . . 0.0 114.16 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 177.95 90.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.613 1.207 . . . . 0.0 114.076 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -89.14 126.87 35.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 100.617 -3.845 . . . . 0.0 100.617 175.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -79.69 140.5 36.99 Favored 'General case' 0 N--CA 1.438 -1.072 0 C-N-CA 123.617 0.767 . . . . 0.0 110.758 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -156.76 125.71 5.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.473 1.509 . . . . 0.0 109.497 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 54.9 t -145.55 142.52 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.47 130.12 52.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 6.1 tt -120.89 122.72 40.84 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -107.31 107.21 18.02 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.69 1.196 . . . . 0.0 110.078 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 171.12 179.49 42.3 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.414 1.007 . . . . 0.0 110.88 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -119.46 175.45 5.82 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.459 1.129 . . . . 0.0 109.886 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 35.4 m80 59.26 8.92 1.21 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.951 1.7 . . . . 0.0 113.39 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 134' ' ' THR . 2.9 t -77.01 163.21 26.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 129.192 2.997 . . . . 0.0 109.249 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 101.14 -30.93 9.32 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.604 1.097 . . . . 0.0 111.252 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.86 113.66 19.21 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 118.252 1.026 . . . . 0.0 112.117 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -130.64 153.11 49.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.983 1.713 . . . . 0.0 111.959 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.2 m -164.49 170.35 16.03 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.372 3.069 . . . . 0.0 104.739 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.39 -5.79 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.399 2.679 . . . . 0.0 116.148 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -98.06 -51.44 4.03 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.768 2.027 . . . . 0.0 107.374 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -71.0 -38.92 72.69 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 125.287 1.435 . . . . 0.0 111.957 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 2.8 p -124.24 152.68 30.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.508 1.123 . . . . 0.0 113.435 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 t -113.89 96.5 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.35 -54.56 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.09 113.04 0.54 Allowed 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.81 97.04 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 125.523 1.529 . . . . 0.0 110.473 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.2 t -178.15 -173.21 0.35 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 128.641 2.776 . . . . 0.0 107.289 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 172.1 100.2 0.13 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.7 m -159.22 122.89 3.79 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -139.82 168.39 19.92 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 125.237 1.415 . . . . 0.0 108.562 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.9 t -166.77 136.95 3.13 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -134.83 168.51 18.92 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.426 1.89 . . . . 0.0 106.763 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 92.9 mt -119.77 3.35 11.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 51.1 36.66 16.06 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.593 1.557 . . . . 0.0 111.633 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.11 152.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 114.493 -1.231 . . . . 0.0 109.964 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.62 92.15 1.49 Allowed 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.824 1.249 . . . . 0.0 109.954 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 136.91 176.49 14.39 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 124.267 0.937 . . . . 0.0 111.192 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -82.16 84.17 7.13 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.12 147.36 31.47 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 121.72 -129.42 7.67 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 104.139 -3.584 . . . . 0.0 104.139 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.8 p -71.91 -17.51 62.09 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.226 1.513 . . . . 0.0 111.17 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -108.56 152.21 25.06 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.623 2.369 . . . . 0.0 105.494 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -123.75 163.69 20.65 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.591 1.156 . . . . 0.0 109.953 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 162.14 179.07 36.54 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -148.69 -82.75 0.11 Allowed 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.115 1.366 . . . . 0.0 107.98 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.281 2.0 mp 66.14 87.44 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 127.146 2.178 . . . . 0.0 109.061 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.8 m . . . . . 0 C--O 1.244 0.789 0 C-N-CA 128.721 2.808 . . . . 0.0 105.622 179.309 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.639 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.7 p -92.0 165.48 13.18 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.709 0.803 . . . . 0.0 111.347 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -125.21 17.35 8.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.291 2.236 . . . . 0.0 110.423 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.82 169.63 34.86 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 128.745 3.069 . . . . 0.0 107.445 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -154.22 144.78 15.94 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 119.774 1.787 . . . . 0.0 110.673 -178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -66.92 122.99 10.42 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 121.891 1.728 . . . . 0.0 110.821 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.07 106.58 10.92 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -109.31 115.93 50.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -70.47 -170.37 8.97 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.742 1.163 . . . . 0.0 113.248 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.02 -128.36 5.96 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 124.54 1.067 . . . . 0.0 111.543 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.84 11.14 6.08 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.471 1.909 . . . . 0.0 109.542 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.6 p -112.77 122.93 49.12 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 127.4 2.28 . . . . 0.0 107.277 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -61.88 132.23 52.37 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 125.091 1.494 . . . . 0.0 113.585 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -143.56 -167.74 2.65 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 126.177 1.791 . . . . 0.0 110.51 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.465 ' HA ' HG13 ' A' ' 33' ' ' ILE . 8.6 mt-30 -128.68 96.61 4.43 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 126.684 1.994 . . . . 0.0 109.733 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -90.22 95.82 10.38 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 35' ' ' ASP . 21.9 tt0 -89.91 159.07 17.13 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.799 -1.188 . . . . 0.0 111.666 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.53 -54.49 0.09 OUTLIER Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.308 1.433 . . . . 0.0 110.396 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.86 -71.8 2.82 Favored Glycine 0 C--N 1.337 0.624 0 O-C-N 121.699 -0.883 . . . . 0.0 112.247 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.8 m -157.3 142.29 16.92 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 117.768 0.784 . . . . 0.0 109.679 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 145.14 -160.74 28.1 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 120.003 1.274 . . . . 0.0 112.73 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.11 94.25 4.16 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 102.452 -3.166 . . . . 0.0 102.452 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -124.9 167.99 13.9 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 119.675 1.125 . . . . 0.0 113.116 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -139.9 100.62 3.98 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 152.17 38.05 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.97 122.64 22.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.565 1.946 . . . . 0.0 107.323 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.83 -56.76 23.13 Favored Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.32 -104.69 0.87 Allowed Glycine 0 C--N 1.335 0.473 0 N-CA-C 109.244 -1.542 . . . . 0.0 109.244 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 91.32 1.29 Allowed 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.78 -140.64 2.94 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-O 123.099 1.389 . . . . 0.0 113.546 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -131.08 40.8 3.42 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 129.469 3.108 . . . . 0.0 107.236 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.94 165.04 24.58 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 128.27 2.628 . . . . 0.0 110.802 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 15' ' ' GLN . 1.0 OUTLIER -132.31 128.04 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.79 148.34 52.56 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-O 121.666 0.746 . . . . 0.0 110.354 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' HB3' ' HA ' ' A' ' 17' ' ' GLN . 10.1 t70 -139.93 134.22 31.27 Favored 'General case' 0 C--O 1.224 -0.255 0 C-N-CA 126.974 2.11 . . . . 0.0 110.034 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -103.87 -52.05 0.92 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.06 -142.64 16.23 Favored Glycine 0 N--CA 1.441 -1.026 0 O-C-N 122.057 -0.672 . . . . 0.0 113.936 177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.53 107.56 19.29 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.221 1.408 . . . . 0.0 108.472 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.04 175.32 22.1 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 124.796 1.188 . . . . 0.0 111.135 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.68 96.45 8.69 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -114.83 161.89 17.61 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.953 0.901 . . . . 0.0 112.605 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.38 128.31 47.94 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 125.287 1.435 . . . . 0.0 108.359 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 148.86 44.55 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.039 0.936 . . . . 0.0 110.81 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.18 123.35 8.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.995 3.318 . . . . 0.0 103.963 178.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.6 -61.92 2.82 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 105.548 -3.021 . . . . 0.0 105.548 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.82 -166.53 12.29 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 108.829 -1.708 . . . . 0.0 108.829 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.77 102.61 8.22 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.84 -162.75 31.28 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 106.804 -2.518 . . . . 0.0 106.804 -178.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.53 85.82 2.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -96.24 165.68 12.1 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.463 0.649 . . . . 0.0 111.357 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.2 m -118.98 115.52 24.52 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -94.29 110.78 22.5 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.899 0.88 . . . . 0.0 109.652 -178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 t -97.33 138.64 21.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -125.58 156.68 38.74 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.027 0.531 . . . . 0.0 110.231 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -109.64 50.82 0.77 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 123.68 1.705 . . . . 0.0 108.07 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 87' ' ' LEU . . . -56.02 -7.11 0.29 Allowed 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 118.028 2.603 . . . . 0.0 118.028 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -58.71 -37.43 76.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 102.784 -3.043 . . . . 0.0 102.784 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -106.99 -37.91 6.19 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.364 3.066 . . . . 0.0 110.355 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -78.83 78.53 5.27 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 119.49 1.041 . . . . 0.0 111.617 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.82 -18.06 0.95 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 121.271 -0.893 . . . . 0.0 112.061 178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.94 -179.6 5.32 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 120.388 1.449 . . . . 0.0 109.375 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.524 ' HG3' ' H ' ' A' ' 68' ' ' PHE . 1.0 OUTLIER -140.33 158.22 44.36 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.598 1.559 . . . . 0.0 109.271 -178.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.461 HG23 ' HG3' ' A' ' 123' ' ' ARG . 74.8 p -131.08 166.13 21.73 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 127.233 2.213 . . . . 0.0 106.237 177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.04 -38.75 92.2 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.285 -0.884 . . . . 0.0 110.615 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.5 t -78.12 -26.52 47.98 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.98 95.81 2.75 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.299 1.04 . . . . 0.0 110.116 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.0 t -98.56 129.52 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.524 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 12.7 m-85 -119.11 46.16 1.94 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.48 108.2 0.91 Allowed 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.245 -0.909 . . . . 0.0 112.918 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -89.26 155.12 19.59 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 124.501 1.12 . . . . 0.0 108.603 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 119.21 9.73 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 129' ' ' LEU . 3.4 mt -108.02 128.22 63.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 123.032 0.533 . . . . 0.0 110.154 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -108.48 160.87 15.56 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.291 2.637 . . . . 0.0 107.311 177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 39.0 t0 29.77 65.4 0.13 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 128.948 2.899 . . . . 0.0 114.0 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -97.53 103.95 15.93 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 127.07 2.148 . . . . 0.0 109.502 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -113.07 96.72 6.09 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.919 0.888 . . . . 0.0 109.917 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -23.18 47.78 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.7 t -63.39 -16.45 60.53 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 118.485 0.584 . . . . 0.0 110.738 178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.52 -50.24 0.99 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.045 1.338 . . . . 0.0 112.086 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -65.31 159.5 23.78 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 123.281 1.515 . . . . 0.0 114.099 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 173.37 11.26 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 128.411 2.684 . . . . 0.0 108.944 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.3 mt -142.28 135.79 28.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.426 ' HA ' ' HB ' ' A' ' 143' ' ' VAL . 68.0 t0 -96.08 126.96 41.67 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.14 6.81 29.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.675 1.59 . . . . 0.0 113.202 -178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.3 p -51.9 -44.96 64.0 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.393 0.997 . . . . 0.0 112.412 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -99.05 10.17 42.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.553 1.141 . . . . 0.0 113.49 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 56' ' ' ALA . 0.3 OUTLIER -86.96 120.53 28.33 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -179.024 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -71.28 18.58 0.91 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.904 1.24 . . . . 0.0 115.245 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.2 -176.18 1.38 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 119.061 1.431 . . . . 0.0 109.903 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.81 -36.6 0.14 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.181 1.792 . . . . 0.0 106.906 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -177.6 -166.59 34.49 Favored Glycine 0 C--N 1.342 0.907 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 88.6 mt -86.28 167.27 14.97 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.923 -0.751 . . . . 0.0 109.064 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 164.83 -103.7 0.21 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -142.13 5.09 1.67 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.76 46.2 5.79 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.045 -1.035 . . . . 0.0 113.359 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -131.8 -100.82 0.29 Allowed 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 125.234 1.414 . . . . 0.0 109.184 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.15 64.19 0.08 OUTLIER Glycine 0 CA--C 1.521 0.43 1 C-N-CA 131.556 4.408 . . . . 0.0 112.485 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 67.17 20.85 71.49 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 36.2 p -101.75 169.99 8.45 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.6 tt -131.84 151.06 51.94 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.384 1.474 . . . . 0.0 108.141 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.4 tp -145.42 141.39 28.36 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.882 0.873 . . . . 0.0 110.376 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.89 144.88 45.8 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 126.463 1.905 . . . . 0.0 107.495 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.47 171.84 18.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.59 1.556 . . . . 0.0 107.388 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 46.1 p -116.42 163.19 16.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.451 0.643 . . . . 0.0 111.441 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.31 167.15 2.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 177.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.14 -52.2 61.83 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.237 0.926 . . . . 0.0 109.336 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.13 -17.1 55.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.123 0.569 . . . . 0.0 112.167 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.89 6.59 72.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.175 0.893 . . . . 0.0 113.123 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -27.72 69.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.252 1.526 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -126.59 165.02 19.96 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 124.653 1.181 . . . . 0.0 110.72 179.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 31.7 m -127.01 123.89 38.1 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -105.96 117.7 34.69 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 103.08 -2.934 . . . . 0.0 103.08 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 pp -149.98 139.8 21.82 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 119.52 1.055 . . . . 0.0 111.098 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 114' ' ' LYS . 0.5 OUTLIER -161.3 176.22 11.43 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.434 1.493 . . . . 0.0 109.048 178.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.6 t -124.37 127.1 47.07 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 103.674 -2.713 . . . . 0.0 103.674 178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.9 t80 68.27 144.33 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 129.626 3.17 . . . . 0.0 113.03 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.94 -178.56 7.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.093 2.157 . . . . 0.0 110.327 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -153.05 -144.49 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.249 1.42 . . . . 0.0 109.636 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -109.52 156.06 20.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.67 1.988 . . . . 0.0 108.032 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -54.58 -23.69 17.94 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -75.55 -29.37 59.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.455 0.702 . . . . 0.0 111.591 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -103.11 -45.8 1.54 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-O 117.893 -1.504 . . . . 0.0 113.144 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.461 ' HG3' HG23 ' A' ' 63' ' ' THR . 0.2 OUTLIER 162.43 136.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 127.039 2.136 . . . . 0.0 112.255 -179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.0 mtm-85 -134.32 155.7 49.77 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 120.34 -1.475 . . . . 0.0 110.268 177.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.24 118.76 22.87 Favored 'General case' 0 N--CA 1.435 -1.215 0 C-N-CA 127.659 2.384 . . . . 0.0 111.871 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -145.59 109.1 4.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.583 176.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.1 160.72 11.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 O-C-N 120.952 -1.093 . . . . 0.0 110.288 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -127.1 121.8 32.49 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.476 HD12 HD13 ' A' ' 72' ' ' ILE . 1.5 tt -120.99 119.82 33.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 178.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -84.96 107.85 17.3 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -124.68 155.54 18.42 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.8 t0 -119.37 -49.06 2.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.458 2.303 . . . . 0.0 109.853 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -78.91 45.62 0.63 Allowed 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.552 1.941 . . . . 0.0 109.504 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 4.1 t 40.35 23.5 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 129.746 3.218 . . . . 0.0 116.885 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.54 24.75 66.34 Favored Glycine 0 CA--C 1.535 1.314 0 O-C-N 120.114 -1.617 . . . . 0.0 109.891 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -60.0 125.62 24.38 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 126.12 1.768 . . . . 0.0 110.495 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -130.27 138.68 50.63 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 126.9 2.08 . . . . 0.0 110.223 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 69.7 m -152.7 179.65 8.43 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 129.786 3.234 . . . . 0.0 104.154 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.66 -32.32 59.02 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.684 1.993 . . . . 0.0 113.105 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -76.23 -37.81 57.2 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 119.478 1.036 . . . . 0.0 112.435 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.8 8.0 3.42 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 127.472 2.309 . . . . 0.0 112.136 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.4 t -131.3 157.37 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.387 1.475 . . . . 0.0 111.792 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 83' ' ' ASP . 99.2 t -123.57 124.63 69.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 104.047 -2.575 . . . . 0.0 104.047 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -74.83 -54.42 7.32 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.85 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 179.83 87.82 0.01 OUTLIER 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.708 2.003 . . . . 0.0 108.859 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -160.58 168.45 24.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 128.247 2.619 . . . . 0.0 108.744 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.2 t -92.68 -47.65 6.98 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -104.33 166.05 15.15 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.13 -149.54 0.41 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.133 0.968 . . . . 0.0 112.454 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.5 p -87.57 -177.66 5.93 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 130.833 3.653 . . . . 0.0 108.776 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.78 90.5 1.15 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -71.03 123.58 22.41 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.2 -2.41 46.31 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.576 1.325 . . . . 0.0 114.576 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.94 171.88 12.7 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.28 1.032 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.7 p -146.74 15.68 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 125.06 2.362 . . . . 0.0 112.948 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 21.1 tp -97.73 80.71 2.82 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 111.801 -2.454 . . . . 0.0 108.935 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.11 166.58 42.5 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.63 144.12 54.6 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 110.05 -179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.59 -167.37 2.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.477 1.035 . . . . 0.0 111.601 179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -168.04 65.89 0.19 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 107.649 -2.18 . . . . 0.0 107.649 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.4 p 60.28 -19.52 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.398 3.479 . . . . 0.0 115.401 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -66.71 169.05 8.43 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.265 1.826 . . . . 0.0 112.897 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -102.54 167.23 10.06 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -167.19 -169.79 31.22 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -145.6 162.36 37.67 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.985 0.914 . . . . 0.0 109.481 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.17 -8.13 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.748 0.819 . . . . 0.0 110.118 178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.251 1.168 0 C-N-CA 127.076 2.15 . . . . 0.0 105.958 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.847 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -125.49 -72.66 0.65 Allowed 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 118.287 1.044 . . . . 0.0 109.905 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.75 157.35 30.47 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 118.396 0.543 . . . . 0.0 111.056 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 53.99 -175.36 0.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.041 1.782 . . . . 0.0 114.623 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -147.77 136.89 11.75 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -62.03 140.15 82.8 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 120.035 1.048 . . . . 0.0 109.773 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -118.57 104.53 10.74 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 103.2 -2.889 . . . . 0.0 103.2 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.0 t -102.74 120.22 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 112.23 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.76 -169.3 38.42 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 127.207 2.337 . . . . 0.0 108.405 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.31 -177.87 15.45 Favored Glycine 0 C--O 1.222 -0.642 0 O-C-N 121.31 -1.112 . . . . 0.0 110.782 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -62.35 -20.31 64.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.098 0.951 . . . . 0.0 111.592 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 p -77.03 113.09 14.36 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -61.68 136.17 57.9 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.813 2.045 . . . . 0.0 114.335 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.46 -179.61 5.04 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.952 1.701 . . . . 0.0 107.14 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -97.26 141.05 30.84 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 mp -127.2 95.17 4.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.07 171.58 8.38 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 120.977 -1.077 . . . . 0.0 110.086 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.58 -28.51 0.57 Allowed Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.335 0.493 . . . . 0.0 113.045 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.45 -93.37 1.11 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.041 -2.424 . . . . 0.0 107.041 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -161.01 165.39 29.93 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.001 1.721 . . . . 0.0 109.351 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.42 -153.12 17.12 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 125.94 1.733 . . . . 0.0 109.321 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.78 93.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 101.514 -3.513 . . . . 0.0 101.514 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -135.31 167.37 21.15 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.43 1.492 . . . . 0.0 110.309 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -142.69 137.68 30.05 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 159.63 30.18 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 178.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' SER . 5.2 t70 -153.82 151.76 29.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 117.71 -1.138 . . . . 0.0 108.283 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.76 -41.43 0.03 OUTLIER Glycine 0 N--CA 1.468 0.822 0 C-N-CA 118.21 -1.948 . . . . 0.0 116.207 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -22.4 93.31 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 1 C-N-CA 131.469 4.366 . . . . 0.0 114.898 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.66 11.32 0.37 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 128.238 2.615 . . . . 0.0 108.702 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.08 -158.09 19.57 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 127.168 2.318 . . . . 0.0 110.123 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -94.55 61.62 2.73 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 128.144 2.578 . . . . 0.0 109.178 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.5 166.73 12.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 125.901 1.68 . . . . 0.0 107.507 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.601 HG22 ' HB ' ' A' ' 51' ' ' THR . 0.2 OUTLIER -133.0 119.77 38.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.01 142.26 51.59 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.486 1.114 . . . . 0.0 113.61 -178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -99.5 161.32 13.69 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.751 -1.218 . . . . 0.0 112.865 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.15 -58.35 1.79 Allowed Glycine 0 CA--C 1.529 0.915 0 N-CA-C 104.975 -3.25 . . . . 0.0 104.975 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.74 164.38 39.58 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.658 1.599 . . . . 0.0 111.807 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.64 106.32 14.4 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 170.71 -161.79 34.71 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 107.456 -2.258 . . . . 0.0 107.456 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -115.99 97.63 6.19 Favored 'General case' 0 CA--C 1.51 -0.574 1 N-CA-C 97.937 -4.838 . . . . 0.0 97.937 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -127.14 161.61 28.08 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 123.899 0.749 . . . . 0.0 112.605 -174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -128.38 100.0 5.63 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.588 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.557 HD11 HG13 ' A' ' 72' ' ' ILE . 1.4 pp -90.97 155.23 18.87 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.915 0.864 . . . . 0.0 109.182 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -149.37 97.15 2.61 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 101.671 -3.455 . . . . 0.0 101.671 179.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.99 -66.62 2.57 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 107.631 -2.188 . . . . 0.0 107.631 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.6 -162.11 22.82 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.86 103.2 15.43 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 176.03 178.0 45.48 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -99.87 64.63 1.26 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -77.08 164.3 25.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 122.461 0.304 . . . . 0.0 111.2 -178.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.601 ' HB ' HG22 ' A' ' 33' ' ' ILE . 36.6 m -122.53 110.24 15.33 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 177.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -81.58 106.58 13.65 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.346 1.459 . . . . 0.0 107.78 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.2 t -80.67 108.22 13.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.742 0 C-N-CA 125.192 1.397 . . . . 0.0 113.206 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -119.49 102.75 8.87 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.152 1.381 . . . . 0.0 107.81 179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 p -145.18 10.92 1.32 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.94 138.28 36.28 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 121.534 1.97 . . . . 0.0 107.993 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -58.97 -21.36 58.5 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.246 0.93 . . . . 0.0 113.453 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.44 -29.64 17.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.0 0.818 . . . . 0.0 110.258 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -72.24 65.44 0.6 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.438 1.895 . . . . 0.0 112.667 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 t -177.42 -27.09 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.357 1.463 . . . . 0.0 113.452 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.51 173.19 11.76 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.5 160.76 20.69 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.1 p -130.69 173.85 10.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.995 0.902 . . . . 0.0 109.581 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.78 -12.58 61.73 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.191 -1.568 . . . . 0.0 111.656 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 6.1 t -116.61 -14.78 10.85 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.883 1.673 . . . . 0.0 113.934 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.03 174.0 14.19 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 120.598 1.545 . . . . 0.0 110.475 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 99.4 t -142.32 125.55 14.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 104.865 -2.272 . . . . 0.0 104.865 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -115.9 23.82 11.95 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.38 0.672 . . . . 0.0 110.784 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.39 105.24 0.22 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.556 1.943 . . . . 0.0 111.697 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.68 152.46 31.62 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 127.148 2.179 . . . . 0.0 107.426 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.56 120.52 17.58 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-O 118.446 -0.787 . . . . 0.0 112.79 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.557 HG13 HD11 ' A' ' 43' ' ' LEU . 1.5 mp -90.88 133.49 32.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.41 -2.441 . . . . 0.0 104.41 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.66 137.52 45.53 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.33 -2.47 . . . . 0.0 104.33 176.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.03 56.33 6.05 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.74 2.416 . . . . 0.0 114.834 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -78.58 128.17 33.15 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.274 1.03 . . . . 0.0 113.207 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -141.39 97.14 3.11 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.046 1.338 . . . . 0.0 109.904 177.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.39 -10.09 1.27 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.814 1.246 . . . . 0.0 112.736 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.1 t -60.69 -25.15 66.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.449 1.1 . . . . 0.0 109.338 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -142.18 -46.93 0.35 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.193 0.997 . . . . 0.0 112.374 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.02 150.16 43.18 Favored 'General case' 0 C--O 1.237 0.437 0 O-C-N 123.839 0.712 . . . . 0.0 111.948 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.46 151.69 47.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.863 0.865 . . . . 0.0 113.27 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.9 mt -111.9 145.22 18.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 O-C-N 119.993 -1.692 . . . . 0.0 108.636 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -113.24 94.76 5.03 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 177.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tp -142.29 58.84 1.46 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.56 1.144 . . . . 0.0 112.385 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.3 t -96.76 -7.59 33.41 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.67 1.188 . . . . 0.0 108.604 177.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.97 -3.0 25.25 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.084 1.754 . . . . 0.0 115.393 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.89 18.17 5.1 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.083 1.882 . . . . 0.0 116.083 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -154.71 -112.13 0.43 Allowed Glycine 0 CA--C 1.521 0.457 0 N-CA-C 104.659 -3.376 . . . . 0.0 104.659 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -154.07 -166.81 2.47 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 127.466 2.306 . . . . 0.0 107.986 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -68.44 -46.05 70.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.928 1.291 . . . . 0.0 112.034 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -148.52 -56.39 0.01 OUTLIER Glycine 0 C--N 1.344 1.0 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.3 126.84 23.38 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 128.971 2.908 . . . . 0.0 104.247 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 98' ' ' GLY . . . 147.82 39.5 0.04 OUTLIER Glycine 0 N--CA 1.468 0.797 0 O-C-N 124.523 1.139 . . . . 0.0 113.14 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -159.02 -31.53 0.07 Allowed 'General case' 0 C--O 1.216 -0.703 0 N-CA-C 120.246 3.424 . . . . 0.0 120.246 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.65 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . -53.53 -86.48 0.02 OUTLIER Glycine 0 N--CA 1.473 1.107 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -176.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -124.17 -119.09 0.28 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 130.858 3.663 . . . . 0.0 106.807 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -16.12 -74.03 0.01 OUTLIER Glycine 0 N--CA 1.473 1.111 0 C-N-CA 130.022 3.677 . . . . 0.0 111.657 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 93' ' ' GLY . . . -167.77 20.1 0.09 OUTLIER Glycine 0 N--CA 1.427 -1.965 0 C-N-CA 128.464 2.935 . . . . 0.0 107.66 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.4 p -152.8 169.57 22.44 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 127.679 2.392 . . . . 0.0 110.144 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.65 ' HA ' ' HA3' ' A' ' 95' ' ' GLY . 0.3 OUTLIER -109.61 168.35 9.47 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -178.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.8 tp -135.3 145.38 47.44 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.899 -1.501 . . . . 0.0 114.197 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.6 pt? -136.04 144.62 45.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.462 2.705 . . . . 0.0 111.194 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.83 160.21 37.51 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 123.662 0.785 . . . . 0.0 111.175 178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 3.1 p -92.45 158.83 15.83 Favored 'General case' 0 C--O 1.244 0.78 0 O-C-N 120.683 -1.261 . . . . 0.0 111.594 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -71.53 -177.23 1.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.7 1.2 . . . . 0.0 108.765 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.4 -50.17 73.84 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.284 -0.885 . . . . 0.0 112.792 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -76.55 -33.63 58.52 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.755 0.422 . . . . 0.0 111.368 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.51 -7.12 53.41 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.452 1.977 . . . . 0.0 112.591 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -33.93 73.85 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.897 2.079 . . . . 0.0 109.501 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 61.4 mtm-85 -111.45 151.54 28.45 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.129 0.972 . . . . 0.0 110.263 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . 0.271 2.0 m -123.16 128.39 50.0 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 127.766 2.426 . . . . 0.0 105.823 -179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.25 115.79 20.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 126.58 1.952 . . . . 0.0 109.218 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 2.7 pp -119.57 161.23 20.97 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 108.871 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -131.66 120.7 23.16 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -122.95 117.68 26.09 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 75.0 t80 45.19 70.25 0.37 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.757 2.023 . . . . 0.0 112.164 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -80.68 157.23 25.98 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.911 -1.118 . . . . 0.0 110.668 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.334 . . -141.5 -140.69 0.13 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 118.896 0.771 . . . . 0.0 112.622 178.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -112.35 137.85 49.92 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.449 2.7 . . . . 0.0 105.723 -178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -48.74 -27.85 3.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.06 -38.01 78.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -87.28 -62.38 1.49 Allowed Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 178.69 146.44 0.16 Allowed 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 127.063 2.145 . . . . 0.0 107.646 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -137.44 149.22 46.71 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.44 139.3 36.52 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -177.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.1 109.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 52.4 t -145.85 147.26 18.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 103.544 -2.761 . . . . 0.0 103.544 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -135.47 118.87 16.79 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.987 179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.0 tp -103.21 119.32 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -109.29 107.76 18.1 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.146 0.884 . . . . 0.0 110.184 178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 174.55 156.41 13.91 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.46 -22.65 60.12 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 116.131 1.9 . . . . 0.0 116.131 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . 0.31 0.1 OUTLIER -58.91 -4.45 0.46 Allowed 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 116.103 1.89 . . . . 0.0 116.103 -178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 37.1 m 58.04 19.69 6.2 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.983 1.713 . . . . 0.0 115.092 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.32 22.23 77.52 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 120.793 -1.192 . . . . 0.0 112.149 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -77.9 143.53 37.64 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.955 1.378 . . . . 0.0 109.441 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 pp -99.12 146.98 25.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 119.078 0.853 . . . . 0.0 109.506 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -107.72 -80.39 0.57 Allowed 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -140.06 -69.04 0.41 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.7 55.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 117.692 -1.147 . . . . 0.0 113.206 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.1 -17.45 10.64 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 t -125.19 147.02 29.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.571 1.548 . . . . 0.0 107.126 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG22 ' H ' ' A' ' 145' ' ' ALA . 1.5 p -59.79 150.27 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -53.36 -31.98 47.07 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.947 1.299 . . . . 0.0 112.421 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.506 ' H ' HG22 ' A' ' 143' ' ' VAL . . . 60.27 75.07 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 127.682 2.393 . . . . 0.0 109.772 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -50.54 108.82 0.25 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.7 t -148.26 131.32 16.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 104.597 -2.372 . . . . 0.0 104.597 178.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.05 -105.26 0.82 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.475 1.512 . . . . 0.0 109.901 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 98.4 m -147.92 171.77 15.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.489 2.316 . . . . 0.0 107.017 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 11.3 t -61.56 157.37 17.47 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.195 -0.941 . . . . 0.0 108.49 177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 11.9 t -151.39 103.52 3.0 Favored 'General case' 0 N--CA 1.446 -0.641 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -61.26 119.2 7.99 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -85.47 76.49 10.05 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -58.61 129.96 44.56 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 p -141.48 173.74 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.422 1.089 . . . . 0.0 110.791 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 41.7 tp -75.81 140.26 42.2 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 86.68 -88.77 1.59 Allowed Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 108.412 -1.875 . . . . 0.0 108.412 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -162.75 161.56 26.33 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.704 1.601 . . . . 0.0 109.526 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.9 t 125.73 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 1 C-N-CA 133.316 4.646 . . . . 0.0 110.195 178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 170.96 -96.12 0.11 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.808 2.146 . . . . 0.0 108.067 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 p -138.6 4.4 2.36 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.247 1.024 . . . . 0.0 112.769 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -133.76 62.06 1.66 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.586 1.154 . . . . 0.0 110.396 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -42.29 112.95 0.39 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 125.763 1.625 . . . . 0.0 113.064 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 145.81 -148.03 19.47 Favored Glycine 0 C--N 1.334 0.432 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -70.98 174.63 5.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.115 0.966 . . . . 0.0 110.432 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 75.2 mt -66.79 132.22 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.249 1.07 0 C-N-CA 124.599 1.16 . . . . 0.0 109.398 -179.51 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -137.01 96.13 3.24 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -144.73 117.65 8.8 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.521 -2.399 . . . . 0.0 104.521 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.45 -177.03 22.48 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 -178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -144.55 140.66 16.82 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 118.548 1.174 . . . . 0.0 110.94 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.03 130.75 22.22 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 122.141 1.894 . . . . 0.0 107.504 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.9 101.92 7.86 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 89.1 t -91.79 129.35 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.52 -167.61 1.02 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 127.925 2.678 . . . . 0.0 113.01 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.08 3.22 30.0 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-O 116.535 -2.258 . . . . 0.0 114.358 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 67.05 25.01 9.31 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 120.345 2.072 . . . . 0.0 111.095 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 t -143.45 160.22 40.98 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 127.954 2.501 . . . . 0.0 110.651 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.35 125.27 25.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.116 -2.311 . . . . 0.0 110.822 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -173.11 -177.27 1.53 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.027 2.531 . . . . 0.0 105.452 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.539 ' HG2' ' CG2' ' A' ' 33' ' ' ILE . 22.0 mt-30 -116.72 120.13 37.63 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.035 1.734 . . . . 0.0 107.509 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB3' HD12 ' A' ' 25' ' ' LEU . 16.6 mt -104.75 142.39 34.79 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 128.005 2.522 . . . . 0.0 106.259 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.91 167.6 19.32 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.424 1.489 . . . . 0.0 111.9 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -132.7 -19.87 1.01 Allowed Glycine 0 CA--C 1.53 0.969 0 C-N-CA 123.98 0.8 . . . . 0.0 113.013 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.32 -90.76 0.37 Allowed Glycine 0 C--N 1.339 0.704 0 CA-C-N 118.982 1.391 . . . . 0.0 111.033 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -157.86 177.4 11.39 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.234 1.414 . . . . 0.0 110.847 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.18 -153.22 24.25 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 106.137 -2.785 . . . . 0.0 106.137 -178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.51 92.88 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 102.545 -3.131 . . . . 0.0 102.545 176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -105.25 167.66 9.58 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 ttt-85 -143.99 112.2 6.35 Favored 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 120.232 -1.543 . . . . 0.0 109.768 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 25' ' ' LEU . 2.4 pt? -107.29 150.38 26.74 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -146.71 115.37 6.79 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.81 -58.39 4.87 Favored Glycine 0 N--CA 1.459 0.178 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.24 -75.94 0.39 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-O 118.507 -1.163 . . . . 0.0 111.274 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -160.81 125.35 3.62 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.553 1.141 . . . . 0.0 110.484 -179.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.81 -167.75 32.72 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.826 0.681 . . . . 0.0 113.377 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -111.07 56.43 0.63 Allowed 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.674 3.189 . . . . 0.0 103.349 177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.22 165.22 13.23 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.21 2.204 . . . . 0.0 110.406 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.539 ' CG2' ' HG2' ' A' ' 15' ' ' GLN . 11.5 tt -125.47 126.1 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 177.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.8 mp -123.75 118.84 28.11 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.758 1.223 . . . . 0.0 111.397 -177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -113.45 117.69 32.43 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -75.73 -10.37 84.87 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 119.013 0.824 . . . . 0.0 114.263 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.0 -166.97 35.83 Favored Glycine 0 CA--C 1.527 0.784 0 O-C-N 121.19 -1.183 . . . . 0.0 112.021 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 58' ' ' GLU . . . -94.43 107.67 19.63 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 126.79 2.036 . . . . 0.0 110.48 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.78 -158.54 28.86 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 96.6 6.17 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 103.357 -2.831 . . . . 0.0 103.357 177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.51 162.66 16.43 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 127.954 2.502 . . . . 0.0 112.882 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.8 ttm-85 -120.04 101.6 7.96 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 124.561 1.144 . . . . 0.0 108.056 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 pp -102.76 143.42 32.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 124.807 1.243 . . . . 0.0 110.883 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 6.5 t -150.24 114.26 5.09 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 103.479 -2.785 . . . . 0.0 103.479 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.98 -62.85 2.68 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 106.581 -2.608 . . . . 0.0 106.581 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.21 -159.2 23.5 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 108.157 -1.977 . . . . 0.0 108.157 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 104.16 15.44 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 171.58 175.62 40.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 126.483 1.992 . . . . 0.0 108.846 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -100.26 68.29 1.41 Allowed 'General case' 0 C--O 1.233 0.184 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . 0.269 5.6 p30 -92.14 165.32 13.21 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.204 1.402 . . . . 0.0 111.833 -177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.4 m -117.11 131.33 56.92 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.037 0.535 . . . . 0.0 111.069 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -107.98 126.42 52.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.666 1.186 . . . . 0.0 108.778 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.2 t -80.9 115.91 24.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ALA . 27.9 t80 -90.74 104.58 17.15 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.563 ' HB2' HD11 ' A' ' 87' ' ' LEU . 3.9 m 66.53 69.72 0.41 Allowed 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.624 ' HA ' ' HB1' ' A' ' 86' ' ' ALA . . . -71.3 -15.33 62.41 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 120.464 3.505 . . . . 0.0 120.464 -175.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -168.49 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 O-C-N 124.314 1.009 . . . . 0.0 110.822 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.402 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -105.16 -10.78 16.9 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 117.903 -1.046 . . . . 0.0 112.177 -179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.79 19.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.258 1.504 . . . . 0.0 111.551 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.8 -40.13 33.84 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 -178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -162.53 -177.87 5.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 120.381 1.446 . . . . 0.0 109.957 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 67' ' ' VAL . 9.1 ptm180 -114.19 147.75 38.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.3 p -140.51 179.83 6.44 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.895 1.278 . . . . 0.0 110.472 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -47.87 97.11 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 131.566 3.946 . . . . 0.0 109.541 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 40.3 p 60.44 12.23 3.38 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 128.023 2.529 . . . . 0.0 112.83 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.45 82.37 2.07 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.116 1.766 . . . . 0.0 107.845 -178.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 62' ' ' ARG . 21.6 t -94.47 139.42 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 179.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -132.86 58.9 1.75 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -86.48 109.51 19.13 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 130.95 3.7 . . . . 0.0 114.993 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.77 155.43 38.87 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 126.938 2.095 . . . . 0.0 111.966 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 tt -144.48 103.9 4.01 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 129' ' ' LEU . 45.7 mt -85.44 136.82 22.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.64 136.01 48.11 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 31.8 t70 51.84 61.72 3.07 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.445 2.298 . . . . 0.0 114.061 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.0 138.52 34.88 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.175 0.99 . . . . 0.0 108.754 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -139.49 93.48 2.68 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.711 2.004 . . . . 0.0 110.985 -179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.32 -23.98 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.258 1.423 . . . . 0.0 113.826 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.3 t -64.18 -26.76 68.66 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.561 0.745 . . . . 0.0 111.338 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -131.74 -53.02 1.0 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.34 157.26 26.66 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 122.466 1.126 . . . . 0.0 112.917 -178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.78 156.14 49.28 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.187 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.3 mt -120.53 119.47 59.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -81.15 116.24 20.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.552 1.141 . . . . 0.0 111.094 -178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 84' ' ' LEU . 11.4 tp -92.38 4.05 54.19 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.039 1.336 . . . . 0.0 113.212 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 73.1 p -76.75 -15.36 59.78 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 118.898 -0.572 . . . . 0.0 112.485 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 56' ' ' ALA . . . -63.84 -29.26 70.47 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 123.497 0.719 . . . . 0.0 110.817 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.563 HD11 ' HB2' ' A' ' 55' ' ' SER . 0.0 OUTLIER -98.67 -75.48 0.56 Allowed 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.05 108.75 1.23 Allowed Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 108.929 -1.669 . . . . 0.0 108.929 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 116' ' ' PHE . 26.8 p90 -123.15 174.69 7.09 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.821 1.648 . . . . 0.0 109.709 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.2 t -142.09 -33.24 0.49 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.46 140.69 6.99 Favored Glycine 0 C--N 1.337 0.592 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 pp -70.87 170.74 11.97 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.252 1.026 . . . . 0.0 111.627 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 172.8 -97.01 0.11 Allowed Glycine 0 CA--C 1.524 0.621 0 CA-C-O 118.092 -1.393 . . . . 0.0 114.091 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 101' ' ' LEU . 1.1 m-20 -126.99 -2.11 6.51 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -177.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.09 36.91 6.93 Favored Glycine 0 N--CA 1.472 1.053 0 CA-C-N 119.642 1.11 . . . . 0.0 111.851 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -123.13 -110.32 0.32 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 119.089 1.444 . . . . 0.0 109.632 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.55 65.89 0.28 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 129.898 3.618 . . . . 0.0 113.538 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.27 10.93 84.08 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 124.393 0.997 . . . . 0.0 113.753 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -102.61 169.76 8.44 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.268 1.427 . . . . 0.0 111.899 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.71 145.33 30.83 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.527 2.331 . . . . 0.0 108.328 -179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 94' ' ' ASP . 62.5 tp -145.32 146.96 31.83 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.7 2.0 . . . . 0.0 111.648 177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.41 152.55 28.53 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.528 1.531 . . . . 0.0 109.48 178.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.7 mmmm -149.59 171.43 16.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.863 2.065 . . . . 0.0 108.257 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 1.2 p -123.52 165.6 16.84 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.118 1.367 . . . . 0.0 107.935 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -69.05 168.6 13.52 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -36.12 -61.63 0.48 Allowed 'General case' 0 C--N 1.344 0.327 0 C-N-CA 127.66 2.384 . . . . 0.0 110.496 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -75.13 -51.29 13.82 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.798 0.839 . . . . 0.0 109.427 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 125.27 -1.4 8.26 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.469 1.509 . . . . 0.0 113.591 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -21.95 66.8 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.695 1.998 . . . . 0.0 111.958 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -126.99 160.66 30.43 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 30.4 m -120.95 141.55 50.58 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.214 1.005 . . . . 0.0 110.506 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -141.0 118.3 11.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.369 2.268 . . . . 0.0 111.078 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 pp -107.7 164.54 12.15 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 120.227 1.376 . . . . 0.0 108.488 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -134.4 122.09 22.06 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -123.53 161.36 25.08 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 89' ' ' PHE . 0.3 OUTLIER -3.47 72.74 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 131.121 3.768 . . . . 0.0 112.85 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -109.41 -171.82 1.92 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -130.83 -108.11 0.27 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.886 1.674 . . . . 0.0 111.887 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -121.22 155.53 34.39 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.187 1.795 . . . . 0.0 111.838 -178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -60.2 -33.44 72.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -93.17 -27.12 17.08 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.731 0.412 . . . . 0.0 109.976 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -77.4 -49.81 7.1 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 119.211 -0.771 . . . . 0.0 112.307 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 161.47 118.23 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 128.905 2.882 . . . . 0.0 109.985 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.1 mtp180 -132.59 157.37 44.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -84.05 108.05 16.76 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 126.091 1.756 . . . . 0.0 109.039 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -120.66 110.6 16.6 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 78.7 t -145.01 156.52 13.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 124.608 1.163 . . . . 0.0 109.432 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -128.32 149.15 50.63 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.334 0.588 . . . . 0.0 110.081 178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.406 HD12 HD12 ' A' ' 72' ' ' ILE . 3.4 tp -125.25 134.09 52.45 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.65 1.58 . . . . 0.0 108.211 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -106.82 107.05 17.87 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -178.17 -171.15 41.22 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 125.397 1.475 . . . . 0.0 111.859 -179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -134.02 -25.54 1.59 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.924 1.69 . . . . 0.0 113.204 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -82.52 57.41 3.7 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 119.428 -2.045 . . . . 0.0 108.51 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.1 t -82.53 145.96 29.47 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.529 2.332 . . . . 0.0 111.996 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.32 -22.74 38.23 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-O 116.831 -2.094 . . . . 0.0 117.598 177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -94.4 106.08 18.06 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.765 2.283 . . . . 0.0 112.204 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.9 mp -125.61 123.34 38.8 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 101.108 -3.664 . . . . 0.0 101.108 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 75.5 m -142.03 -175.34 4.38 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -52.85 -20.22 3.12 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 127.083 2.153 . . . . 0.0 114.499 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -91.36 -58.37 2.47 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.408 1.083 . . . . 0.0 109.276 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -61.5 -12.67 16.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.687 1.595 . . . . 0.0 112.957 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.76 143.35 35.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 O-C-N 119.578 -1.951 . . . . 0.0 106.289 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 t -115.59 141.61 32.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -48.57 8.87 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.887 1.275 . . . . 0.0 108.438 179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.35 114.83 0.67 Allowed 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.865 2.066 . . . . 0.0 106.066 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -56.35 111.58 1.01 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 25.1 p -146.14 174.27 11.46 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.816 1.247 . . . . 0.0 109.703 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -110.06 6.48 30.76 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 124.144 0.878 . . . . 0.0 111.941 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.9 m -71.91 167.96 18.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.27 1.428 . . . . 0.0 110.998 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.2 p -71.7 151.31 43.73 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.833 2.053 . . . . 0.0 109.05 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.82 163.79 13.2 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.222 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' C ' ' H ' ' A' ' 154' ' ' GLU . 68.6 mm-40 -122.7 -171.1 2.21 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.431 1.492 . . . . 0.0 111.538 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.1 tp 65.35 -10.63 0.19 Allowed 'General case' 0 C--N 1.343 0.308 1 C-N-CA 131.943 4.097 . . . . 0.0 110.932 -178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 152' ' ' GLU . 1.6 tp10 -85.03 81.4 8.91 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.8 t -130.21 23.77 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.344 1.458 . . . . 0.0 112.165 -178.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.31 63.46 1.09 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 126.493 1.917 . . . . 0.0 109.717 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 165.32 -179.26 39.89 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.21 169.1 8.68 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 126.948 2.099 . . . . 0.0 108.87 178.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 27.3 p 41.56 40.18 1.3 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.405 1.882 . . . . 0.0 113.84 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -95.29 -166.87 35.45 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.7 p -67.96 -20.72 65.08 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 118.968 -0.539 . . . . 0.0 111.354 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -59.83 99.39 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.963 2.105 . . . . 0.0 110.604 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -157.59 119.96 3.83 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 125.635 1.574 . . . . 0.0 106.818 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -81.53 -94.05 0.49 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -161.47 161.07 29.97 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.266 1.827 . . . . 0.0 106.587 179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . 0.291 16.1 pt 51.4 13.13 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 127.31 2.244 . . . . 0.0 116.925 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.379 14.5 p . . . . . 0 C--O 1.248 0.997 0 CA-C-O 114.371 -2.728 . . . . 0.0 110.249 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.067 0 N-CA-C 112.128 -0.389 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.7 m -157.85 163.72 37.69 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.172 1.789 . . . . 0.0 107.597 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -123.58 -16.81 6.64 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.167 1.787 . . . . 0.0 111.101 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.86 168.56 24.22 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -124.98 158.99 61.04 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 124.548 1.139 . . . . 0.0 109.856 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.47 139.09 8.89 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.87 3.047 . . . . 0.0 113.361 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -125.62 129.64 50.03 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 128.916 2.886 . . . . 0.0 103.47 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.8 t -134.74 126.44 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 124.031 0.932 . . . . 0.0 109.935 -178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.54 -65.97 2.19 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 107.295 -2.322 . . . . 0.0 107.295 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.11 -88.28 0.4 Allowed Glycine 0 C--N 1.334 0.453 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 12' ' ' THR . 1.3 p-10 -173.77 85.48 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 11' ' ' ASP . 7.3 p -166.43 125.12 1.48 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 128.079 2.551 . . . . 0.0 108.705 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.08 121.12 13.41 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.749 0.785 . . . . 0.0 112.319 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.11 -172.12 1.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.714 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 10.5 tm0? -124.44 107.16 10.81 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.83 109.76 16.51 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -114.09 165.92 12.15 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.398 0.679 . . . . 0.0 110.747 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.81 89.44 0.62 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.939 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -126.07 -1.65 7.34 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 125.69 1.614 . . . . 0.0 111.057 178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 p -49.43 148.99 2.42 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.751 2.02 . . . . 0.0 111.894 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.18 -117.92 11.14 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 117.987 -1.452 . . . . 0.0 110.074 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -122.31 99.13 6.26 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -132.68 166.95 20.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.65 104.82 3.78 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -114.85 129.75 56.75 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.799 0.727 . . . . 0.0 109.555 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -116.12 116.75 28.4 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.909 1.284 . . . . 0.0 109.021 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -55.26 -65.56 3.46 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.28 -94.79 0.43 Allowed Glycine 0 CA--C 1.524 0.628 0 C-N-CA 123.959 0.79 . . . . 0.0 112.806 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.99 135.57 8.32 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.666 1.587 . . . . 0.0 108.668 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.06 -146.12 18.17 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -128.42 66.52 1.39 Allowed 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 130.634 3.574 . . . . 0.0 103.302 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -107.7 164.58 12.11 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' A' ' 51' ' ' THR . 24.3 pt -132.34 136.86 55.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 120.749 -1.219 . . . . 0.0 109.879 -178.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.89 158.64 40.84 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.089 0.956 . . . . 0.0 112.078 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -136.17 111.9 9.42 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.34 1.856 . . . . 0.0 110.266 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.56 -2.0 32.96 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 126.306 1.908 . . . . 0.0 114.347 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 65.46 -152.66 51.37 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 119.788 1.794 . . . . 0.0 111.87 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.3 108.16 13.84 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 126.468 1.907 . . . . 0.0 107.49 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.83 172.22 17.66 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 124.663 1.125 . . . . 0.0 111.259 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -79.22 98.08 6.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 179.22 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.47 162.34 15.2 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 128.275 2.63 . . . . 0.0 105.723 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.2 ttp85 -122.34 99.85 6.64 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 pp -91.75 139.28 30.83 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.836 -178.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -145.11 88.71 1.9 Allowed 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.43 -53.07 47.76 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.49 -175.09 15.58 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -80.07 103.49 9.98 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 102.278 -3.23 . . . . 0.0 102.278 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.46 -179.73 44.32 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.13 57.4 0.81 Allowed 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.77 164.84 25.48 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 124.325 1.05 . . . . 0.0 109.986 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.509 ' HB ' HG22 ' A' ' 33' ' ' ILE . 82.1 m -131.46 113.64 13.95 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -88.31 110.45 20.77 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.071 1.348 . . . . 0.0 110.268 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.9 t -84.07 126.98 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -94.85 146.39 24.24 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.5 m -75.38 -67.74 0.63 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -177.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -160.83 -179.18 7.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 55.3 mtm180 -54.02 -33.45 57.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.432 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.05 -37.83 75.15 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 118.406 0.548 . . . . 0.0 111.259 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.83 61.39 5.94 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 123.402 1.573 . . . . 0.0 107.134 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.67 5.35 0.04 OUTLIER 'General case' 0 C--O 1.236 0.371 0 O-C-N 120.477 -1.39 . . . . 0.0 113.169 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' CD2' ' HB3' ' A' ' 123' ' ' ARG . 4.9 p90 -164.89 -178.09 5.04 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.273 1.429 . . . . 0.0 107.193 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -115.47 150.73 36.02 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 57.1 p -123.8 163.46 21.15 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.87 -31.74 72.55 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -65.08 -44.66 88.17 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.06 149.12 12.08 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 123.094 1.426 . . . . 0.0 111.997 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG12 ' H ' ' A' ' 69' ' ' ASN . 54.1 t -89.9 143.17 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 178.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -132.19 42.57 3.11 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.523 ' H ' HG12 ' A' ' 67' ' ' VAL . 1.4 p-10 -63.64 112.72 2.95 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -79.95 141.83 35.65 Favored 'General case' 0 C--O 1.245 0.868 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 96.2 mt -137.55 104.46 5.34 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.8 mt -84.7 133.08 30.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 155.33 21.34 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.237 2.215 . . . . 0.0 107.321 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 34.98 40.15 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 128.546 2.738 . . . . 0.0 117.33 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 47.9 t80 -58.49 135.84 57.38 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.369 1.067 . . . . 0.0 111.188 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -131.54 75.13 1.63 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.55 ' HB2' ' CE2' ' A' ' 75' ' ' PHE . . . -51.12 -22.82 2.71 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -49.84 68.83 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.342 0.657 . . . . 0.0 109.52 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -114.04 -22.59 9.98 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.12 147.84 23.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 120.109 1.322 . . . . 0.0 112.448 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -134.09 167.67 20.22 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.357 1.463 . . . . 0.0 112.361 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.8 mt -146.79 131.47 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 O-C-N 121.133 -0.98 . . . . 0.0 112.789 -177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -103.4 95.28 5.98 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.453 HD22 ' CD1' ' A' ' 87' ' ' LEU . 70.8 mt -101.53 25.45 8.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.616 1.566 . . . . 0.0 111.415 -178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 52.1 p -54.18 -22.46 11.41 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.1 -0.22 30.98 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' CD1' HD22 ' A' ' 84' ' ' LEU . 12.2 mt -89.06 153.05 21.3 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -41.61 -16.27 0.02 OUTLIER Glycine 0 CA--C 1.538 1.516 0 C-N-CA 130.062 3.696 . . . . 0.0 116.8 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -146.59 163.84 34.54 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 127.952 2.501 . . . . 0.0 105.995 176.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -87.29 -43.14 12.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.705 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -124.36 -129.79 3.46 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 110.669 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.3 pt? -125.19 166.56 16.24 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.524 1.53 . . . . 0.0 112.086 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -179.04 -105.85 0.2 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.721 -1.581 . . . . 0.0 110.546 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -124.92 5.21 8.02 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 52.33 41.41 54.8 Favored Glycine 0 CA--C 1.5 -0.881 0 CA-C-O 118.224 -1.32 . . . . 0.0 113.222 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -156.71 163.28 39.45 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.203 -2.518 . . . . 0.0 104.203 177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.78 -17.44 0.01 OUTLIER Glycine 0 CA--C 1.541 1.691 0 C-N-CA 129.575 3.465 . . . . 0.0 116.646 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.95 27.32 0.13 Allowed Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.677 2.561 . . . . 0.0 111.413 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 49.5 p -121.23 -168.74 1.72 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.116 1.958 . . . . 0.0 109.443 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.8 tt -141.03 129.5 22.53 Favored 'General case' 0 N--CA 1.473 0.693 0 O-C-N 120.438 -1.414 . . . . 0.0 107.774 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.95 139.0 44.41 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 119.628 1.104 . . . . 0.0 110.019 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.34 139.04 54.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt -138.62 171.27 14.61 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 11.8 p -129.82 164.15 24.72 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.235 0.614 . . . . 0.0 112.063 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.22 176.62 1.27 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.268 1.827 . . . . 0.0 109.04 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.39 -45.56 72.91 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.45 1.023 . . . . 0.0 111.662 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.43 -19.84 19.56 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.889 0.876 . . . . 0.0 112.824 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 99.71 5.76 55.08 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.34 0.972 . . . . 0.0 114.216 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -18.53 63.09 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 128.21 2.604 . . . . 0.0 112.443 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -140.06 144.38 36.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.133 1.773 . . . . 0.0 108.196 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' A' ' 129' ' ' LEU . 54.6 m -114.55 130.5 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -129.49 116.95 19.73 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.03 166.51 11.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.534 1.934 . . . . 0.0 112.286 -179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -119.23 175.93 5.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.951 1.7 . . . . 0.0 106.579 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.2 t -138.56 155.91 47.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -14.32 -80.04 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 128.402 2.681 . . . . 0.0 114.129 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.78 153.84 1.11 Allowed 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.284 1.033 . . . . 0.0 109.692 179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 160.88 163.25 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 129.63 3.172 . . . . 0.0 112.999 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -103.93 156.15 18.07 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 131.01 3.724 . . . . 0.0 104.061 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.498 ' N ' ' HG3' ' A' ' 124' ' ' ARG . . . -59.05 -2.88 0.29 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -94.2 7.42 45.37 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.986 2.515 . . . . 0.0 110.386 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.32 -50.58 0.01 OUTLIER Glycine 0 C--N 1.338 0.681 0 CA-C-O 116.054 -2.526 . . . . 0.0 118.351 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.425 ' HB3' ' CD2' ' A' ' 61' ' ' TYR . 1.8 mpt_? -158.11 48.98 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 121.604 2.702 . . . . 0.0 116.588 -177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.498 ' HG3' ' N ' ' A' ' 120' ' ' ALA . 2.0 mmm180 -76.85 140.46 40.63 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.471 -2.018 . . . . 0.0 112.458 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -86.93 106.94 18.13 Favored 'General case' 0 N--CA 1.424 -1.764 0 C-N-CA 129.147 2.979 . . . . 0.0 115.44 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.79 109.5 4.61 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 103.667 -2.716 . . . . 0.0 103.667 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 t -144.99 166.09 11.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 128.599 2.76 . . . . 0.0 108.075 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 71' ' ' LEU . . . -147.87 120.98 8.87 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 119.27 0.941 . . . . 0.0 112.601 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 111' ' ' THR . 2.5 tt -103.44 127.37 50.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -99.92 120.43 39.77 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 173.79 167.43 33.43 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -113.9 15.14 18.6 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.104 1.361 . . . . 0.0 110.813 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 86.9 m-70 -93.51 16.37 13.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.914 2.086 . . . . 0.0 113.009 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.302 23.5 m 53.45 18.76 1.44 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.739 1.216 . . . . 0.0 113.544 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.51 29.06 65.94 Favored Glycine 0 CA--C 1.53 1.001 0 O-C-N 120.313 -1.492 . . . . 0.0 111.914 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.72 134.9 57.23 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.217 1.807 . . . . 0.0 113.269 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 33.8 mt -130.37 148.26 52.17 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 127.292 2.237 . . . . 0.0 106.261 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.456 ' H ' ' HB3' ' A' ' 141' ' ' ASN . 47.5 m -148.92 -175.65 5.03 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 125.595 1.558 . . . . 0.0 108.595 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -48.46 -44.45 35.61 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 128.939 2.896 . . . . 0.0 113.732 -178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -80.93 -34.25 33.44 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.14 0.976 . . . . 0.0 111.146 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.456 ' HB3' ' H ' ' A' ' 138' ' ' SER . 27.0 t-20 -54.58 -52.53 61.84 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.478 1.111 . . . . 0.0 111.472 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.1 139.67 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.144 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.54 159.39 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 123.79 0.836 . . . . 0.0 108.797 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.3 -28.08 68.42 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.048 -1.033 . . . . 0.0 111.322 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 52.49 77.4 0.16 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.104 2.162 . . . . 0.0 111.195 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -48.32 114.58 0.98 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.583 1.553 . . . . 0.0 108.606 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.3 t -127.6 -14.33 5.22 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.119 0.968 . . . . 0.0 112.726 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 174.81 -174.65 46.78 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -117.73 81.72 1.71 Allowed 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.3 p -146.32 127.54 14.78 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.116 1.366 . . . . 0.0 109.199 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 59.4 p -136.46 72.66 1.43 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 152' ' ' GLU . 1.1 pm0 -78.96 160.06 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.409 0.684 . . . . 0.0 109.805 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.19 19.9 3.42 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.062 0.545 . . . . 0.0 112.329 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.52 47.4 21.02 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.464 1.106 . . . . 0.0 111.733 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.6 t -74.97 145.21 11.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.38 92.78 4.85 Favored 'General case' 0 C--N 1.334 -0.098 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 168.04 59.15 0.03 OUTLIER Glycine 0 C--O 1.226 -0.371 0 CA-C-O 118.418 -1.212 . . . . 0.0 110.682 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 25.6 t0 35.78 53.93 0.88 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.864 2.466 . . . . 0.0 112.336 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.4 t -160.52 -179.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.778 1.631 . . . . 0.0 107.706 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -154.34 -63.2 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 125.54 1.543 . . . . 0.0 109.58 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.8 p -75.77 -0.81 22.29 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.563 1.945 . . . . 0.0 114.479 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -144.84 153.11 41.27 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 119.72 1.145 . . . . 0.0 108.179 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -131.74 160.56 35.17 Favored 'General case' 0 C--O 1.228 -0.074 0 C-N-CA 124.345 1.058 . . . . 0.0 109.673 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -80.52 -63.52 1.92 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . 51.02 18.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.306 1.842 . . . . 0.0 115.453 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.27 149.73 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 124.626 1.17 . . . . 0.0 109.314 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 C--O 1.255 1.366 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 179.193 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.526 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 68.9 6.93 5.88 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.349 1.459 . . . . 0.0 111.193 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.43 -18.83 58.61 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.37 1.868 . . . . 0.0 109.475 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.67 -175.17 37.46 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.073 2.273 . . . . 0.0 110.461 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.33 137.98 15.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.1 132.44 22.79 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 N-CA-C 106.027 -2.336 . . . . 0.0 106.027 178.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.03 116.21 24.61 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -177.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.5 t -110.64 121.4 63.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 104.017 -2.586 . . . . 0.0 104.017 178.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.65 -159.29 2.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 125.843 1.687 . . . . 0.0 115.545 -178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.66 -148.94 13.22 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.9 -1.65 . . . . 0.0 109.208 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -159.13 40.27 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 125.47 2.557 . . . . 0.0 109.94 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.6 p -135.28 -90.89 0.31 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 109.812 -3.358 . . . . 0.0 109.3 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -164.89 134.66 3.72 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 131.588 3.955 . . . . 0.0 107.81 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -158.54 176.27 12.62 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 126.682 1.993 . . . . 0.0 107.953 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.1 tt0 -128.6 109.0 10.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.4 mp -103.1 132.54 49.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.274 1.03 . . . . 0.0 108.929 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 147.7 52.0 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.515 1.526 . . . . 0.0 110.356 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -101.01 -83.52 1.74 Allowed Glycine 0 CA--C 1.524 0.616 0 N-CA-C 104.283 -3.527 . . . . 0.0 104.283 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.22 -91.58 0.21 Allowed Glycine 0 C--N 1.336 0.539 0 CA-C-N 119.173 1.487 . . . . 0.0 115.312 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -150.25 -7.89 0.29 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.138 0.975 . . . . 0.0 113.619 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -86.43 -159.65 33.24 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 126.846 2.165 . . . . 0.0 113.956 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.76 94.77 4.42 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 102.413 -3.181 . . . . 0.0 102.413 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.26 7.2 p-10 -129.4 171.7 12.26 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 129.256 3.022 . . . . 0.0 110.612 -177.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -131.52 100.66 5.22 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.9 151.99 19.68 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 120.483 1.492 . . . . 0.0 111.13 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -152.08 128.95 10.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.836 1.654 . . . . 0.0 112.7 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.13 -64.41 0.6 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 18.29 55.83 0.01 OUTLIER Glycine 0 C--N 1.328 0.137 1 C-N-CA 132.859 5.028 . . . . 0.0 118.979 -178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.29 21.42 0.19 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 117.97 0.885 . . . . 0.0 112.25 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.67 -156.39 27.25 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -100.72 87.31 3.3 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 129.131 2.972 . . . . 0.0 104.495 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -123.23 165.75 16.39 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.244 1.818 . . . . 0.0 110.023 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.566 HD11 ' HG2' ' A' ' 15' ' ' GLN . 0.2 OUTLIER -114.54 137.68 47.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.42 133.22 46.18 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-O 122.051 0.929 . . . . 0.0 108.558 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -146.01 117.1 7.81 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.497 1.519 . . . . 0.0 107.091 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -83.75 -15.56 70.25 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.645 -0.659 . . . . 0.0 112.264 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.35 -162.85 54.76 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 120.69 -1.476 . . . . 0.0 110.442 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.23 169.91 11.2 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.958 0.885 . . . . 0.0 109.123 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.81 -170.1 39.58 Favored Glycine 0 N--CA 1.444 -0.786 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -116.91 100.48 7.8 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 126.523 1.929 . . . . 0.0 106.225 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.37 163.54 16.21 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 126.955 2.102 . . . . 0.0 110.206 -178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.18 99.74 8.05 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.81 153.89 18.04 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.9 m -141.64 106.45 4.91 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.33 -56.92 6.44 Favored Glycine 0 C--O 1.222 -0.645 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.29 -160.96 31.07 Favored Glycine 0 CA--C 1.523 0.554 0 CA-C-N 119.694 1.747 . . . . 0.0 111.862 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.84 103.7 2.27 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.271 0.628 . . . . 0.0 109.373 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.84 -169.61 41.62 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -136.99 66.21 1.48 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 100.89 -3.745 . . . . 0.0 100.89 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.16 166.1 24.17 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 127.636 2.375 . . . . 0.0 116.02 -173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 17.8 m -120.38 105.72 11.16 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -86.88 97.45 10.67 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 49.3 t -88.3 130.04 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 122.926 0.49 . . . . 0.0 109.703 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.78 150.67 21.5 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.943 0.897 . . . . 0.0 109.186 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.6 t -74.87 -65.19 0.9 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 125.763 1.625 . . . . 0.0 113.58 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 169.33 171.65 0.05 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 129.695 3.198 . . . . 0.0 108.317 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -28.29 -33.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 129.865 3.266 . . . . 0.0 118.142 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -70.69 -26.33 63.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 121.13 -0.981 . . . . 0.0 112.081 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -71.87 -51.0 24.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 125.302 2.477 . . . . 0.0 113.101 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.2 m -44.63 -27.19 0.45 Allowed 'General case' 0 C--N 1.294 -1.817 1 C-N-CA 138.478 6.711 . . . . 0.0 118.222 -176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.69 -179.03 6.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.22 1.008 . . . . 0.0 110.013 -177.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -114.19 151.23 33.05 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.7 p -131.91 -179.88 5.66 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.839 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -44.89 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 130.574 3.55 . . . . 0.0 108.679 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . 0.254 76.9 p 55.04 17.02 1.72 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 129.698 3.199 . . . . 0.0 114.164 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.87 89.83 2.88 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.231 1.812 . . . . 0.0 107.585 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.1 t -85.88 141.1 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 125.318 1.447 . . . . 0.0 107.937 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.79 42.73 3.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 122.977 1.37 . . . . 0.0 108.736 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -66.89 100.85 0.76 Allowed 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 125.5 1.52 . . . . 0.0 111.675 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 155.08 39.01 Favored 'General case' 0 C--O 1.243 0.711 0 C-N-CA 126.157 1.783 . . . . 0.0 107.983 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 tt -142.7 105.64 4.54 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.5 mt -91.53 139.36 17.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.46 143.57 38.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.612 1.565 . . . . 0.0 109.035 176.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 41.91 77.12 0.06 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 129.197 2.999 . . . . 0.0 113.823 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -97.38 144.32 27.25 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 126.119 1.768 . . . . 0.0 107.293 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -141.26 87.12 2.06 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.895 1.678 . . . . 0.0 106.851 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.76 -25.32 7.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.32 0.648 . . . . 0.0 112.58 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.3 m -67.95 -18.47 64.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.893 0.877 . . . . 0.0 112.465 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -124.26 -55.51 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 126.279 1.832 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.4 160.17 11.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.269 1.028 . . . . 0.0 111.681 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.2 mtt180 -135.86 152.38 50.99 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.712 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.436 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -115.2 133.1 62.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 C-N-CA 123.797 0.839 . . . . 0.0 110.797 -179.118 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -120.47 95.24 4.65 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 124.16 0.984 . . . . 0.0 109.528 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 mp -101.71 19.87 17.31 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.104 1.762 . . . . 0.0 110.134 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.2 p -59.88 -25.16 64.85 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.194 -1.566 . . . . 0.0 111.788 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -79.18 -3.13 44.17 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.121 0.968 . . . . 0.0 112.951 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.7 -69.69 0.76 Allowed 'General case' 0 C--N 1.343 0.288 0 CA-C-N 119.519 1.054 . . . . 0.0 112.32 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 121.66 94.02 1.28 Allowed Glycine 0 N--CA 1.468 0.799 0 CA-C-N 120.154 1.343 . . . . 0.0 114.88 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -145.62 173.64 11.88 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.711 2.004 . . . . 0.0 108.476 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.91 -15.0 4.39 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.085 0.954 . . . . 0.0 111.534 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 165.97 -167.21 39.1 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 92' ' ' LEU . 2.4 pt? -87.15 177.71 7.11 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.859 0.838 . . . . 0.0 110.219 178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 160.69 -94.85 0.13 Allowed Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.89 -14.19 2.12 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 107.6 9.15 29.39 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-O 117.777 -1.569 . . . . 0.0 113.247 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -121.7 167.98 12.32 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 120.46 2.13 . . . . 0.0 109.082 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 36.42 53.19 1.35 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.857 1.218 . . . . 0.0 114.241 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.38 8.89 85.67 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 117.718 -1.601 . . . . 0.0 115.865 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.1 p -102.09 176.5 5.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.488 1.644 . . . . 0.0 112.203 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.27 142.77 29.77 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.98 1.712 . . . . 0.0 110.39 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -144.05 130.02 19.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 125.199 1.4 . . . . 0.0 109.848 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 102' ' ' LEU . 2.3 pt? -119.45 133.91 55.47 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 127.807 2.443 . . . . 0.0 108.856 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -143.06 157.39 44.58 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.444 1.498 . . . . 0.0 108.144 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 64.0 p -103.63 157.05 17.33 Favored 'General case' 0 C--O 1.242 0.671 0 O-C-N 121.571 -0.706 . . . . 0.0 111.104 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -60.7 164.74 4.41 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.451 1.101 . . . . 0.0 108.058 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -53.96 -34.73 60.54 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.808 -1.183 . . . . 0.0 111.028 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -96.15 -10.39 28.32 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.342 1.057 . . . . 0.0 112.653 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 79.22 8.03 88.08 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 119.417 1.008 . . . . 0.0 112.444 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.38 -30.5 67.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.19 1.396 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 83.0 mtm-85 -139.16 131.67 28.69 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 122.778 0.431 . . . . 0.0 111.939 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 59.1 m -100.57 136.63 40.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -114.38 118.92 35.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.737 2.015 . . . . 0.0 106.45 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.36 119.69 25.53 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 124.792 1.237 . . . . 0.0 110.867 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.99 122.62 43.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.53 0.732 . . . . 0.0 109.483 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.0 p -105.34 106.76 17.4 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 1.1 t80 33.85 65.87 0.27 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.681 1.993 . . . . 0.0 112.781 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -75.22 -178.01 3.73 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.559 1.544 . . . . 0.0 110.235 178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.323 . . -141.18 -150.43 0.31 Allowed 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 123.834 0.854 . . . . 0.0 112.33 178.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -105.33 157.16 17.51 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 128.618 2.767 . . . . 0.0 110.812 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -49.3 -25.94 2.73 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 125.367 1.467 . . . . 0.0 113.384 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -99.27 -3.09 34.94 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.595 1.089 . . . . 0.0 113.078 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.71 -35.5 1.7 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.132 1.349 . . . . 0.0 113.589 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 144.98 136.82 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 130.613 3.565 . . . . 0.0 107.27 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.04 146.17 51.47 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 121.044 1.747 . . . . 0.0 110.873 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -79.73 139.28 37.37 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.52 1.128 . . . . 0.0 113.754 -177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -163.43 108.52 1.07 Allowed 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 175.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.92 170.89 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 127.588 2.355 . . . . 0.0 107.179 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -151.48 120.86 6.83 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.71 135.46 34.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -76.3 112.62 12.98 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 79.32 -174.35 55.23 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.114 1.34 . . . . 0.0 112.964 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -131.02 175.48 9.05 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 131.039 3.736 . . . . 0.0 107.506 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -131.61 -4.92 3.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.372 1.869 . . . . 0.0 111.088 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . 0.255 12.8 t 45.29 40.07 4.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.115 2.166 . . . . 0.0 112.327 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 167.31 64.8 0.03 OUTLIER Glycine 0 C--N 1.331 0.278 0 N-CA-C 107.807 -2.117 . . . . 0.0 107.807 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -58.22 136.98 57.4 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.366 1.467 . . . . 0.0 112.26 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.49 156.97 17.31 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.512 1.525 . . . . 0.0 108.36 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 49.6 m -149.74 -80.38 0.12 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.984 1.313 . . . . 0.0 110.142 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -54.81 -18.36 4.69 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.154 1.782 . . . . 0.0 113.038 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.07 -9.94 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.618 1.567 . . . . 0.0 113.127 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -114.39 -81.2 0.6 Allowed 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.662 1.185 . . . . 0.0 111.558 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 82' ' ' ILE . 18.7 t -52.59 136.58 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 C-N-CA 128.378 2.671 . . . . 0.0 112.472 -177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.49 150.94 7.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.295 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -72.76 -32.08 65.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 123.413 0.685 . . . . 0.0 111.922 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 55.6 65.52 1.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.735 2.014 . . . . 0.0 112.301 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 52.45 37.67 23.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.626 1.97 . . . . 0.0 116.172 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 14.0 t -155.8 -173.95 4.75 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.798 1.639 . . . . 0.0 107.341 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.8 71.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.523 0 CA-C-N 119.536 1.062 . . . . 0.0 113.139 179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.29 156.71 48.26 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . 0.287 71.1 p 39.79 33.66 0.14 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 129.302 3.041 . . . . 0.0 113.039 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.5 m -69.35 2.25 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.539 2.736 . . . . 0.0 113.941 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -53.06 109.13 0.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.959 1.704 . . . . 0.0 109.396 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.43 -9.88 4.18 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 116.786 2.143 . . . . 0.0 116.786 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 41.53 64.66 0.99 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 129.165 2.986 . . . . 0.0 116.51 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.0 t -109.16 16.42 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 123.76 1.743 . . . . 0.0 114.803 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 80.5 mt -99.99 169.47 9.17 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.926 1.29 . . . . 0.0 110.469 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.58 -22.13 60.7 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.52 114.85 7.11 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.689 1.995 . . . . 0.0 108.081 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 7.6 p -160.51 -171.38 3.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.437 1.495 . . . . 0.0 110.537 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 139.37 166.45 10.62 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.555 1.55 . . . . 0.0 111.074 179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 p -94.12 149.72 20.98 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.722 1.209 . . . . 0.0 109.196 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 45.17 32.7 0.98 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.936 2.094 . . . . 0.0 113.141 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.37 159.81 33.45 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.49 0.662 . . . . 0.0 110.602 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 161.26 -173.74 37.73 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -149.51 170.71 17.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.678 1.991 . . . . 0.0 107.097 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 7.4 tp -151.82 171.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 125.087 1.355 . . . . 0.0 107.616 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.247 0.924 0 C-N-CA 128.259 2.624 . . . . 0.0 104.549 179.223 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -145.74 132.39 19.91 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -84.92 65.63 9.3 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.44 148.17 21.32 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -178.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -149.55 124.39 4.8 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 107.238 -1.394 . . . . 0.0 107.238 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -81.29 155.07 19.06 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.407 2.071 . . . . 0.0 111.397 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -126.32 113.89 17.52 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.3 t -100.56 117.18 45.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 172.21 34.05 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.275 1.893 . . . . 0.0 113.994 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.41 -105.75 0.13 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 126.495 1.997 . . . . 0.0 115.273 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -169.51 0.0 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 p -135.66 164.93 26.74 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 129.019 2.928 . . . . 0.0 109.311 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -52.03 124.07 11.98 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 126.397 1.879 . . . . 0.0 110.97 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -156.31 -179.2 7.94 Favored 'General case' 0 C--O 1.243 0.74 0 C-N-CA 127.948 2.499 . . . . 0.0 106.004 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.434 ' HG3' HD11 ' A' ' 33' ' ' ILE . 1.5 tm0? -128.76 136.34 50.42 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 77.5 mt -121.84 135.05 54.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.77 146.17 32.93 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.96 -83.98 0.07 OUTLIER Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.498 1.047 . . . . 0.0 112.691 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.38 51.89 0.96 Allowed Glycine 0 CA--C 1.523 0.534 0 O-C-N 121.375 -1.074 . . . . 0.0 110.589 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.7 p 36.42 113.83 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.429 1 C-N-CA 133.535 4.734 . . . . 0.0 116.781 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.74 161.78 8.84 Favored Glycine 0 N--CA 1.443 -0.895 0 C-N-CA 129.423 3.392 . . . . 0.0 106.969 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.72 93.71 4.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.325 1.563 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.27 166.59 10.31 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 127.274 2.23 . . . . 0.0 107.488 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -137.34 98.87 3.82 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 pp -98.57 148.72 23.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.313 0.578 . . . . 0.0 109.852 -179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -145.56 131.62 19.32 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 125.267 1.427 . . . . 0.0 109.432 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.97 -59.85 3.06 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.22 -80.73 0.29 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.292 -1.282 . . . . 0.0 111.168 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.26 121.66 4.35 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.1 1.36 . . . . 0.0 109.965 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 133.3 145.58 5.39 Favored Glycine 0 C--N 1.331 0.265 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -66.25 83.96 0.09 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.38 164.73 14.41 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 128.487 2.715 . . . . 0.0 107.581 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' A' ' 15' ' ' GLN . 0.7 OUTLIER -116.74 136.59 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.137 0 O-C-N 121.759 -0.588 . . . . 0.0 111.179 179.702 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mp -128.29 149.12 50.63 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.16 0.984 . . . . 0.0 109.077 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.92 107.71 6.62 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -26.17 -61.82 0.07 OUTLIER Glycine 0 C--N 1.335 0.527 0 C-N-CA 130.683 3.992 . . . . 0.0 114.973 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.64 -146.73 17.85 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.23 106.24 11.32 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 94.69 -158.2 22.6 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.393 -0.817 . . . . 0.0 111.256 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.584 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -82.36 96.59 7.99 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -179.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -121.87 163.31 19.43 Favored 'General case' 0 C--N 1.321 -0.659 1 C-N-CA 132.158 4.183 . . . . 0.0 105.037 -178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -124.81 103.4 8.06 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.578 2.066 . . . . 0.0 116.578 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 pp -91.46 160.22 15.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.543 0.687 . . . . 0.0 110.924 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 71.7 m -149.42 124.55 10.09 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 127.967 2.507 . . . . 0.0 105.33 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.65 -57.42 4.19 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 106.56 -2.616 . . . . 0.0 106.56 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 122.48 -162.1 16.41 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 106.887 -2.485 . . . . 0.0 106.887 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -77.89 104.6 8.55 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 175.02 -152.59 13.9 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 118.378 -1.868 . . . . 0.0 115.889 -178.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -135.85 57.49 1.78 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 131.648 3.979 . . . . 0.0 106.458 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.88 166.26 23.59 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 126.478 1.911 . . . . 0.0 112.803 -177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.8 m -126.69 117.37 22.59 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.488 0.715 . . . . 0.0 110.41 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -95.92 113.91 25.58 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.28 112.1 28.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 125.253 1.421 . . . . 0.0 113.361 -177.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CD1' HD11 ' A' ' 82' ' ' ILE . 86.5 m-85 -114.62 98.35 6.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.1 m -98.44 -3.18 37.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.356 -0.84 . . . . 0.0 112.732 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 59' ' ' ASP 0.254 . . 56.02 18.67 3.24 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -63.93 -40.2 95.91 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -108.21 -39.13 5.57 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 128.321 2.648 . . . . 0.0 113.735 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 7.5 m-20 -66.31 95.51 0.31 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.4 m -72.65 -107.34 0.01 OUTLIER 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.067 -0.97 . . . . 0.0 113.508 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' PHE . 0.2 OUTLIER -165.81 -179.24 5.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 120.668 -1.27 . . . . 0.0 110.365 -176.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HB2' HG13 ' A' ' 67' ' ' VAL . 8.1 ptm180 -116.61 162.69 17.23 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 122.073 0.94 . . . . 0.0 109.267 177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -137.49 178.06 7.39 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -77.47 -18.38 57.19 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.143 -1.598 . . . . 0.0 110.724 178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 43.1 p -99.98 -22.05 15.41 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.17 22.18 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 124.875 1.27 . . . . 0.0 108.794 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 62' ' ' ARG . 2.0 t -124.59 114.74 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 127.708 2.403 . . . . 0.0 107.465 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -95.86 35.15 1.42 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.063 0.945 . . . . 0.0 109.215 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -81.02 132.26 35.36 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.93 156.17 39.12 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 126.098 1.759 . . . . 0.0 106.95 176.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 mp -120.76 105.63 10.93 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.15 1.38 . . . . 0.0 107.839 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -82.03 125.35 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -107.12 151.77 24.94 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.355 1.062 . . . . 0.0 109.29 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 45.84 66.84 0.85 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.619 2.368 . . . . 0.0 109.875 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CD2' HD11 ' A' ' 129' ' ' LEU . 55.6 t80 -88.02 130.99 34.81 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 -178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -129.6 88.53 2.69 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.253 1.021 . . . . 0.0 109.254 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.73 -9.33 1.69 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -57.8 -43.5 85.72 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -132.94 -19.17 2.29 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -64.14 145.72 55.47 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 119.925 1.239 . . . . 0.0 108.83 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -127.04 158.43 36.99 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 142' ' ' VAL . 0.3 OUTLIER -137.34 121.99 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.47 0.708 . . . . 0.0 111.205 -178.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -101.41 102.0 12.73 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.158 1.383 . . . . 0.0 107.786 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.98 17.88 4.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.791 1.237 . . . . 0.0 113.259 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 t -50.49 -31.52 15.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 115.802 1.779 . . . . 0.0 115.802 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -73.89 -33.48 64.04 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.056 0.843 . . . . 0.0 113.177 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.26 96.65 4.78 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.801 2.041 . . . . 0.0 106.944 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.97 114.1 1.18 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -99.71 168.87 9.65 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 125.746 1.618 . . . . 0.0 108.246 178.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.1 t -88.95 -13.99 37.7 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.495 -0.753 . . . . 0.0 111.762 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.64 140.43 23.42 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 106.663 -2.575 . . . . 0.0 106.663 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.1 pp -124.73 176.87 6.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.801 2.04 . . . . 0.0 111.479 -178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 167.45 -93.64 0.11 Allowed Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -138.61 -4.15 1.63 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.324 1.602 . . . . 0.0 115.324 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.35 42.16 75.51 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -137.93 -57.73 0.67 Allowed 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 123.014 1.388 . . . . 0.0 114.073 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -91.79 30.64 6.41 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 127.053 2.263 . . . . 0.0 114.268 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.52 52.85 3.24 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.248 -2.341 . . . . 0.0 107.248 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 p -142.32 -168.64 2.77 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.461 1.504 . . . . 0.0 112.035 -178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -147.87 130.53 15.96 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 108.933 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 tt -145.68 154.98 42.69 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.195 1.798 . . . . 0.0 109.568 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . 2.3 pp -123.29 150.45 43.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.571 1.549 . . . . 0.0 109.338 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -139.43 170.2 16.35 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.449 2.3 . . . . 0.0 109.316 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 33.8 p -125.37 148.31 48.82 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -63.67 179.24 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.986 1.714 . . . . 0.0 110.837 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.97 63.0 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -95.26 -11.51 27.83 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.087 0.955 . . . . 0.0 112.484 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 71.26 29.86 67.95 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.199 -0.938 . . . . 0.0 112.082 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.9 p -105.18 -18.64 14.07 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.497 2.319 . . . . 0.0 111.85 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 52.9 mtt85 -128.52 128.67 44.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.812 2.045 . . . . 0.0 108.488 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 54.2 m -107.2 117.95 35.43 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 109.495 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -104.43 151.18 23.82 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' LEU . 0.3 OUTLIER -147.38 118.03 7.53 Favored 'General case' 0 CA--C 1.512 -0.519 0 O-C-N 120.817 -1.177 . . . . 0.0 109.731 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 121.76 41.54 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.7 t -102.94 128.41 49.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 103.731 -2.692 . . . . 0.0 103.731 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . 0.274 1.9 m-85 34.33 17.1 0.0 OUTLIER 'General case' 0 N--CA 1.42 -1.942 1 C-N-CA 132.608 4.363 . . . . 0.0 120.696 177.97 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -35.49 98.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 131.258 3.823 . . . . 0.0 110.224 178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 139.76 60.25 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.324 1 C-N-CA 134.232 5.013 . . . . 0.0 106.031 -179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.62 ' HB3' ' H ' ' A' ' 123' ' ' ARG . 30.5 t70 -65.83 160.43 23.19 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.785 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -46.87 -30.42 2.5 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.235 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -106.07 9.71 32.33 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.829 2.452 . . . . 0.0 112.925 178.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.48 15.08 81.42 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 127.666 2.555 . . . . 0.0 118.846 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.62 ' H ' ' HB3' ' A' ' 119' ' ' ASP . 17.3 ptt180 -149.64 116.74 6.0 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.534 1.934 . . . . 0.0 111.462 -179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -110.17 168.24 9.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 128.6 2.76 . . . . 0.0 108.575 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.53 ' HA ' ' HA ' ' A' ' 61' ' ' TYR . 16.9 t80 -77.71 143.27 38.2 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.192 1.472 . . . . 0.0 114.269 -176.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.64 147.44 46.87 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 128.009 2.524 . . . . 0.0 107.176 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.3 t -141.57 153.85 19.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 127.808 2.443 . . . . 0.0 107.927 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -120.11 129.69 54.29 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.514 HD11 ' CD2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -110.99 129.64 55.83 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -89.6 107.75 19.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 101.325 -3.583 . . . . 0.0 101.325 177.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -73.83 132.32 15.44 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-O 119.085 -0.842 . . . . 0.0 111.714 -177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -131.56 -67.84 0.67 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 117.904 -1.046 . . . . 0.0 111.396 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -87.56 -88.3 0.14 Allowed 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.32 145.6 50.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.645 1.578 . . . . 0.0 109.086 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -114.52 15.74 19.71 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.518 1.532 . . . . 0.0 109.598 178.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.63 105.05 5.54 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.438 1.495 . . . . 0.0 109.668 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -101.11 134.78 43.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.961 1.304 . . . . 0.0 107.661 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.6 m -162.78 -177.96 5.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 130.063 3.345 . . . . 0.0 103.831 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.83 -8.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.783 2.033 . . . . 0.0 115.467 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.4 -58.81 2.67 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -61.02 1.99 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 123.583 1.659 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.52 ' HA ' HG22 ' A' ' 82' ' ' ILE . 13.1 t -72.31 148.79 9.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.1 p -61.02 151.59 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -59.03 -26.58 64.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.595 -0.691 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 59.17 79.22 0.23 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 127.551 2.341 . . . . 0.0 107.989 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.34 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.976 1.71 . . . . 0.0 109.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 31.8 p -124.75 -35.58 2.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.987 1.715 . . . . 0.0 108.485 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 147.36 129.73 1.97 Allowed Glycine 0 C--N 1.338 0.686 0 CA-C-N 118.675 0.67 . . . . 0.0 112.32 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.9 t -175.44 175.95 2.06 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 128.009 2.524 . . . . 0.0 106.23 178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 22.4 p -73.79 174.24 8.73 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 119.253 0.933 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.3 m -65.16 158.05 27.05 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.152 1.381 . . . . 0.0 109.106 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -66.88 159.66 27.82 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.642 -0.661 . . . . 0.0 109.978 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.6 tt -88.17 64.83 7.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -75.87 -172.33 1.91 Allowed 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.878 1.271 . . . . 0.0 109.203 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.09 164.08 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.804 1.287 . . . . 0.0 111.82 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 4.1 tt -77.36 98.27 5.18 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.4 -179.09 19.76 Favored Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -82.34 51.99 1.94 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.198 0.999 . . . . 0.0 109.07 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 68.3 m -165.78 157.7 14.48 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 127.044 2.137 . . . . 0.0 108.759 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 111.7 -164.49 12.11 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.111 0.862 . . . . 0.0 110.967 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.1 p -123.91 13.65 9.18 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.899 1.28 . . . . 0.0 111.216 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -137.09 168.49 19.5 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.343 2.257 . . . . 0.0 107.682 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -152.4 174.12 14.24 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.904 1.282 . . . . 0.0 108.173 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -171.26 176.35 44.58 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -154.48 171.64 19.06 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.098 1.759 . . . . 0.0 107.763 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 12.0 tt -155.93 -177.67 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.486 1.914 . . . . 0.0 106.657 179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.246 0.875 0 N-CA-C 103.472 -2.788 . . . . 0.0 103.472 179.18 . . . . . . . . 0 0 . 1 stop_ save_